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GENERAL INTRODUCTION 
1. AIM OF THE STUDY 
All living organisms are continuously exposed to pathogenic 
agents from the surrounding milieu, e.g. viruses, bacteria, 
fungi and parasites. Skin and mucous membranes form efficient 
barriers to these agents, but sometimes this defense is over-
come. If an infectious agent succeeds in penetrating into the 
"milieu int€rieur", at first granulocytes and mononuclear 
phagocytes become involved in the elimination of the intruding 
microorganisms. This part of the defense system is largely 
aspecific. Apart from this, vertebrates have a well developed 
immune system which can mount specific immune responses to in-
vading organisms and foreign substances. The specificity of 
the immune reaction is based on the presence of receptors on 
the individual lymphocytes which recognize specifically any 
one of many foreign substances. Only after the recognition of 
the immunogenic material is a lymphocyte activated to perform 
its function. Immunogenic substances or antigens are operation-
ally defined by their capacity to induce an immune response. 
The recognition of a particular antigen by the receptors of an 
individual lymphocyte is predetermined, i.e. the diversity of 
lymphocytes, each specific for one of the numerous imaginable 
foreign substances is generated before encounter with immuno-
genic material. In addition to the specificity of lymphocytes 
for a particular antigen, lymphocytes must also discriminate 
between self and non-self. If they should fail to do so, an 
immune response to tissues of the individual's own body would 
arise, leading to autoimmune disease (Burnet, 1972). 
Immunity can be mediated in two ways: humoral immunity and 
cellular or cell-mediated immunity. Humoral immunity is mediated 
by humoral products of plasmacells, i.e. antibodies, which are 
present in large amounts in the blood and can act at a long 
distance from the place of origin. Humoral immunity can be 
transferred to other individuals by means of serum. Cellular 
immunity is mediated by lymphocytes, or by factors secreted by 
them, which act at a short distance. This latter type of 
immunity can only be transferred to other individuals by means 
of cells (Mackaness and Blanden, 1967). Examples of cell-
mediated immunity are resistance to several bacteria and viruses, 
graft rejection, and delayed type hypersensitivity (DTH). DTH 
has found a general application in the diagnosis of infection 
with tubercle bacilli. Thus, people who have been infected with 
tubercle bacilli show a positive Mantoux reaction upon injection 
into the skin of antigens, derived from tubercle bacilli ·(O'Grady, 
1967) 0 
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stimulation of the immune system by an antigen not only leads 
to an active immune response to the antigen, but also to the 
development of immunological memory specific for this antigen. 
A state of memory causes a more vigorous and faster humoral or 
cellular immune response upon the second contact with the anti-
gen. The effectiveness of vaccination against certain infectious 
diseases reflects the capacity for memory formation by the 
immune system. Immunological memory is carried by lymphocytes 
with a lifespan of many months (Miller and Mitchell, 1969}. 
The lymphocytes whose progeny produces antibodies are called B 
lymphocytes. The lymphocytes, which are capable of mediating 
cellular immunity are called T lymphocytes. B lymphocytes are 
not essential for cell-mediated immune responses (Allison, 1972). 
Both B and T lymphocytes must be considered as heterogeneous 
populations of cells, which can be subdivided into many sub-
populations, according to their function, differentiation stage, 
lifespan, etc. 
The experiments described in this thesis were intended to cha-
racterize the T lymphocytes involved in delayed type hypersen-
sitivity, and to investigate some aspects of their differen-
tiation pathway. The genetic requirements for induction and 
expression of DTH to a particular group of tissue antigens was 
also analysed. In this study, the mouse was chosen as the expe-
rimental animal since (1) this species has a number of techni-
cal advantag~s, which makes the mouse a protagonist in the 
study of immunology, (2} large numbers of genetically well 
defined inbred mouse strains are available and (3} DTH reacti-
vity can easily be induced and measured in mice (Crowle, 1975). 
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2. STRUCTURE OF THE IMMUNE SYSTEM OF THE MOUSE 
2.1. Central and peripheral lymphoid organs 
In the central lymphoid organs the antigen-independent differ-
entiation of haemopoietic stem cell derived precursor cells 
into immunocompetent lymphocytes occurs. Thus, the bone marrow 
is the major production site for immunocompetent, "virgin" B 
lymphocytes (Phillips et al., 1977) During the differentiation 
in the bone marrow B lymphocytes acquire immunoglobulins on 
.their surface membrane (Osmond, 1975). These immunoglobulins 
serve as the antigen-specific receptor of the B lymphocytes. In 
the thymus, committed precursor cells mature and differentiate 
into immunocompetent T lymphocytes (Roelants et al., 1976; 
Cantor and Weissman, 1976). For the maturation and differentiat-
ion of the precursor cells into T lymphocytes the close prox-
imity of thymic epithelial cells and the influence of thymic 
hormone are essential (Stutman, 1975; Kruisbeek, 1978). The T 
lymphocytes do not acquire surface immunoglobulins during their 
differentiation in the thymus, but some surface antigens (e.g. 
Thy-1, Lyt, and H-2) become fully expressed, and others (TL) may 
arise and disappear during further differentiation. Moreover, T 
cells acquire an antigen-specific receptor in the thymus. The 
nature of this receptor is not yet fully understood (see chapter 6). 
The generation of immunocompetent lymphocytes in the central 
lymphoid organs is reflected by the relatively high proliferat-
ive activity in these organs, compared to the other, peripheral, 
lymphoid organs (Osmond and Nossal, 1974; Bryant, 1974). Upon 
maturation the "virgin" T and B lymphocytes leave the thymus and 
bone marrow, respectively, and migrate to the peripheral lym-
phoid organs, where a further, antigen-driven, differentiation 
may take place. The most important peripheral lymphoid organs 
are the lymph nodes, spleen, and the gut associated lymphoid 
tissues. Part of the lymphocytes can migrate from blood into 
peripheral lymphoid tissues, and re-enter the blood again via 
the thoracic duct lymph. This migration pattern is named re-
circulation, and results in a continuously changing distribution 
of the lymphocytes over the different lymphoid organs (Gowans 
and Knight, 1964; Goldschneider and McGregor, 1968). 
The induction of a cellular or humoral immune response generally 
occurs in the peripheral lymphatic tissues. After antigenic 
stimulation B lymphocytes proliferate and transform into plasma-
cells, which remain localized in the peripheral lymphatic tissues. 
Similarly, T helper cells are also retained in the lymphatic 
tissue during their helper activity. On the other hand, T cells 
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mediating an effector function in cellular immune responses emi-
grate from the peripheral lymphoid organ after the induction 
phase and may perform their function anywhere in the body. The 
involvement of peripherally localized effector T cells manifests 
itself in the DTH reaction and graft rejection. 
The distinction between central and peripheral lymphoid organs 
is an oversjmplification, since exceptions to this compartment-
alization of antigen-independent and antigen-driven differen-
tiation exist: 
1. The presence of the bone marrow is not obligatory for the 
production of immunocompetent B lymphocytes, since in the 
absence of functional bone marrow their generation can also 
occur in the spleen (Kincade et al., 1978i Razing et al., 
1978). 
2. Immunocompetent lymphocytes can migrate back into the cen-
tral lymphoid organs, where large numbers of effector cells 
for humoral and cellular immune responses can reside 
(Youdim et al., 1973; Benner and Haaijman, 1979). 
2.2. Thymus-derived lymphocytes 
Cells, belonging to the T cell lineage carry the Thy-1 surface 
antigen (Raff and Wortis, 1970). This antigen is not expressed 
on other blood cells, except on the so-called natural killer 
cells. This latter cell type is a lymphoid cell and might also 
belong to the T cell lineage (Herberman et al., 1978), but does 
not require differentiation in the thymus. The stem cell-derived 
precursor cells, committed for T cell differentiation, also carry 
Thy-1 antigen, though in small quantity (Roelants et al., 1975). 
Morphologically, T lymphocytes form a heterogeneous population, 
consisting of small, medium and large sized cells. The lifespan 
ofT lymphocytes varies considerably. A large proportion of the 
recirculating small lymphocytes has a lifespan of several months 
(Sprent and Basten, 1973). 
In the spleen and lymph nodes the T lymphocytes are largely found 
in the periarteriolar lymphoid sheath and paracortical areas, 
respectively (Waksman et al., 1962; Parrott et al., 1966). They 
are generally situated between the cytoplasmic extensions of the 
interdigitating cells, which constitute their microenvironment 
(Veldman, 1970; Van Ewijk et al., 1974; Veerman and Van Ewijk, 
1975; Van Ewijk, 1977). 
T lymphocytes are essential in cell-mediated immunity. As so 
called T helper cells they may cooperate with B cells in the 
humoral immune response. T lymphocytes perform their immunologi-
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cal effector functions either by the release of humoral factors 
which act at a short distance (e.g. in T helper function and in 
T cell-mediated activation of macrophages in DTH) or by direct 
cell-cell contact. CytotoXic T cells use this latter mechanism 
in the killing of target cells (e.g. in graft rejection). T helper 
function and cytotoxic T cell function are mediated by two 
separate subsets of T lymphocytes which can be distinguished 
from each other by the presence of ce:ttain surface antigens, 
belonging to the Lyt-system (Cantor and Boyse, 1975a; b). T cells 
of one subset cannot differentiate into cells of the other subset 
(Huber et al., 1976a). 
2.3. Bone marrow-derived lymphocytes 
Like T lymphocytes, bone marrow-derived lymphocytes (B cells) 
are a heterogeneous population of cells, consisting of small, 
medium-sized and large cells. In the peripheral lymphatic tissues 
B cells are largely found in the follicles, where they lie in 
close contact with the follicular dendritic cells. These follic-
ular dendritic cells may retain immune complexes on their surface 
(Nossal et al., 1968) and are probably involved in antigen-depen-
dent B cell differentiation (Chen et al., 1978). 
Immunocompetent B cells are characterized by the presence of 
immunoglobulins on their cell surface. After appropriate anti-
genic stimulation B cells can differentiate into plasma cells. 
These cells perform the effector function of the B cell lineage 
by production and secretion of antibodies. Antibodies act syste-
mically and can persist for several days. T lymphocytes are able 
to enhance as well as to suppress the response of the B lympho-
cytes to most antigens. 
The population of B lymphocytes consists of both short-lived and 
long-lived cells (Elson et al., 1976). A considerable part of 
the long-lived B cells recirculate, and carry immunological 
memory (Strober, 1975; Fidler et al., 1977). 
2.4. Mononuclear phagocytes 
Mononuclear phagocytes are derived from blood borne monocytes 
(Van Furth and Cohn, 1968; Crofton et al., 1978). Macrophages 
constitute the basic elements of the mononuclear phagocyte sys-
tem (MPS). Mononuclear phagocytes can occur free or tissue bound. 
Kupffer cells of the liver, macrophages in the lung, and pre-
sumably the interdigitating cells in the lymphoid organs belong 
to this MPS (Veerman and Van Ewijk, 1975). Macrophages are essen-
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tial for the induction of humoral as well as cellular immune res-
ponses, since they are involved in the antigen-processing and the 
presentation of antigens in an immunogenic form as suggested by 
in-vitro and in-vivo experiments (Mosier and Coppleson, 1968; 
Unanue, 1972; Van Ewijk et al., 1977). 
Substances having the capacity to enhance non-specifically the 
immune response to a simultaneously injected antigen are called 
adjuvants. The adjuvant used mostly in animal studies is Freund's 
complete adjuvant (FCA), which is composed of water in oil emul-
sion, containing tubercle bacilli. The mineral oil has a depot 
function, while a glycopeptide constituent of the cell wall of 
mycobacteria (muramyldipeptide) carries the adjuvant property 
(Merser et al., 1975; Hiu, 1977). Adjuvants initiate a long-last-
ing accumulation of lymphocytes within the draining lymph nodes. 
Macrophage function seems to be linked to the adjuvant-induced 
changes in lymphocyte migration (Frost and Lance, 1978). They 
become activated by the adjuvant and process the antigen in such 
a way that the presented antigen provides a good immunogenic 
stimulus for the T cell system in particular. 
In cell-mediated immunity macrophages often perform an aspecific 
effector function. Humoral substances produced by antigen-specific 
T lymphocytes can "switch on 11 macrophages to phagocytize and 
eliminate the antigen more vigorously (Waksman, 1979). Activated 
T lymphocytes can also secrete antigen-specific cytophilic factors, 
which adhere to macrophages, and 11 arm" them for specific killing 
of target cells. This factor was called specific macrophage arming 
factor (Evans and Alexander, 1970). Cytophilic antibodies can 
adhere to the macrophage surface as well, and thus enhance phago-
cytosis of the specific antigen (Boyden, !963). 
In conclusion it is apparent that at all stages of the immune 
response cells of the MPS play an important role. 
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3. HISTOCOMPATIBILITY ANTIGENS 
3.1. General outline 
Depending on the way antigens are presented to the immune system, 
two types can be distinguished, viz: 
1. Conventional antigens 
2. Tissue antigens 
Most conventional antigens require processing and presentation by 
macrophages in order to become immunogenic for both B and T lym-
phocytes (Unanue, 1972). Conventional antigens are either part-
iculate (e.g. bacteria, sheep red blood cells) or soluble {e.g. 
proteins, polysaccharides, hapten-carrier complexes). An optimal 
humoral response to part of these antigens requires the coopera-
tion of T and B cells. These antigens are called thymus-dependent 
antigens. A number of conventional antigens exists, which do not 
require macrophage processing, but are potent activators of B cells 
without T cell help (Feldman, 1972a; b). The latter antigens (e.g. 
polyvinylpyrrolidone) are called thymus-independent antigens. 
Tissue antigens often do not require presentation or processing 
by macrophages. Their ·immunogenicity is mainly due to their pre-
sence on the surface of viable tissue cells (S¢renson, 1972). 
The tissue antigens which account for the phenomenon of graft 
rejection, the so-called histocompatibility (H)antigens, can 
be subdivided into two main groups, according to the strength 
with which they lead to graft rejection (Counce et al., 1956): 
1. major histocompatibility antigens, which cause a rapid, acute 
graft rejection. 
2. minor histocompatibility antigens, which account for compara-
tively slow and more chronic graft rejections. 
In the mouse the major H-antigens are coded for by a cluster of 
genes, lying on chromosome 17. This cluster of genes became 
known as the major histocompatibility complex (MHC) or in the 
mouse, the H-2 complex. In other vertebrates (e.g. frog, dog, 
rat, cattle, human) the presence of a MHC has also been demon-
strated. It is obvious that study of the MHC in man (the HLA 
complex) is of the utmost importance in improving the clinical 
results of transplantations. On the other hand, the minor H-
antigens which are coded for by genes spread all over the genome 
also influence the success of organ transplantations. 
Another group of "tissuen antigens are the surface antigens, 
which appear, for example, due to viral infection or when spon-
taneous tumours arise .. Virally induced surface antigens and 
tumour associated antigens may be considered as antigens which 
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cause a modification of the antigenic structure of the cell 
(Zinkernagel and Doherty, 1977). Antigens of this kind can also 
be produced artificially by chemical treatment of lymphoid cells 
with trinitrophenol (TNP). TNP-altered cells provide a model to 
study the immune response to this type of antigens. Both minor 
H-antigens and the type of tissue antigens described in this 
paragraph are usually associated with MHC-coded antigens and are 
sometimes referred to as modified syngeneic tissue antigens 
(Paul and Benacerraf, 1977). 
3.2. The H-2 complex 
3. 2.A. Genetics 
In 1946 Snell developed a breeding scheme to produce strains of 
inbred mice which differed from each other by a single H-antigen, 
or a cluster of H-antigens. As the criterion for H-antigen diffe-
rence between two strains he used the survival time of skin grafts 
exchanged between the two mouse strains (Snell, 1948). Mouse 
strains differing from each other in a single gene coding for an 
H-antigen, are termed congenic mouse strains. Nowadays a large 
number of congenic mouse lines have been established, defining 
H-2 as well as non H-2 genes (Klein, 1975). 
In heterozygous mice genetic recombination during meiosis can 
occur. After backcross of such a heterozygous mouse to a paren-
tal strain, recombinant mice may arise. These recombinants have 
a chromosome which is constituted of genetic material derived 
partly from the one and partly from the other original parental 
strain. Serological analysis of the H-2 complex coded antigens, 
originally started by Gorer (1947), made it possible to discover 
intra H-2 complex recombinants. The availability of inbred con-
genic recombinant mice and the possibility of serological analysis 
of H-2 complex coded antigens finally led to the complicated 
model of the mouse MHC, as shown in Fig. 1. 
3.2.B. The map of the H-2 complex 
The H-2 complex of the mouse is situated on chromosome number 17 
and can be divided into five regions, the K, I, S, G and D region. 
The I-region consists of at least 5 subregions I-A, I-B, I-J, I-E 
and I-C. Each region or subregion contains minimally one marker 
gene locus, or cluster of loci (Fig. 1). Recently, at the D-end, 
a new H-2 locus, the H-2L locus, has been reported, and at least 
ten loci are now known in the H-2 complex (Klein, 1978). 
The H-2K and H-2D loci code for complex surface antigens. It is 
possible to raise antibodies against parts of these large mole-
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Fig. 1 
The genetic map of the H-2 complex and the T-region. The loci in the T-region are tenta-
tively ordered> since their relative positions have not yet been established. 
cular structures (molecular weight of approximately 50,000 dal-
tons) . Therefore these antigens are also referred to as serol-
ogically-defined (SD) antigens. Against some antigenic determ-
inants of the large molecules constituting the SD antigens anti-
sera can be raised which "cross-react" with SD antigens of one 
or more unrelated mouse strains. These antigens were therefore 
called public antigens. Other antisera were found which only 
reacted to antigenic determinants, which were specific for a 
mouse strain with a particular allele, and no cross-reactivity 
was found with unrelated strains. These antigens are named pri-
vate antigens, and they can distinguish the different unrelated 
H-2 alleles of the K or D locus. 
The surface antigens coded for by the I-region were initially 
not detectable serologically. The existence of this MHC-region 
was demonstrated in experiments on the responsiveness of differ-
ent mouse strains to one and the same antigen. It was found that 
the strength of the immune response to such an antigen was regu-
lated by genes situated between the K and D region (McDevitt et 
al., 1972). These genes were termed immune regulatory genes (Ir 
genes). At the same time it became apparent that some genes in 
the I-region code for cell surface antigens, which in vitro can 
induce proliferation of allogeneic T lymphocytes (Bach et al., 
1972). Following this observation, these I-region coded antigens 
were also known as lymphocyte defined (LD) antigens, or lympho-
cyte activating determinants (LAD). Recently, it became possible 
to detect I-region coded antigens serologically, and the serolo-
gically detected surface antigens are now known as immune res-
ponse antigens or Ia antigens (Shreffler et al., 1974). It is 
not clear as yet whether the Ir genes, the genes coding for LAD 
and those coding for Ia antigens are identical. 
The S-region contains two marker loci, the serum substance (Ss) 
gene and the sex-limited protein (Slp) gene. Both genes control 
the levels of some serum substances (a.o. the fourth component 
of complement), and they divide the H-2 complex into a K-end 
and a D-end. Furthermore, the G-region contains the H-2G locus, 
which controls surface determinants on red blood cells. 
Distal to the H-2 complex the T-region is situated. The T-region 
was originally defined by the Tla locus, which codes for the TL 
surface antigen, present on thymic leukemia cells and on thymo-
cytes of some mouse strains. TL antigens are serologically 
defined. Recently it was found that antisera against antigens 
coded for by the Tla locus were specific for certain peripheral 
lymphocytes. Since TL antigens only occur on thymocytes, it was 
concluded that this antiserum defined a distinct antigenic systemj 
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and this group of antigens was termed Qa. Now, a total of three 
Qa loci have been defined serologically (Flaherty et al., 1978). 
The T region also codes for a number of histocompatibility anti-
gens, which can be involved in graft rejection (e.g. H-2T, 
Fig. 1). 
According to convention, alleles of a single locus of the MHC are 
designated by small superscript letters, indicating their genetic 
origin (e.g. H-2Kk, H-2Db). The combinations of allelic forms of 
the loci within the H-2 complex are called haplotypes and they 
are also designated by small letter superscripts (e.g. H-2b, H-2d). 
The H-2 loci occur in many variant alleles, and the total number 
of identified H-2 haplotypes now known is 109, including those 
from wild mice (Klein et al., 1978). This large number indicates 
the polymorphic nature of the H-2 complex. In Table 1 the H-2 
haplotypes and the alleles of the different loci have been pre-
sented for a number of frequently used congenic mice. 
TABLE 1 
H-2 HAPLOTYPE AND MAJOR HISTOCOMPATIBILITY COMPLEX ALLELES OF 
FREQUENTLY USED CONGENIC MOUSE STRAINS 
H-2 MHC region or subregion 
Strain haplotype K I-A I-B I-J I-E I-C s D 
BlO.ScSn; BALB.B b b b b b b b b b 
BALB/c; DBA/2; Bl0.D2 d d d d d d d d d 
AKR; C3Hf; BlO.Br k k k k k k k k k 
A; BlO.A a k k k k k d d d 
SWISS; A.SW s s s s s s s s s 
BlO.AQR yl q k k k k d d d 
B10.T(6R) y2 q q q q q q q d 
A.TL tl s k k k k k k d 
A.TH t2 s s s s s s s d 
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3.2.C. Lymphocyte-defined antigens versus serologically-defined 
antigens of the H-2 complex 
The fundamental distinction made between the K- and D-region code( 
antigens on the one hand, and the I-region coded antigens on the 
other hand, was initially based on the possibility of serological 
detection only of the SD antigens and the ability to induce T 
cell proliferation exclusively by the LD antigens. This view 
was strengthened by the observation that cytotoxic T cells were 
directed only against SD antigens on the surface of target cells, 
but not to I-region coded antigens (Alter et al., 1973). Later 
it became apparent that this distinction between LD and SD anti-
gens was somewhat artificial, since K-region coded antigens could 
also stimulate T cell proliferation (Klein, 1978): thus a locus 
of the K--region presumably codes for a LAD. Furthermore, it was 
found that both the I-A and the I-C subregion contained a locus 
coding for a histocompatibility antigen, accounting for skin 
graft rejection (Klein et al., 1976). These loci were termed H-2A 
and H-2C locus, respectively. The antigens they code for can also 
serve as a target for cytotoxic T cells (Klein, 1978). Again, it 
is not known whether the H-2A and H-2C locus are identical to the 
Ia-1 and Ia-3 locus, respectively. 
TABLE 2 
THE DISTRIBUTION OF Ia ANTIGENS 
Cell types I-A I-B I-J I-E I-C 
B lymphocytes + + 
T lymphocytes + + + + 
Macrophages + + + 
Epidermal cells + + + 
(Langer hans cells) 
Serum + + 
The presence of SD antigens on cells is ubiquitous, but Ia anti-
gens can only be found on a limited number of cell types, most 
notably on B lymphocytes, spermatocytes, some subpopulations of 
T lymphocytes and macrophages,and on epithelial cells (Hammer-
ling, 1975). The Ia loci may provide surface markers for parti-
cular subpopulations of T lymphocytes, since some of them are 
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selectively expressed in functionally distinct lymphocyte popu-
lations (Murphy, 1978). For example, the Ia-4 determinant coded 
for by the Ia-4 locus in the I-J subregion was only found on 
suppressor T lymphocytes (Okumara et al., 1977; Murphy, 1978). 
The cellular distribution of Ia antigens, coded for by the diffe-
rent I subregions has been given in Table 2. 
3.3. Minor histocompatibility antigens in the mouse 
The histocompatibility antigens which are coded for by genes out-
side the H-2 complex are termed minor H-antigens. In the mouse 
these antigens are known as non H-2 alloantigens. Presumably, 
the antigens coded for by genes of the T-region do not belong to 
this group of non H-2 alloantigens (Klein, 1978). In the mouse 
about 40 of these minor H-antigens have been defined with congenic 
mouse strains (Klein, 1975). The genes coding for non H-2 allo-
antigens are spread over the entire genome. Some of the non H-2 
alloantigens act more strongly than others in graft rejection, and 
for most of them only a few allelic forms have been described. 
Probably, the genes coding for non H-2 alloantigens are by no 
means as polymorphic as the genes of the H-2 complex. It has been 
suggested that their function is non-immunological in nature, 
and they would serve normal 1 household functions in the cell, 
which require their expression on the cell membrane (Ohno, 1977; 
Klein 1 1978). It was suggested that many more surface antigens 
may exist in mice than the 40 presently known minor H-antigens 
(Klein, 1975). The absence of allelic forms of the other surface 
antigens in the inbred laboratory mouse strains would prevent 
their immunological detection. For one minor H-antigen, the male 
specific H-Y antigen, coded for by a gene on the Y-chromosome, 
no allelic phenotypes have been described yet. The H-Y antigen 
can cause the rejection of male-derived skin by syngeneic female 
mice. It appears that only mouse strains of a particular H-2 
haplotype can give a good cellular immune response to H-Y anti-
gen (Gasser and Silvers, 1972). This aspect of immune respons-
iveness to particular antigens will be discussed later (Chapter 6). 
Exceptional minor H-antigens are the surface antigens, coded for 
by the Mls locus. This locus is situated on chromosome number 1. 
Mls locus coded products are mainly expressed on B lymphocytes 
of adult mice, on macrophages and tooth germ, but not on T lymph-
ocytes (Festenstein, 1976). In contrast to other minor H-anti-
gens (Bevan, 1975; Gordon et al., 1975), products coded for by 
the Mls locus can induce strong proliferation of unprimed H-2 
compatible T lymphocytes (Festenstein, 1973). Their relevance 
for skin graft rejection is dubious, and cytotoxic T cells 
directed to Mls locus coded products cannot be induced (Festen-
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stein, 1976). However, both tooth germ transplant survival and 
graft-versus-host reactivity was influenced by Mls locus incom-
patibility (Huber et al., 1973; Bartova and Ivanyi, 1975), and 
therefore the Mls locus products can be considered as histocompa-
tibility antigens. 
Five alleles have been described for the Mls locus, based on sti-
mulatory capacity in different strain combinations (Table 3), 
though it has not yet been formally established that these various 
stimulatory tissue antigens are all coded for by the Mls locus on 
chromosome number 1. The Mls-allelic phenotypes vary considerably 
in their capacity to stimulate T cell proliferation. In man no 
analogue for the Mls locus has been found as yet. 
TABLE 3 
STRAIN DISTRIBUTION OF Mls-ALLELES 
Stimulatory 
Allelic form capacity Mouse strain 
Mls a +++ DBA/2; DBA/!; AKR; NZB 
Mls b CBA/H; CBA/H T6T6; C57BL/6; 
C57BL10 and all congenic 
strains on BlO background 
Mls c C3H/He; ++ C3Hf; A; SJL 
Mls d CBA/J ++ 
Mls e +++ C3H/Tif 
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4. T LYMPHOCYTE DIFFERENTIATION 
4.1. Generation ofT cells in the thymus 
Prethymic precursor cells in the bone marrow, derived from pluri-
potent haemopoietic stem cells and committed to T cell different-
iation, arise in the bone marrow and are able to migrate to the 
thymus (Kadish and Basch, 1976; Abramson et al., 1977). According 
to Stutman and Good (1969) the migration into and the different-
iation of precursor cells in the thymus are very sensitive to 
histocompatibility differences between the precursor cells and 
the thymus. In the thymus the committed precursor cells require 
contact with the thymic stromal cells for their further differ-
entiation. During this differentiation and maturation the pre-
cursor cells acquire some new surface antigens (e.g. Lyt-antigens) , 
and other surface antigens come to full expression (e.g. Thy-1 
antigen). Recent studies have suggested that during maturation 
the thymic epithelial cells are important in determining which H-2 
specificities the maturing T cells will be able to recognize as 
self in the periphery (Zinkernagel et al., 1978a). 
According to their localization in the thymus thymocytes can be 
distinguished as cortical and medullary cells. The cortical thym-
ocytes express a high density of Thy-1 antigen on their surface 
(high Thy-1) and are immature, immunoincompetent cells. In con-
trast the medullary thymocytes carry a low density of Thy-1 on 
their surface (low Thy-1) and they constitute the more mature 
immunocompetent pool of thymocytes. After treatment of mice 
with cortisone, the cortical thymocytes disappear. The medullary 
thymocytes are resistant to this treatment. Two main models of 
T cell development in the thymus have been proposed (reviewed 
by Shortman et al., 1975). In the first model, the cortical thym-
ocytes would proliferate and mature, gradually losing part of 
the Thy-1 antigens. Large numbers of the cortical thymocytes die 
in situ (Joel et al., 1977), but the remaining cells would mi-
grate to the medulla. At this site as low Thy-1 cells they would 
further mature and subsequently emigrate to the peripheral lym-
phoid tissues. The second model presumes two separate lines of 
T cell differentiation, a cortical and a medullary~ The cortical 
lineage would be eliminated largely as a consequence of the 
anti-self reactivity of these cells (Von Boehmer and Byrd, 1972; 
Gorczynski and MacRae, 1979). The medullary lineage would be 
derived from low Thy-1 medullary precursor cells and after a few 
divisions these cells would give rise to the immunocompetent 
medullary thymocytes. Finally, the latter cells would migrate to 
the peripheral lymphoid organs. 
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The Lyt-surface antigens constitute a system of surface markers 
which are selectively expressed on functionally distinct T cell 
populations (see section 4.3.). The Lyt-system consists of three 
antigens, Lyt-1, Lyt-2 and Lyt-3, which are expressed on T cells 
only. More than 90% of the thymocytes bear Lyt-1 as well as 
Lyt-2 and Lyt-3 antigens (i.e. Lyt-123+). The peripheral T lymph-
ocyte population consists of only approximately 50% Lyt-123+ cello 
the other cells are either Lyt-1+, or Lyt-23+ (Cantor and Boyse, 
1975a, b). The Lyt-1+ cells cannot differentiate into Lyt-23+ 
cells (Huber et al., 1976a), but in peripheral lymphoid organs 
Lyt-123+ cells may give rise to Lyt-1+ and Lyt-23+ cells (Cantor 
and Boyse, 1976; Stutman, 1978). On the basis of these findings 
it was postulated that all thymocytes are originally Lyt-123+, 
and that the functionally distinct immunocompetent T cell subsets 
would derive from them in an antigen-independent step, after they 
have left the thymus (Fig. 2A; Huber et al., 1976a; Cantor and 
Boyse, 1977). 
A 8 
Thymus Thymus 
~ 
Lyt 123+ Lyt123+ 
1\ j j 
Lyt 23 + Lyt23+ Lyt1+ 
Fig. 2 
The development of the functional T cell subsets. 
(A) Intrathymic differentiation of a single T cell lineage. 
(B) Intrathymic differentiation of two separate T cell lineages. 
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Recently it was found, however, that the cortisone-resistant 
T cell pool in the thymus contains a significant proportion of 
Lyt-1+ cells, in frequency comparable to that in the peripheral 
T cell pool (Mathieson et al., 1979). Moreover, it was shown 
that intrathymically labelled thymocytes, recovered in the spleen 
3 hours after the labelling, were partly Lyt-1+ cells, and partly 
were Lyt-123+ cells (Scollay et al., 1978). The latter finding 
indicates that Lyt-1+ cells arise intrathymically before migration 
to the periphery. Altogether these observations suggest, but do 
not prove, that there exist two separate lines of intrathymic 
differentiation, one line leading to the Lyt-1+ cells and the 
other to the Lyt-123+ cells (Mathieson et al., 1979). The latter 
cells might further differentiate into the Lyt-23+ cells, after 
their migration to the periphery (Cantor and Boyse, 1976; Scollay 
et al., 1978). Fig. 2B shows this differentiation pathway. 
4.2. Post-thymic T cell differentiation 
Peripheral T lymphocytes in the mouse represent a heterogeneous 
popullation.',Raff and Cantor (1971; 1972a; b) proposed that the 
peripheral T lymphocytes should be divided into two subpopulat-
ions, namely T1 and T2 cells. The population of T1 cells is 
short-lived as can be shown by their rapid disappearance after 
adult thymectomy (ATx): they have a half life of 3-4 weeks. 
Because of its sessile nature the Tl subset is resistant to the 
in-vivo effe€ts of small doses of anti-thymocyte serum (ATS) 
(Lance et al., 1973). Th~T2 cells have a long lifespan after 
ATx, and since they recirculate, they are sensitive to treat-
ment with ATS. The Tl and T2 cells would correspond to "virgin" 
and "memory" T cells, respectively. The presence of T2 cells 
specific for certain antigens in unimmunized animals may be ex-
plained by an antigen-independent conversion of cells of the Tl 
subset into T2 cells, suggesting a predetermined differentiation 
of T1 cells into T2 cells (Cantor and Boyse, 1975a). The presence 
of recirculating T lymphocytes in the fetal lamb suggests that 
in immunologically unstimulated animals T2 cells can arise 
(Pearson et al., 1976; Cahill et al., 1979). The immunocompetence 
of the recirculating T cells was not studied, so the relevance 
of this observation for the maturation of immunocompetent T cells 
has not been established as yet. The hypothesis that the conver-
sion of Tl into T2 cells is antigen-dependent (Araneo et al., 
1977) is very attractive, since this hypothesis fits nicely in 
the clonal selection theory. This theory states that the specif-
icity of the receptors of lymphocytes depends on a random, anti-
gen-independent process. Due to the short lifespan of the T1 
cells, those T1 cells with an irrelevant antigenic specificity 
disappear, since they are not driven by antigen to differentiate 
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into long--lived T2 cells. Environmental antigens would conti-
nuously select those Tl cells with relevant antigen-receptors. 
According to the original hypothesis of Raff and Cantor only T2 
cells are responsible for primary immune responsiveness, but 
other authors suggested that T1 cells may also contribute to 
primary responses (Kappler et al., 1974; Araneo et al., 1977). 
Fig. 3 
THYMUS 
T1 
antigen? antigen? 
T2? T2 antigen T memory (:T2?) 
* * * 
T effector T effector T effector 
* * 
Funct1on Function Funct1on 
Pr1mary 1mmune response Secondary 1mmune 
response 
*These steps are dr•ven by ant1gen 
Scheme of peripheral T cell differentiation. 
After deliberate priming with antigen long-lived recirculating 
T memory cells might also arise, which account for the second-
ary immune response upon booster injection with the specific 
antigen. It was suggested that these latter T memory cells can 
be derived from Tl cells as well as from the already existing 
T2 cells (Araneo et al., 1977). It remains questionable whether 
the T memory cells accounting for secondary immune responses 
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are qualitatively different from the T2 cell population. 
Next to T1 and T2 cells, the peripheral T lymphocyte pool con-
stitutes of effector T lymphocytes. The generation of effector 
T cells is antigen-driven, and these cells carry out the im-
munological function. The effector T lymphocytes are short-lived 
cells, and are resistant to treatment with ATS (Araneo et al., 
1976). 
The differentiation stages of the peripheral T lymphocytes and 
their relationships as outlined in Fig. 3, were mainly demon-
strated in experiments on the T helper system, but it was sug-
gested that this model may also be valid for suppressor activity 
and the other T cell lines, committed to particular immunological 
functions, e.g. delayed type hypersensitivity, or cytotoxic activ-
ity. On the other hand, it might be that this differentiation 
model only holds for those T cells which are reactive to convent-
ional antigens. 
The clarity of the model depicted above is blurred by the demon-
stration of synergism of T1 and T2 cells. Such a synergistic 
effect has been shown in GvH reactivity (Cantor and Asofsky, 
1970; 1972; Tigelaar and Asofsky, 1973), T helper functions 
(Feldmann et al., 1975a; Muirhead and Cudkowicz, 1978), T sup-
pressor function (Feldmann and Kontiainen, 1976), during in-vitro 
T cell proliferation (Cohen and Howe, 1973) and the generation of 
cytotoxic T cells (Cantor and Simpson, 1975) in response to allo-
geneic cells. The synergism may be due to particular experimental 
conditions, since it can only be seen in models where small numbers 
of T2 cells are used (Cantor and Simpson, 1975). Therefore, some 
authors considered T1-T2 synergism as an irrelevant phenomenon 
(Araneo et al., 1977). Others suggested that T1 cells perform an 
amplifying function during their differentiation into T2 cells. It 
is also possible that the T1 population contains amplifier cells 
which are not subject to further differentiation and thus consti-
tute a separate T cell lineage (Beverley et al., 1977). 
4.3. T cell surface markers 
4. 3.A. General 
Functionally different subsets of T lymphocytes can be class-
ified on the basis of their surface antigens. Three distinct sur-
face marker systems will be considered here: those of the Lyt-
system, Ia antigens, and the Qa-1 antigen. As discussed in section 
4.1. the Lyt-system consists of 3 different antigens, Lyt-1, Lyt-2 
and Lyt-3, each of which can occur in two allelic forms. The Lyt-2 
and Lyt-3 antigens are always expressed concomittantly on T cells, 
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and thus three T cell subsets can be distinguished with the Lyt 
surface markers, namely Lyt-1+, Lyt-23+ and Lyt-123+ T cells. 
The Ia antigens are coded for by gene loci in the H-2 complex, 
and these molecules may perform a regulatory function in the 
immune system. This became apparent from the finding that im-
munologically active helper and suppressor factors contain Ia 
antigens (Munro, 1978). The Qa-1 antigen is a recently detected 
surface marker, and is coded for by a gene in the T-region (Fig. 
1). Qa-1+ cells occur in the Lyt-1+ and Lyt-23+ T cell pool 
(Stanton et al., 1978). 
4.J.B. Surface markers on functional T cell subsets 
Based on the Lyt-system the peripheral T cells can be classified 
into 3 main groups (Table 4): 
1. The Lyt-1+ cells corresponding to the T helper cell pool. 
These T helper cells include both the T cells, helping B 
cells in the humoral response, and the T cells which prolif-
erate in a mixed lymphocyte reaction (MLR} in response to 
LD antigens (Cantor and Boyse, 1975a; b). The MLR-reactive 
cells are termed T helper cells, since they cooperate with 
precursor cells of the cytotoxic T cells in the production 
of cytotoxic effector cells (Schendel et al., 1973). T cells 
mediating DTH to SRBC or proteins are also Lyt-1+ cells 
(Vadas et al., 1976; Huber et al., 1976b). Since they stimu-
late macrophages they can be considered as a type of T help-
er cells. Both the precursor and the effector (helper) T 
cells are Lyt-1+ cells. 
2. The Lyt-23+ cells represent both the cytotoxic T cells, 
directed to SD-antigens on allogeneic target cells, and the 
suppressor T cells, which may inhibit T helper function 
antigen-specifically or aspecifically (Feldmann et al., 
1975b; Cantor et al., 1976; Jandinsky et al., 1976). Both 
the precursor cytotoxic T cells and the precursor suppressor 
T cells are Lyt-23+ (Cantor and Boyse, 1975a; Beverley et 
al., 1976), and are found in the T2 cell pool (Feldmann et 
al., 1977). Also the cytotoxic effector cell directed to 
TNP-modified syngeneic target cells are Lyt-23+ cells, but 
in this case the precursors belong to the Lyt-123+ pool 
(Cantor and Boyse, 1976; Burakoff et al., 1978). 
3. The Lyt-123+ cells in the peripheral T cell pool were initi-
ally thought to be the precursors of the Lyt-1+ and Lyt-23+ 
cells and they were therefore designated as early T cells 
28 
(TE) . According to some authors the differentiation of Lyt-123 
cells into Lyt-23+ cells is antigen-independent (Cantor and 
Boyse, 1977), but other authors suggested that this process 
is driven by antigen (Burakoff et al., 1978). After ATx part 
TABLE 4 
LYT-PHENOTYPE AND T CELL FUNCTION 
Lyt-phenotype 1 
Lyt-phenotype 23 
Lyt-phenotype 123 
Helper precursor in antibody formation 
Helper effector in antibody formation 
Delayed type hypersensitivity to SRBC 
MLR-reactive precursor to LD antigens and 
H-2K mutant antigens 
Proliferating cells in MLR 
Cytotoxic precursor in CML to allo-MHC 
Cytotoxic effector in CML to allo-MHC 
antigens and a number of modified 
syngeneic antigens 
Suppressor precursor 
Suppressor effector 
Cytotoxic precursor in CML to modified 
syngeneic antigens 
Cytotoxic effector to tumor associated 
antigens 
Helper amplifier 
Suppressor amplifier 
+ Precursor of Lyt-23 cells 
of the TE population disappears from the peripheral lymphoid 
organs, and it was suggested that the Tl and TE population 
were identical (Cantor and Boyse, 1977). In analogy with the 
synergism demonstrated between Tl and T2 cells for T helper 
function and T suppressor function, it was found that Lyt-123+ 
cells could amplify T helper and T suppressor function 
(Beverley et al., 1977). Additionally, it was shown that the 
amplifying Lyt-123+ cells were T1 cells, whereas the Lyt-1+ 
and Lyt-23+ cells were T2 cells (Feldmann et al., 1977). Again 
these data fit nicely with the hypothesis that T1 and TE 
cells are identical. 
However, it was found that not all TE cells are eliminated 
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within longer periods after ATx. Even normal numbers of TE 
cells can still be found in the thoracic duct of ATx mice at a 
time when the numbers of Lyt-1+ and Lyt-23+ cells in periph-
eral organs are already decreasing (Simpson and Beverley, 
1977). Finally, it was shown that precursors of cytotoxic T 
cells directed to modified syngeneic antigens on target cells 
(i.e., minor H-antigens and tumour associated antigens) may 
be found in the Lyt-123+ cell pool (Cantor and Boyse, 1976; 
Pang et al., 1976; Simpson and Beverley, 1977; Burakoff et 
al., 1978). Moreover, the cytotoxic effector cells, directed 
to syngeneic tumour cells may also be Lyt-123+ cells (Shiku 
et al., 1976). These data indicate that the Lyt-123+ cell 
population cannot be considered identical to T1 cells, but 
suggest that they may be represented in the T1, T2 and effec-
tor T cell population. 
A more refined classification of peripheral T cells can be 
achieved, when, in addition to the Lyt-system, Ia- and Qa-antigen 
markers are also related to T cell function. Thus, the cytotoxic 
Lyt-23+ cells can be distinguished from the Lyt-23+ suppressor 
cells by the selective presence of the Ia antigens on the latter 
population (Murphy, 1978). Cytotoxic T cells probably do not 
carry Ia antigens. By means of the Qa-1 antigen the Lyt-1+ helper 
T cells can be divided into a Qa-1 positive, and a Qa-1 negative 
population (Cantor et al., 1978). The Lyt-1+, Qa-1+ T helper 
population has the ability both to enhance antibody formation by 
B cells and to stimulate suppressor T cells, inhibiting the T 
helper function. Thus a feed-back system in the humoral response 
has been demonstrated. T helper cells cooperating with B cells in 
the antibody response to SRBC, and DTH-reactive T cells may also 
be distinguished from each other, on the basis of the Ia system. 
Some T helper cells are probably ra+ cells, whereas the DTH react-
ive T cells are Ia- cells (Huber et al., 1976b; Okumara et al., 
1977). This finding may indicate a qualitative difference between 
some of the T helper cells and the DTH-reactive T cells. Further 
study on the surface markers of T cells mediating T helper acti-
vity and DTH-reactivity should be performed, in order to settle 
this problem. Such studies should not be restricted to the 
antigen SRBC. 
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5. T CELL FUNCTIONS 
5.1. Helper functions in the humoral immune response 
For optimal humoral responses to most conventional antigens the 
cooperation of helper T cells with antigen-reactive B cells is 
required. These T cells help in stimulating B cells to produce 
IgM, IgG and IgA antibodies (Taylor and Wortis, 1972; Benner et 
al., 1974; Van Muiswinkel et al., 1975). The mechanism of T-B 
cooperation is not fully understood, although it has become 
clear that both antigen-specific (Taussig, 1974; Munro and 
Taussig, 1975) and non-antigen-specific (Schimpl and Wecker, 
1972) soluble T cell factors can account for B cell activation. 
The molecular weight of the antigen-specific factors is in the 
order of 50,000 Dalton, and these helper factors contain I-A 
region coded products (Taussig et al., 1975). 
Helper T cell function can be assayed by in-vitro culturing of 
limited numbers of primed helper T cells together with a non-
limiting number of non-primed B cells and the specific antigen. 
The number of antibody forming cells per culture is thought to 
reflect the helper activity of the added T cells. Using this 
assay Araneo et al. (1977) studied the kinetics of helper activ-
ity in mice immunized with the thymus-dependent antigen SRBC. 
They showed that helper activity in the spleen appeared by day 
2 or 3 after primary i.v. immunization, peaked on day 4 and 
declined subsequently. The activated helper T cells were short-
lived, but priming of mice with SRBC also induced long-lived 
recirculating memory cells which could promptly generate activ-
ated helper cells after booster with the specific antigen. 
Araneo et al. (1977) proposed that the activated helper cells 
should be called effector cells, in order to distinguish these 
short-lived cells from their precursors which are largely long-
lived, recirculating T lymphocytes (T2 cells). It was found that 
11 Virgin 11 T precursor cells which are also short-lived, may con-
tribute to the pool of effector cells after primary immunization 
(Araneo et al., 1976). The generation of effector T cells from 
the short-lived "virgin" Tl precursor cells appeared to be a 
more time-consuming process than their generation from the T2 
precursor cells. The authors did not exclude the possibility, 
however, that the T1 cells may pass through a T2-like different-
iation stage, during their differentiation into effector T 
cell (Fig. 3). 
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5.2. Resistance to intracellular bacteria and viruses 
The resistance to facultative intracellular bacteria is mediated 
by T cells (Campbell, 1976). Immunization of mice with low doses 
of viable intracellularly growing bacteria can induce a state of 
immunity, which can protect these animals towards an otherwise 
lethal dose of these bacteria (Campbell, 1976). Vaccination with 
killed bacteria without the use of adjuvants generally does not 
evoke such a state of cell-mediated immunity (Bloch and Segal, 
1955; Collins, 1971; 1973). During the immune response to the in-
fecting microorganisms S-phase T lymphoblasts are delivered into 
the thoracic duct (Lefford et al., 1973a; McGregor et al., 1978; 
McGregor and Logie, 1973). With these cells a state of resistance 
can be transferred to normal syngeneic hosts. It has also been 
shown that the protective T cells are functionally short-lived, 
non-recirculating cells (North, 1973; Lefford et al., 1973a; b). 
However, they have the capacity to migrate aspecifically into in-
flammatory foci (McGregor and Logie, 1974). At these sites they 
may perform their protective function by the release of cell pro-
ducts, the so called "lymphokines", if they encounter the specific 
antigen (Mackaness, 1971; Simon and Sheagren, 1971; North and 
Spitalny, 1974; McGregor and Kostiala, 1976). Lymphokines cause 
the accumulation of mononuclear cells at the inflammatory site, 
and can aspecifically increase their bactericidal potency. 
At longer intervals after vaccination, protection can be adoptive-
ly transferred by recirculating small lymphocytes (Lefford et 
al., 1973a). Challenge of the recipient with a high dose of 
bacteria most probably results in transformation of the injected 
small lymphocytes and the accelerated production of short-lived 
blast cells which mediate the protective function. This process is 
associated with proliferation (North, 1975). Thus, the immunizing 
injection with facultative intracellular bacteria leads to: 
1. a short-lived state of active resistance to the bacteria, and 
2. a long-lived state of memory, during which period a rapid 
recall of resistance can be elicited by the second injection 
of the same bacteria (Collins, 1973; North and Deissler, 1975). 
Resistance to viruses can also be mediated by T cells. Cell-
mediated immune responses to acute virus infection have especial-
ly been studied by infecting mice with ectromelia virus. It has 
been shown that spleens from these mice contained T lymphocytes 
capable to lyse ectromelia infected target cells specifically 
during in-vitro incubation for a couple of hours (Gardner et al., 
1974). Such cytotoxic T lymphocytes are probably also responsible 
for the in-vivo elimination of the virus-infected cells (Blanden 
and Gardner, 1976). Spleen cells from mice which had been infect-
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ed 2 weeks to 16 months before with ectromelia virus could be 
restimulated during in vitro culture for 2 days with virus infect-
ed syngeneic macrophages or spleen cells to produce "secondary" 
cytotoxic T cells (Gardner and Blanden, 1976). Primary cytotoxic 
responsiveness to virus infected target cells could not be induced 
in vitro, which implies a major quantitative or qualitative differ-
ence between unprimed T cells and "memory" T cells present in 
mice after recovery from an acute virus infection. 
The above mentioned experiments indicate that functionally differ-
ent T cell subpopulations mediate the resistance to intracellular 
bacteria and viruses. Apparently, elimination of intracellular 
bacteria is aspecifically performed by macrophages activated by 
sensitized antigen-specific T lymphocytes. Virus-infected cells, 
on the other hand, are destroyed by cytotoxic T cells themselves. 
Destruction of bacteria-containing cells by cytotoxic T cells 
would unfavourably result in the release and dissemination of the 
bacteria. Lysis of virus-infected cells during the eclipse phase 
of the virus will eliminate the virus. It should be borne in mind 
that elimination of viruses is not entirely mediated by cytotoxic 
T cells, since antibodies also may contribute to the elimination 
of freely occurring viruses and virus-infected cells (Doherty and 
Zinkernagel, 1974; Perrin et al., 1977). 
In cell-mediated immunity to bacteria as well as to viruses anti-
gen-specific T memory is induced by the primary infection. These 
T memory cells account for the capacity of accelerated and en-
hanced generation of effector cells upon restimulation with the 
infectious agent in both cases. It remains unclear whether the 
persistence of small amounts of immunogenic material is essential 
for the maintenance of T memory cells. Persisting viable organisms 
are probably not necessary for the propagation of T cell-mediated 
resistance to bacteria (Lefford and McGregor, 1974). 
5.3. Reactivity to histocompatibility antigens 
Allogeneic organ or cell grafts generally induce an immune res-
ponse of the host against the graft which ultimately may result 
in its rejection. This type of immune reaction is termed host-
versus-graft (HvG) reaction. The opposite, the graft-versus-host 
(GvH) reaction can occur when immunocompetent cells are introduced 
into an allogeneic recipient. A GvH disease will develop if the 
host is incapable of mounting a sufficient immune response to the 
transplanted immunocompetent alloantigen-reactive cells. In the 
latter situation the grafted immunocompetent cells mount an immune 
response which causes injuries to the tissues of the host and 
ultimately may cause its death. In-vitro techniques are commonly 
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used to assay the capacity of responder cells to proliferate 
(MLR) or to produce cytotoxic T cells (CTL) after stimulation 
with allogeneic cells. This section will deal with the cellular 
aspects of the in-vivo and in-vitro immune response to histocom-
patibility (H-)antigens, presented on allogeneic cells. 
5.3.A. Host-versus-graft reaction 
The host-versus-graft (HvG) reaction has been mostly studied by 
means of skin transplantation which is a convenient and very 
sensitive organ transplant assay for detection of histocompat-
ibility (H-)antigens in the mouse. An acute first set skin graft 
rejection (i.e. within 3 weeks after transplantation) occurs 
when donor and recipient either differ in antigens coded for by 
the MHC or in multiple minor H-antigens. Chronic rejection, 
occurring beyond the 3rd week after transplantation, occurs when 
donor and recipient only differ in a limited number of minor H-
antigens. Grafting across single regions of the MHC (K, I or D) 
in congenic recombinant mouse strains, results in equal survival 
times of the grafts, namely about 3 weeks, but grafts across both 
the K- and I-region are generally rejected much earlier (Klein, 
1975). This might be a cumulative effect of K- and I-region coded 
antigens, as has been similarly demonstrated for graft rejection 
caused by multiple minor H-antigens. Minor H-antigen differences 
may also contribute to the rejection of MHC incompatible grafts, 
since the rejection time for skin grafts differing by MHC-coded 
antigens and multiple minor H-antigens is often shorter than in 
the case of differences in MHC-coded antigens only (Billingham 
et al., 1954; Graff and Bailey, 1973). 
Presensitization of mice with an allograft results in acceler-
ated rejection of the second set graft. This acceleration of 
graft rejection is more pronounced for minor H-differences than 
for major H-differences (Hildemann, 1970). The presensitization 
by means of an H-2 incompatible allograft is not fully specific 
for the donor strain, since the rejection time for third party 
grafts carrying a different H-2 haplotype than the donor strain 
of the first graft, was intermediate between that of a first set 
and second set graft rejection, even if minor H-differences were 
eliminated (Klein and Murphy, 1973). These findings suggest 
cross-reactivity between unrelated H-2 haplotypes, may be of 
public antigens. 
Graft rejections across major as well as across minor H-antigen 
differences are mainly mediated by T lymphocytes. According to 
Cohen and Livnat (1976) T cell activation can occur in the skin 
graft itself, where a subset of circulating immunocompetent T 
34 
lymphocytes comes into contact with cells which carry the allogeneic 
H-antigens~ These activated T cells subsequently migrate to the 
draining lymphatic tissue and recruit another subset of T lymph-
ocytes which proliferates, and differentiates into specific effec-
tor cells mediating the graft rejection. The nature of the T cells 
involved in second set graft rejection has not been yet fully 
established. Possibly, long-lived effector T cells, induced by the 
first allograft, may account for the second set graft rejection, 
although the contribution of a true secondary immune response by 
restimulation of long-lived T memory cells has not been excluded 
(Brent et al., 1962). Recent experiments by Hallet al. (1977; 
1978a; b) in the rat, indicate that non-recirculating long-lived 
T memory cells induced by a primary MHC-incompatible skin graft 
may account for the second set graft rejection of a cardiac allo-
graft. Since no increased immunological activity was seen in the 
lymphatic tissues during the second set reaction, the authors 
suggested, that these memory cells are already existing "end" 
cells, mediating the effector function without the requirement of 
proliferation or differentiation within a lymphoid organ. 
To test the thymic-dependence of precursor T cells and memory T 
cells involved in the first set, and second set graft rejections, 
respectively, Hall et al. (1978b) thymectomized rats either before 
or after grafting. They observed that neither the pool-size of 
precursors of effector cells mediating first set graft rejection, 
nor that of the precursors of the "memory" cells, nor that of the 
"memory" cells themselves was affected by ATx. Lance et al. (1973) 
showed that depletion of the recirculating T cell pool by means of 
ATS treatment in vivo markedly prolonged skin graft rejection t.imes. 
Thus, the precursor T cell pool accounting for first set skin graft 
rejection consists of recirculating T cells, and these cells may 
therefore belong to the T2 cell pool. Wood and Monaco (1972) repor-
ted that thymectomy several weeks previously potentiated the 
effectiveness of ATS treatment in the prolongation of the survival 
time of allogeneic grafts. It follows that the thymus is required 
for the recovery of the recirculating alloreactive precursor T cell 
pool after depletion by ATS. On the other hand, the presence of the 
thymus is not essential for maintenance of the population of allo-
reactive memory T cells (Hallet al., 1978b). Elimination ofT 
cell memory for major H-antigens by ATS treatment has been difficult 
to achieve (Lancer 1968; Russell and Monaco, 1967). This observation 
can be understood on the basis of the data provided by Hall et al. 
(1978a; b) in the rat, who showed that the memory cells are non-
recirculating, and can thereby escape from the effect of ATS treat-
ment. Compared to T cells from unprimed animals, the above described 
memory cells have a greatly increased potency of alloreactivity, 
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measured by adoptive transfer of lymphoid cells derived from primed 
donors. It is surprising that the second set allograft rejection 
across MHC differences is not as strikingly accelerated despite 
the presence of these memory cells (Hallet al., 1977; 1978b). 
5.3.B. Graft-versus-host reactivity 
A graft-versus-host (GvH) reaction occurs when immunocompetent 
cells are introduced into allogeneic recipients and it may accom-
pany HvG reactions after organ transplant, when the transplant 
itself contains alloreactive cells. GvH reactions can be assayed 
in vivo by mortality, splenomegaly and popliteal lymph node assays, 
which are generally performed in irradiated, neonatal and normal 
adult hosts, respectively. Differences between the I-region of the 
MHC of donor and host induce stronger GvH reactions, than diffe-
rences in the other regions of the MHC (Klein, 1975). Minor H 
differences alone can also be sufficient for the induction of GvH 
reactivity (Cantrell and Hildemann, 1972). Presensitization of 
donors will result in a more vigorous GvH reaction, only if minor 
H-antigens are involved (Lind and Szendberg, 1961; Ford and 
Simonsen, 1971). 
As might be expected GvH reactions are mainly mediated by T lympho-
cytes (Sprent and Miller, 1971; Cantor and Asofsky, 1972). Surpri-
singly large numbers of the peripheral T cell pool (1-10%) are able 
to respond to a host of a given allogeneic H-2 haplotype, as com-
pared to the very small fraction (0.01%) ofT lymphocytes respon-
ding to conventional antigens or minor H-antigens (Simonsen, 1967; 
Ford et al., 1975). 
Cantor and Asofsky (1970; 1972) showed synergism between periphe-
ral blood lymphocytes and thymocytes, and between peripheral blood 
lymphocytes and anti-lymphocyte serum (ALS) treated spleen cells 
in the GvH reaction. In these experiments peripheral blood was 
used as a source of T2 cells. Thymocytes and ALS treated spleen 
cells were considered as a source of T1 cells. These latter cells 
would actually mediate the GvH reaction, while the T2 cells would 
merely amplify this effector function. It should be stressed, 
however, that these results were obtained with the splenomegaly 
assay; contrasting results might be obtained in other GvH assays. 
5.3.C. In vitro assays for alloreactivity 
Co-culture of lymphocytes derived from two allogeneic individuals 
may result in blast transformation and mitotic activity (Bain et 
al., 1964; Bach and Hirschhorn, 1964). This T cell dependent in-
vitro phenomenon is called the mixed lymphocyte reaction (MLR), 
and is generally considered as the in-vitro analogon of both the 
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proliferation phase during a GvH reaction (Wilson, 1971), and the 
induction phase of a HvG reaction (Hayry et al., 1972). Generally 
an one-way MLR is used, i.e. the proliferation of the lymphoid 
cells of one individual is inhibited by antimitotic treatment, 
so that these cells can only act as stimulators. The lymphocytes 
of the other individual act as responders to the histocompatibility 
antigens of the stimulator cells. During a MLR, cytotoxic T lymph-
ocytes (CTL) are generated which can specifically lyse lympho-
blasts, derived from the original stimulator individual (Cerottini 
et al., 1970a, b). Peak numbers of CTL are found after the peak 
of proliferative activity (Cerottini and Brunner, 1974). This lytic 
reaction, called cell-mediated lympholysis (CML), might be the in-
vitro counterpart of the effector phase of the in-vivo allograft 
reaction (Cerottini and Brunner, 1974). Both blast cells and small 
lymphocytes can mediate CML (Shortman et al., 1972). In-vivo CTL 
are generated after injection of allogeneic cells or after allo-
geneic skin transplantation. It was found that, at the time of 
skin graft rejection, the number of CTL is maximal (Cerottini 
and Brunner, 1974), but the presence of CTL is not always so well 
correlated with the rejection of the allograft (Wilson, 1974). Not 
only can CTL be found at the rejection site, but also large num-
bers of non-lymphoid alloreactive cells (Hayry and Roberts, 1977}. 
Thus, it is not clear what contribution is made by the different 
subpopulations of T lymphocytes and non-lymphoid cells to the 
process of graft rejection. During acute GvH reactions CTL are 
also generated, but their role in the symptoms of GvH remains 
doubtful, since in-vivo and in-vitro generated CTL do not produce 
GvH reactivity in a splenomegaly assay (Sprent and Miller, 1971; 
Rouse et al., 1972; Rouse and Wagner, 1972). In contrast, the 
same CTL did accelerate graft rejection. 
After the peak of the blast response in an one way MLR to H-2 in-
compatible cells, the number of small lymphocytes increases 
(Hayry and Andersson, 1974). This indicates that a proportion of 
the blast cells reverts to small lymphocytes. Selective recovery 
of the blast cells and subsequent culture of these blast cells 
without antigen on a syngeneic feeder layer, revealed that these 
small lymphocytes indeed develop from blast cells. These small 
11 secondary11 lymphocytes have at least two characteristics, dis-
similar from non-primed T cells: 
1. They proliferate in a secondary MLR with the original stimul-
ator cells in an accelerated fashion. 
2. They could be recovered up to 5 months after i.v. transfer 
into T cell deprived syngeneic recipients. When tested in 
vitro in a secondary MLR they give rise to a prompt CML to 
the original stimulator cells (Hayry and Andersson, 1974} . 
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Thus, these "secondary" lymphocytes apparently have the 
functional properties of memory T cells. The generation of 
CTL from their memory precursor cells is not necessarily 
accompanied by proliferation (MacDonald et al., 1975). This 
might explain the observation that the memory cells themselves 
can sometimes perform an effector function (Hayry and Anders-
son, 1974). 
Proliferation in a primary MLR occurs when responder and stimulat-
or cells differ in the I-region of the MHC; K- or D-region differ-
ences can induce only weak proliferative activity (Schendel et 
al., 1973). On the other hand, strong CML can be induced to K- or 
D-region coded antigens of stimulator cells and only comparatively 
weak CML to I-region coded antigens (Billings et al., 1977). Simil-
arly as in GvH a high proportion of T cells responds to the stimul-
ator cells of a given haplotype in an one way MLR and CML to allo-
geneic H-2 incompatible cells {Jones, 1973; Bevan et al., 1976; 
Lindahl and Wilson, 1977; Teh et al., 1977). The CTL predominantly 
recognize the private determinants of the so-antigens, but some 
public antigens may also induce a rather strong and specicific CML 
(Lindahl et al., 1975). This CML reactivity to public antigens may 
account for the considerable cross-reactivity of CTL sometimes 
found for third-party target cells in primary CML and for third-
party stimulator cells in the secondary CML (Corley, 1977). 
In addition to K- or D-region coded alloantigens, sometimes the 
presence of I-region coded alloantigens is required for an op-
timal CML to the latter SD antigens (Schendel et al., 1973). This 
observation led to the assumption that a separate T cell popul-
ation, stimulated by I-region coded determinants, proliferates 
in MLR and cooperates with precursors of CTL reactive to K- or D-
region coded antigens to produce an optimal CML. Shortly there-
after it was shown that the helper T cells and cytotoxic T cells 
carry different Lyt surface antigens (Cantor and Boyse, 1975a; b). 
The helper effect was only demonstrated under experimental conditions 
in which the numbers of precursors of CTL are very small. Recently, 
it has been shown that a similar T cell cooperation is required 
for the generation of CML in a MLR across a mutant H-2K locus 
difference. It appeared that Lyt-1+ T helper cells were required 
for the induction of Lyt-23+ killer cells directed against the 
target cells from the H-2K mutant strain. It is very likely that 
these helper cells were not induced by LD antigens, but by antigenic 
determinants on the H-2K locus coded molecule (Melief et al., 
1979). The need for helper cells appeared to be more stringent 
in the case of CML to the H-2K locus mutant-derived cells than in 
a CML to K- and I-region coded alloantigens. Probably many fewer 
clones of CTL precursors are directed against antigens coded for 
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by a mutant H-2K locus than against H-2K and H-2I coded allo-
antigens. These experiments suggest that the requirement for 
Lyt-1+ helper T cells depends on the number of antigen-reactive 
precursor CTL during the MLR. 
Minor H-antigens can hardly induce an MLR, with the exception 
of products of the Mls locus on chromosome number 1. Mls locus 
incompatible, H-2 compatible stimulator cells can induce a MLR 
comparable in strength to MLR observed in H-2 incompatible com-
binations (Festenstein, 1973). In-vivo priming of mice with single 
or multiple minor H-antigens by means of intraperitoneal injection 
of allogeneic H-2 compatible spleen cells or by skin grafting 
leads to considerable MLR and CML responsiveness of the recipient 1 S 
cells against these minor H-antigens. This also occurs in the 
absence of a stimulatory Mls locus product (Bevan, 1975; Gordon 
et al., 1975). Obviously, in-vitro MLR and CML to minor H-antigens, 
except those coded for by the Mls locus, require the presensitizat-
ion of the mice used as donors for the responder cells. This might 
indicate that the population of unprimed T cells must undergo a 
quantitative or qualitative change in order to obtain the capacity 
of inducing MLR and CML to minor H-antigens. Recent frequency 
analyses of precursor T cells responsible for MLR and CML before 
and after in-vivo priming, suggest an increase in the frequency 
of the specific T cells as the most likely explanation (MacDonald, 
personal communication) . 
5.3.D. Conclusions 
To summarize, both HvG and GvH reactivity are largely dependent 
on T lymphocytes. In-vitro assays provided data on: (1) the 
existence of functionally different T cell subpopulations involv-
ed in alloreactivity and (2) the relative importance of major 
and minor H-antigens in the activation of alloreactive T cells 
(Table 5) . The contribution of alloaggressive CTL in the rejection 
of H-2 incompatible grafts is beyond doubt (Hayry and Roberts, 
1977). In contrast, it is questionable whether CTL play a signi-
ficant role in GvH (Dennert, 1976), since their GvH activity 
could not be demonstrated in the splenomegaly assay {Rouse et al., 
1972). In other GvH assays CTL might prove to be more effective. 
Memory can be seen in alloreactivity against both major and minor 
H-antigens, but the cellular basis of memory to minor H-antigens 
is not completely clear as yet. Long-lived non-recirculating T 
lymphocytes induced by a primary H-2 incompatible allograft might 
function as effector cells in a second set graft rejection. These 
cells might be identical to the small "secondary" lymphocytes 
induced in a primary MLR to H-2 incompatible cells. Cooperation 
of different subsets of T cells has been shown in vitro, and in 
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the GVH assay. Cooperation of different T cell subsets may also 
be involved in the in-vivo host-versus-graft reaction (R6llinghof 
et al., 1977). In addition, it became apparent from the experi-
ments of Cohen and Livnat (1976} that a particular subpopulation 
of T lymphocytes, the initiator T lymphocytes, can recruit 
another T cell subset to generate effector cells against a graft. 
TABLE 5 
ROLE OF HISTOCOMPATIBILITY ANTIGENS IN THE VARIOUS ASSAY SYSTEMS 
FOR CELLULAR IMMUNITY 
Histocompatibility Function 
antigen Primary MLR Primary CML GvH HvG 
K,D + +++ + ++ 
I +++ + ++ ++ 
Mls +++ ? ? 
Minor H, except Mls + + 
5.4. Delayed type hypersensitivity 
Delayed type hypersensitivity (DTH) is the only form of allergy 
which is classified as a cell-mediated immune phenomenon, since 
it can be mediated by antigen-reactive T lymphocytes without the 
essential involvement of B lymphocytes or their products. Skin 
reactions due to DTH are distinguished from antibody-mediated 
skin reactions of immediate type hypersensitivity by the delayed 
onset of the skin lesions of the former type. The DTH reaction 
is characterized by a slowly developing induration, erythema and 
oedema which becomes maximal at about 24-96 hr after its elicit-
ation, depending on the species tested and the antigen used 
(Crowle, 1975). Furthermore, Chase (1945) showed that DTH could 
be transferred to non-immune guinea-pigs by injection of living 
peritoneal exudate cells from sensitized donors, but not by 
antiserum. A state of DTH will arise after appropriate sensitiz-
ation, and its expression can be elicited either locally or 
systemically by local or systemic challenge with the specific 
antigen, respectively. Skin testing, footpad challenge and ear 
testing are all examples of local cutaneous elicitation of DTH, 
while shock, body temperature changes, or haemorrhagic changes 
in the lungs may occur after intravenous systemic challenge of 
sensitized animals (Crowle, 1975). 
5.4.A. Classification 
DTH was originally described as a manifestation of bacterial 
allergy (Zinsser, 1921; Zinsser and MUller, 1925) because of its 
common association with bacterial infection. Later on it became 
apparent that a great number of other antigens, e.g. foreign 
proteins (Jones and Mote, 1934), simple chemicals (Landsteiner 
and Chase, 1937), and transplantation antigens (Brent et al., 
1958), also could induce DTH. The phenomenology of DTH varied 
considerably with the different antigens used. Thus, it was 
realized that not all DTH responses are similar and that the 
term DTH might stand for a heterogeneity of immunological pro-
cesses. Classic tuberculin type DTH is produced by the injection 
of antigen emulsified in Freund's complete adjuvant (FCA) or in 
other mixtures containing products of Mycobacterium tuberculosis 
(Freund, 1956). Similar reactivity occurs after mycobacterial, 
fungal or viral infection. The classic tuberculin type state of 
DTH is long-lasting and stable. Once a state of tuberculin type 
DTH is established, desensitization is not easily achieved by 
second injection of antigen (Rothschild et al., 1934; Benacerraf 
and McCluskey, 1963). The transient state of DTH seen in man and 
guinea-pigs after sensitization with antigen-antibody complexes 
(Uhr et al., 1957) or small amounts of antigen, administered 
either emulsified in an adjuvant not containing mycobacteria or 
without adjuvant, was termed Jones-Mote type hypersensitivity 
(Raffel and Newel, 1958). Dose and route of immunization are 
decisive for the induction of such a type of DTH. A Jones-Mote 
type reactivity occurs early after immunization and is evanes-
cent, waning with the appearance of antibody (Lagrange et al., 
1974; Parish, 1972). It is sensitive to a second injection of 
antigen (Coe and Salvin, 1964). Contact sensitivity reactions 
which occur after painting the skin with simple chemicals like 
oxazolone or dinitrochlorobenzene, are often considered as 
Jones-Mote type hypersensitivity reactiolls although the state 
of DTH can be maintained during a long period after the sensitiz-
ation (Crowle, 1961). Antibodies seem to play a role in contact 
sensitivity (Zembala and Asherson, 1970). In mice both a stable, 
long-lasting state of classic DTH and an evanescent Jones-Mote 
DTH can be induced, just as in man and guinea-pigs. 
Histologically, skin reactions of delayed onset are characterized 
by a local infiltration of predominantly mononuclear cells. It 
was shown that monocytes are essential to enact a DTH reaction 
elicited in the skin (Lubaroff and Waksman, 1967) or footpad 
(Volkman and Collins, 1972). Polymorphonuclear cells are often 
seen in the reaction site also, especially in mice (Crowle, 1975). 
Jones-Mote type skin reactions in guinea pigs are generally 
associated with the local accumulation of basophils. As a result 
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Jones-Mote type allergy in guinea-pigs was termed cutaneous baso-
phil hypersensitivity (Richerson et al., 1970}. Tuberculin type 
DTH to haptens in guinea-pigs may also be associated with a 
basophil-rich infiltration of the skin test site (Askenase et 
al., 1976}. It has been suggested that antibodies as well as T 
cell factors play a role in the accumulation of basophil-rich 
infiltrations in the reaction site (Askenase et al., 1976). 
5.4.B. In-vitro assays for delayed type hypersensitivity 
In-vitro assays have been developed to test the presence of cells 
mediating a state of DTH. Most in-vitro tests make use of the 
capacity of sensitized T lymphocytes to produce humoral substan-
ces, called lymphokines, which act on macrophages (Waksman, 1979) 
The release of lymphokines is an antigen-dependent process. 
Macrophage migration inhibition factor (MIF) is one of the many 
lymphokines. The migration inhibition assay is thought to be the 
in-vitro correlate of tuberculin type DTH only, since during 
Jones-Mote type hypersensitivity no MIF activity can be demon-
strated when sensitized lymphocytes and macrophages are incubated 
together with the specific antigen (Ohmichi et al., 1976; Himeno 
et al., 1977). This finding can be taken as an argument to dis-
tinguish tuberculin type and Jones-Mote type DTH at the cellular 
level. On the other hand, the negative MIF tests in Jones-Mote 
type hypersensitivity can also be explained by the possible 
interference of antigen-antibody complexes in this assay. Besides 
MIF production is only one aspect of the in-vivo DTH reaction. 
In-vitro proliferation and blastogenesis upon antigenic stimul-
ation might reflect the early in-vivo events in the draining 
lymphatic tissue during the induction of DTH (Davies et al., 
1969). The in-vitro blastogenesis seems to be a good correlate 
for Jones-Mote type DTH. 
5.4.C. The cellular basis of delayed type hypersensitivity 
Several authors have attempted to characterize the cellular 
mediator of DTH. Originally this mediator was suggested to be 
a functionally short-lived lymphocyte (Neveu et al., 1963}, as 
well as a long-lived T lymphocyte, i.e. a typical recirculating 
memory cell (Chase, 1963}. It was later proposed that in tuber-
culin type DTH both long-lived and short-lived T lymphocytes 
might mediate DTH reactivity (Lefford and McGregor, 1974}. 
In studies on contact sensitivity it has been shown that removal 
of the draining lymph nodes during the proliferation stage in-
hibits the subsequent development of DTH (Turk and Stone, 1963; 
Neveu et al., 1963). Once a state of DTH has been establisfled, 
extirpation of the draining lymph nodes did not affect the DTH 
reactivity of the animal (Turk and Stone, 1963}. It was concluded 
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that the immunologically stimulated cells leave the regional 
lymph nodes in the early phase of the sensitization period (Turk, 
1975). Asherson and Zembala (1973) showed that after immunization 
of mice with oxazolone cells of various lymphoid organs succes-
sively became capable of transfer of the contact sensitivity to 
non-immune recipients. These results are compatible with the 
notion that after the induction stage seeding of long-lived 
reactive cells to other lymphoid organs occurs (Asherson et al., 
1974). An argument for the existence of long-lived DTH-reactive 
cells is the finding that tuberculin type hypersensitivity per-
sists for a long time after infection of rats with viable BCG. 
Even elimination of viable mycobacteria did not affect the level 
of DTH (Lefford and McGregor, 1974). However, it can be argued 
that immunogenic bacterial remnants persist in such animals. 
Other evidence for the case of long-lived DTH-related effector 
cells was the observation that recipients of immune spleen or 
peritoneal exudate cells remained hypersensitive for periods of 
more than one month (Chase, 1963; Lagrange and Mackaness, 1975). 
Treatment of mice, which were donors for sensitized cells, with 
the antimitotic agent vinblastine did not impair their capacity 
to transfer DTH (Lagrange and Mackaness, 1975; North and Deissler, 
1975). Thus, it was concluded that persistent DTH to purified 
protein derivative {PPD), L. Monocytogenes, and SRBC is mediated 
by long-lived cells which do not or hardly proliferate. This vin-
blastine resistance of DTH-related T cells was only observed at 
rather long intervals after immunization. 
The recent observation that thoracic duct lymphocytes from rats 
immunized with living BCG were not able to transfer DTH to normal 
rats at longer intervals after immunization (Kostiala et al., 
1978), provides contradictory evidence to the view that the T 
cell mediating tuberculin type DTH is a long-lived recirculating 
cell. This opinion was also opposed by earlier experiments which 
showed that chronic thoracic duct drainage did not impair the 
level of DTH, as might be expected if sensitivity would be 
mediated exclusively by recirculating lymphocytes (Coe et al., 
1966). Moreover, it has never been shown that small lymphocytes 
have the capacity to migrate into inflammatory foci, while this 
is a characteristic of lymphoblasts (Russell et al., 1975). 
Another phenomenon which has been considered to support the 
possible existence of long-lived DTH-reactive effector cells is 
the capacity of anamnestic DTH in animals primed many months 
previously. Booster of such animals with the specific antigen 
resulted in a sudden accelerated increase of DTH reactivity 
(Crowle, 1975; Tamura and Egashira, 1976). It was believed that 
the anamnestic response depends on the same long-lived memory 
cells which account for the persistent state of DTH (Crowle, 1975). 
At present, convincing evidence exists that short-lived T cells 
can perform an effector function in both Jones-Mote type DTH 
and the initial stage of tuberculin type DTH (Kettman and 
Mathews, 1975; Kettman and Turner Lubet, 1976; Askenase et al., 
1977; Vander Kwast et al., 1977). Consequently, it was proposed 
that after immunization for tuberculin type DTH a short-lived 
blast cell would mediate initial DTH reactivity, while after 
longer periods a long-lived effector cell would account for the 
DTH responsiveness (North and Deissler, 1975; Lefford and Mc-
Gregor, 1978). Persisting antigen or a high antigen dose would 
be required to drive a particular T cell subclass to become such 
a long-lived cell (Askenase et al., 1977). 
An intriguing problem is the physiological role of the DTH-react-
ive T lymphocytes. DTH reactions are known to play a role in a 
number of pathological processes, e.g. granuloma formation, some 
autoimmune diseases, neurological involvement in leprosy and in 
contact eczema (Turk, 1975). These DTH-related phenomena can be 
considered as derangements of the normal immune response to patho-
genic agents. Cell-mediated immunity and delayed type hypersens-
itivity have often been used as synonyms, as was suggested by 
the development of DTH after allografting, and during resistance 
to bacterial infection or viruses. Only T helper function for 
humoral responses did not coincide with an active state of DTH. 
In fact, an inverse relationship was generally found between T 
helper activity and DTH reactivity (Lagrange et al., 1974; Parish, 
1972). A recent study of Lagrange and Mackaness (1978) indicated 
that after i.v. priming with high doses of SRBC suspended in 
saline, DTH-reactive effector cells can indeed be found in the 
spleen together with T helper cells. It was suggested that 
antigen-antibody complexes retain these DTH-reactive cells in 
germinal centres, where they might perform a helper function. 
In view of these data it seems worthwhile to consider the hypo-
thesis that somewhere in the differentiation pathway of precur-
sor T cells to effector T cells, either directed against bacte-
ria, mediating cytotoxic functions for virus-infected cells and 
allogeneic cells, or mediating helper function in the humoral 
response (Kerckhaert, 1974), a stage exists at which the cells 
can exhibit DTH reactivity to such an antigen. The discrepancies 
observed between the occurrence of DTH reactivity and several 
in-vivo T cell functions can be explained by central recruitment 
of antigen-reactive cells which would not allow the expression of 
peripheral DTH reactivity. Also, the appearance of suppressor (T) 
cells acting upon DTH-reactive T cells (Ramshaw et al., 1976; 
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Asherson and Zembala, 1975) might obscure the correlation between 
DTH-reactivity and other T cell functions. Since the cellular 
basis of DTH reactivity has not been elucidated as yet, the hypo-
thesis that the DTH-reactive cell is a common differentiation step 
for all "functional" T cell subsets can neither be rejected nor 
accepted. 
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6. ANTIGEN RECOGNITION 
6.1. T cell activation 
About 2 decades ago Mitchison (1954) and Lawrence (1959) suggest-
ed that successful cell-mediated immunity to bacterial antigens 
could only be expected when these antigens were presented on the 
surface of the individual's cells. The association of self-anti-
gens with the foreign bacterial antigen was thought to lead to 
cell-mediated immunity to these bacteria. In 1973 Rosenthal and 
Shevach reported that T cells, derived from guinea pigs immunized 
with FCA could be restimulated to proliferate in vitro by adding 
PPD, presented together with syngeneic or semiallogeneic macro-
phages, but not when the antigen was given together with allo-
geneic macrophages. Later studies confirmed these results (Paul 
et al., 1977). Blocking of this T cell proliferation induced by 
antigen-pulsed macrophages was achieved by addition of allo-
antisera directed to the Ia antigens specific for the macrophages 
of the strain which could effectively present the antigen to the 
immune T cells (Rosenthal and Shevach, 1973; Thomas et al., 1977). 
However, antisera raised against the native antigen, PPD, could 
not block the stimulatory capacity of these antigen-pulsed macro-
phages (Ellner et al., 1977; Thomas et al., 1977). Altogether 
these observations suggested that the sensitized T cells are 
triggered to proliferate and to produce lymphokines (Ellner et 
al., 1977) by recognition of the antigen in association with 
cell surface antigens coded for by the major histocompatibility 
complex {MHC), but not by the antigen alone. 
Since in-vivo primed guinea pig Fl (Pl x P2) T cells can be re-
stimulated by antigen-pulsed macrophages from either parental 
strain (here indicated as P1 and P2), these F1 T cells might 
consist of 2 different antigen-reactive populations: one set 
primed to respond to the antigen associated with specific surface 
determinants of P1 macrophages and the other to the antigen asso-
ciated with specific surface determinants of P2 macrophages. 
Evidence for this hypothesis was provided by selective killing of 
proliferating T cells restimulated by antigen-pulsed macrophages 
from one parental strain. It was shown that the remaining T cells 
were only capable of responding to the antigen, when associated 
with macrophages from the other parental strain (Paul et al., 
1977). The experimental data mentioned so far were obtained in 
a model which measured restimulation of previously primed T cells 
by soluble antigens associated with syngeneic or semiallogeneic 
macrophages. A number of other reports showed similar results 
in man and mouse (Bergholtz and Thorsby, 1977; Kappler and 
Marrack, 1976; Pierce et al., 1976). The latter authors demon-
strated that in antigen-primed F1 (P1 x P2) mice 2 sets of immuno-
competent T cells can be distinguished on the basis of the speci-
ficity of their antigen receptor: F1-derived T cells recognize an 
antigen in association with a MHC-coded antigen of the one or the 
other parental strain. Antigen receptors of sensitized T cells 
apparently have a dual specificity, namely, for the antigen and 
for a self-MHC-coded cell surface antigen. This phenomenon of 
obligatory recognition of antigen in association With MHC-coded 
antigens has been termed MHC-restriction, or, in the mouse, H-2 
restriction. 
To test whether this phenomenon of H-2 restriction is predeterm-
ined, prior to the encounter of 
(1977a) and Zinkernagel et al., 
T cells with antigen, Bevan 
(1978a) reconstituted irradiated 
parental strain (Pl) recipients with haemopoietic cells from Fl 
(Pl x P2) mice, and allowed these mice a few months to repopulate 
the lymphoreticular system. Finally, these chimaeric mice were 
immunized with minor H-antigens (Bevan, 1977), or vaccinia virus 
(Zinkernagel, et al., 1978a). In both cases it appeared that the 
CTL were preferentially activated by the antigen, presented in 
association with Pi-derived MHC-coded antigens, and not when 
presented in association with P2-derived MHC-coded antigens. 
Zinkernagel et al. (1978a) showed conclusively that the genotype 
of the thymic environment imposed this MHC-restriction on the 
developing F1 (P1 x P2) T cells, prior to their encounter with 
antigens. It was similarly demonstrated that F1 (P1 x P2) T cells, 
helping antibody production (Waldmann et al., 1979; Bevan, 1978) 
or mediating DTH reactivity (Miller et al., 1978) recognize 
antigens, only when associated with macrophages, which have the 
same MHC-coded surface antigens as they encountered in the thymic 
environment in which these T cells were generated. The presence of 
MHC-coded antigens on the epithelial cells of the thymus 
(Hoffman-Fezer et al., 1978; Rouse et al., 1979; Wiman et al., 
1978) ensures that maturing T cells can indeed learn self-pre-
ference in the thymus. 
In general, T cells recognize antigens only in association with 
self-MHC products on the cell surface of antigen-presenting 
cells. However, arguments against this type of obligatory self-
recogniton were obtained from other studies, showing that un-
primed peripheral T cells could be sensitized by antigens pre-
sented on completely allogeneic macrophages. In most of these 
experiments alloreactive T lymphocytes were eliminated, in order 
to avoid a cytotoxic response to these allogeneic macrophages. 
It appeared that the remaining, unprimed T cells could be activ-
ated with antigens, presented on fully MHC incompatible cells 
(Thomas and Shevach, 1977; Heber-Katz and Wilson, 1976; Wilson 
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et al., 1977). In other experiments, using fully MHC-incompa-
tible chimaeras, produced by reconstitution of irradiated 
strain A mice with haemopoietic cells from strain B, Matzinger 
and Mirkwood (1978) recently showed that cytotoxicity to minor 
H-antigens could be induced by minor H-antigens presented on 
cells with the H-2 haplotype of the reconstituting strain B. 
This result is contradictory to what would be expected from 
Zinkernagel's hypothesis that T cells only recognize antigens in 
assocation with the H-2 antigens encountered in the thymus in 
which they are educated. However, other authors failed to observe 
stimulation of unprimed T cells by allogeneic antigen-bearing 
macrophages {Janeway et al., 1978; Bennink and Doherty, 1978; 
Shearer and Schmitt-Verhulst, 1977). More investigations are 
required to settle this matter which has important theoretical 
implications (see section 6.3.). 
6.2. T cell recognition in the effector phase 
Obviously, antigen recognition is necessary for all classes of 
sensitized T cells to exert their effector function (Fig. 3). 
Therefore, a similar MHC restricted recognition of antigens by 
effector T cells can be expected during the expression of their 
function as that observed during the activation of their precurs-
ors. Not all H-2 coded antigens play an identical role in H-2 
restriction. The antigens coded for by the different subregions 
of the H-2 complex are selectively involved in antigen recognition 
by the various functional T cell subpopulations (Table 6) . As a 
rule, the same H-2 antigens which restrict the effector function 
of a particular T cell subpopulation are also responsible for res-
tricting the induction of these T cells. 
It has been shown that T helper cells cooperate with B cells for 
the production of antibodies to thymus-dependent antigens only 
when they have identical I-A regions of the MHC (Kindred and 
Shreffler, 1972; Katz and Benacerraf, 1975). Transfer of resist-
ance to Listeria monocytogenes by immune T cells appeared to be 
similarly restricted by MHC-coded antigenic determinants (Zinker-
nagel et al., 1977). The host had to be I-A region identical to 
the effector T cells in order to be protected efficiently by those 
cells. However, resistance of recipient mice to various virus 
infections was not restricted by the I-A region, but was only 
achieved when immune donor T cells had an identical K- or D-
region of the MHC as that of the host (Doherty et al., 1976). 
One year earlier it had been shown that in-vitro recognition and 
subsequent lysis of virus infected target cells by virus specific 
cytotoxic T cells could only occur when the K- or D-region of the 
TABLE 6 
REGIONS OF THE H-2 COMPLEX INVOLVED IN ANTIGEN-RECOGNITION BY THE 
VARIOUS FUNCTIONAL T CELL SUBPOPULATIONS 
Restricting 
H-2 region 
I-A 
K,D 
no 
no 
no 
K,I-A,D 
Type of antigen 
conventional 
conventional 
conventional 
modified syngeneic 
modified syngeneic 
modified syngeneic 
modified syngeneic 
modified syngeneic? 
MHC-coded 
? 
? 
T cell subpopulation 
T helper in antibody formation 
Resistance to Listeria 
DTH to proteins 
CTL to virus-infected cells 
CTL to minor H-antigens 
CTL to low-density TNP-
altered cells 
DTH to virus 
CTL to high-density TNP-
altered cells 
CTL to K-, I- and D-region 
coded alloantigens 
CTL to T-region coded allo-
antigens 
DTH to contact sensitizers 
responding T cells was the same as that of the infected target 
cells (Zinkernagel and Doherty, 1975). Uninfected MHC-compatible 
target cells were not lysed, and inhibition of lysis of 51cr-
labelled infected target cells was only observed in the case of 
addition of unlabelled virus infected cells with the same K- or 
D-region as that of the labelled target cells. T cell mediated 
cytotoxicity to multiple minor H-antigens is similarly restricted 
by K- or D-region coded antigens (Bevan, 1975). 
Transfer of DTH reactivity also requires matching of certain parts 
of the MHC between the donors of sensitized T cells and the re-
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cipients. However, the region(s) involved in MHC restriction, are 
determined by the antigen (Table 6). Some antigens require matching 
of the I-A region only, others of the K- or D-region, and a third 
group of the K-, I- or D-region. Thus, using proteins as antigens, 
the MHC region involved in restriction is I-A, whereas in the case 
of DTH to virus infected cells, an identical K- or D-region in 
donor and recipient is required for successful transfer of DTH 
reactivity. In contact sensitivity, the mutual identity of donor 
and recipient's K-, I-A or D-region is sufficient for successful 
transfer (Vadas et al., 1977; Miller et al., 1977). 
As stated above, helper T cells cooperating with B cells, require 
identical I-A regions. It is possible that this I-A restriction 
also holds for helper T cells cooperating with cytotoxic T cells 
(Zinkernagel et al., 1978b; Von Boehmer et al., 1977). A number 
of helper factors, produced by helper T cells, or macrophages, 
often contain Ia antigens coded for by the I-A subregion (Erb 
and Feldmann, 1975). T suppressor cells can communicate with 
other cells by the production of antigen-specific or aspecific 
factors, which contain Ia antigens, coded for by the I-J subregion 
(Tada, et al., 1976) or I-C subregion (Rich et al., 1979). The 
observation that a number of these helper and suppressor factors 
are restricted by the MHC in their interaction with target cells, 
indicates that at least a proportion of the regulatory T cells 
are MHC restricted in their action. 
In contrast to the T cell responses to most antigens, cell-mediat-
ed immunity to cell surface antigens of allogeneic cells coded 
for by either the K-, I- or D-region is not restricted by MHC-
coded antigens (Klein, 1978). Apparently, the immune response to 
antigens which themselves are involved in MHC restriction is not 
subject to restriction. Cytotoxic T cell responses to T-region 
coded antigens on allogeneic cells are also unrestricted by 
MHC-coded antigens (Klein, 1978). With regard to cytotoxicity to 
TNP-modified cells, H-2 restriction could not be demonstrated 
provided that a high density of TNP molecules is present on the 
cell surface (Pohlit et al., 1979). 
6.3. The antigen receptor ofT cells 
6.3.A. Immune regulatory genes 
The important role of MHC-coded surface determinants in antigen-
recognition by T cells makes it obvious that the immunogenicity 
of an antigen is not only determined by the characteristics of 
the antigen itself, but also by its capacity to associate with 
MHC-coded molecules. It is known that some genes in the MHC. can 
indeed determine the level of immune responsiveness to certain 
antigens. These Ir genes can be found in the I-region (Katz and 
Benacerraf, 1975) as well as in the K- or D-regions of the MHC 
(Zinkernagel et al., 1978c; Von Boehmer et al., 1978}. Recently, 
it was clearly demonstrated by Von Boehmer et al. (1978} that 
these Ir genes do not code for the antigen receptor of the T cell. 
They demonstrated that, irrespective of the genotype of the T 
cells, the genotype of the thymus in which these T cells differ-
entiated and matured, determines the responsiveness of the T 
cells to a particular antigen. Thus, since it was possible to 
change low-responder T cells into phenotypically high-responder 
T cells, the Ir genes of the T cell do not themselves code for 
the antigen receptor. It is very likely that Ir gene products 
and the antigens responsible for H-2 restriction are the same. 
The effect of Ir gene coded antigens on the immune responsiveness 
can be explained in two (not mutually exclusive) ways: 
1. The Ir gene coded antigens might be unable to associate with 
the antigen and would thus fail to provide an immunogenic 
complex for induction of T effector cells and for the ex-
pression of T cell function, or 
2. The Ir gene coded antigens might influence the T cell recept-
or repertoire during the T cell differentiation in the thymus. 
The latter possibility can be understood if it is assumed that the 
combination of an antigen X plus a particular MHC-coded antigen is 
identical to a normal mouse membrane component. No response to 
antigen X will then occur because of self-tolerance (Schwartz, 
1978}. It has also been suggested that MHC-coded antigens present 
in the thymus, interact with T cell receptors that recognize these 
self-antigens. Mutation of the genes coding for the receptors 
recognizing self-antigens results in the formation of a mutant 
receptor, recognizing a foreign antigen. Because some antigens 
cannot be recognized by any of the occurring receptor mutants, 
the set of receptors for foreign antigens does not encompass all 
foreign antigens. The sets of antigens "recognized" by the recept-
ors of T cells, i.e. the antigen repertoire, will be determined 
by the MHC of the thymus, if it is assumed that mutants of recept-
ors for self-MHC-coded antigens of mouse strain A are different 
from those for self-MHC-coded antigens of strain B (Jerne, 1971; 
Von Boehmer et al., 1978). In this way an explanation is provided 
for the fact that strain A is a responder to antigen X, while 
strain B is a non-responder, since the latter is not able to 
generate mutant receptors for this same antigen (Jerne, -1971; 
Von Boehmer et al., 1978}. 
It has been demonstrated that any one particular cytotoxic T cell 
has receptors with specificity for either K-region coded products 
or for D-region coded products, but not for both (Zinkernagel and 
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Doherty, 1975). This genetic exclusion of the presence of receptor 
with specificity for K- or D-region coded products stands in con-
trast to the presence of both K- and D-region coded antigenic de-
terminants on the same cell. The consequence of the resulting two 
distinct subsets of T cells, each showing receptor specificity ex-
clusively for K- or D-region coded antigens, is that the individua 
animal is not dependent on a single "Ir gene" for a particular 
pathogenic organism but on two different "Ir genes". The set of 
T cells with the most suitable receptor for the antigen will be 
stimulated, at the expense of the set of T cells which have a 
low responder trait for this antigen {Zinkernagel et al., 1978c). 
The occurrence of many alleles of the genes present in the MHC 
of any one species can also be explained by the proposed influence 
of MHC-coded antigens on the T cell receptor repertoire. On the 
basis of this hypothesis, it follows, that the polymorphism of 
the MHC is advantageous for the maintenance of the species. The 
existence of many alleles of a certain "Ir gene" minimizes the 
overall incidence of low responsiveness to life-threatening patho-
genic organisms (Zinkernagel et al., 1977). 
6.3.B. Models of the T cell receptor 
A number of alternative models have been proposed to explain MHC-
restricted recognition of antigens by T cells {Dutton et al., 
1978): the altered-self model and the dual recognition model 
(Fig. 4). In the altered-self hypothesis it is assumed that an 
antigen X associates with the MHC-coded antigen to form a hybrid 
molecule or a neoantigen. This complex molecule is then recognized 
by a single receptor for this altered-self MHC-coded antigen. The 
dual recognition hypothesis states that a T cell has two diffe-
rent receptors, one for antigen X, and another for a particular 
self-MHC-coded antigen. A variant of the dual recognition hypo-
thesis, the separate site hypothesis, assumes that a single 
receptor recognizes the antigen X and the self-MHC-coded anti-
gen (Fig. 4). Cross-linking of two of these identical receptors 
would result in the activation of the T cells. 
In the thymus the T cells learn to recognize self-MHC-coded 
antigens and there they develop their receptor repertoire. These T 
cell receptors are generated endogeneouslyi they are not passive-
ly adhered to the cell surface (Von Boehmer et al., 1979). Accor-
ding to the altered-self model T cells which have a receptor for 
antigens only slightly different from self-MHC-coded antigens will 
be positively selected in the thymus. According to the dual 
recognition_ theory, in the differentiation of T cells one receptor 
is positively selected for its (low) affinity for self-MHC-coded 
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antigens in the thymus, and the other receptor, of independent 
origin, is negatively selected on the basis of non-reactivity 
with self-antigens. 
T 
~ 
antigen presenting cell antigen presenting cell ~ antigen presenting cell 
Altered-self Separate-site Dual- r ec ognit ion 
~ neoantigen formed by association of antigen X and MHC-coded antigen 
6. antigen X 
• MHC-coded antigen 
Fig. 4 
Models of the antigen receptor of T cells. 
According to the altered-self hypothesis, allo-MHC-coded antigens 
must be considered as identical to altered-self antigens. Since 
all T cells are reactive to altered-self antigen, and might cross-
react with allo-MHC-coded antigens, the high number of alloreact-
ive T cells is not suprising if the altered-self hypothesis is 
accepted (Matzinger and Bevan, 1977) . Support for this hypothesis 
can also be found in observations that H-2 restricted killer cells 
specific for antigen X can lyse allogeneic target cells expressing 
neither the antigen X, nor the restricting self-MHC-coded antigen 
(Bevan, 1977a; Finberg et al., 1978; Von Boehmer et al., 1979). 
Reports showing self-preference of immunocompetent peripheral T 
cells rather than absolute self-restriction in antigen recognition, 
also argue for the altered self-hypothesis. This is because, in 
principle, no difference exists between modified self-MHC-coded 
antigens and modified nonself-MHC coded antigens since both are 
formed by the interaction of a MHC-coded molecule and a foreign 
antigen. The altered-self hypothesis predicts the existence of 
cells in a normal T cell population that are specifically react-
ive in a H-2 restricted manner to modified H-2 incompatible allo-
geneic cells. Thus, T cell receptors may exist which recognize 
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both antigen X in association with a particular allo-MHC-coded 
antigen, and antigen z in association with a self-MHC-coded 
antigen (Doherty and Bennink, 1979). The failure to find this 
"cross-reactivity" in some studies (Shearer and Schmitt-Verhulst, 
1977) would appear to reflect the existence of only a limited 
number of T cell receptors with such a cross-reactivity. 
The dual recognition theory does not explain the high frequency 
of T cells which are specific for allo-MHC-coded products, since 
no positive selective force exists in the thymus for T cells 
with this type of receptor. On the other hand, it has been sug-
gested recently that the number of alloreactive T cells, directed 
only to MHC-coded antigens, is not as large as has generally been 
assumed. A preliminary observation reported by Marbrook et al. 
(1978), showed that the number of precursor CTL for H-2 allo-
antigens was much less if assayed in the absence of accompanying 
minor H-alloantigens. The dual recognition theory can explain thiE 
finding by assuming that the anti H-2 antigen receptors have a 
wide range of affinity for these H-2 alloantigens. Cells with a 
low affinity receptor for an H-2 alloantigen require binding of 
the anti-X receptor with a minor H-antigen for optimal stimula-
tion. 
At present, the altered-self hypothesis is the most accepted one, 
mainly because of it 1 s attractive simplicity and the demonstratior 
that T cells which are specifically reactive to allo-MHC-coded 
antigens can indeed recognize foreign antigens in an H-2 restrict-
ed manner. The self-preference, rather than absolute restriction, 
in antigen recognition, demonstrated in several studies (e.g. 
most recently of Blanden and Andrew, 1979), also points to a T 
cell receptor commensurate with the altered-self hypothesis. 
6.3.C. The variable part of the T cell receptor 
The antigen receptor repertoire of T cells and B cells is partly 
the same. Despite the demonstration of a number of differences 
in antigen recognition between T and B cells, a common gene 
pool, coding for parts of the T cell as well as the B cell recep-
tor, cannot be ruled out (Lindahl and Rajewski, 1979). The 
antigen receptor of B cells consists of a surface immunoglobulin 
molecule composed of heavy (H-)chains and light (L-)chains. The 
immunoglobulin molecules partly have a constant amino acid 
sequence; the part determining the antigen specificity of the 
receptor has a variable sequence. Variable regions can be found 
on the H-chains (V ) as well as on the L-chains (V ) . The antigen 
"f" 't f h H L specl lCl y o t e VL and VH chains are thought to result from 
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a random process of somatic mutation of genes coding for the VL 
and VH chains of the immunoglobulin molecules (V-genes) (Jerne, 
1971). The antigen-binding sites of such an immunoglobulin 
receptor lie within the V-region (Jerne, 1971). Antibodies spe-
cific for the antigen-recognition sites in the V-region of the 
immunoglobulin receptor (anti-idiotypic antibodies) can effect-
ively inhibit antigenic stimulation of antigen-specific B cells. 
With these anti-idiotypic antibodies it has been demonstrated 
that T cells and B cells can utilize similar V-gene products when 
responding to an antigen (Binz and Wigzell, 1975; Cosenza et al., 
1977). In addition, it has been suggested that different function-
al T cell subsets selectively utilize either VH or VL gene-
coded structures for antigen recognition in contrast to B cells 
which use both (Lanai et al., 1978). It is uncertain whether genes 
in the H-2 complex can influence the T cell receptor idiotypes. 
Thus, while Krammer and Eichman (1977) presented data which clearly 
showed that the T cell receptor idiotypes, recognizing alloantigens, 
are controlled by H-2 genes, Bellgrau and Wilson (1978) were unable 
to demonstrate MHC-polymorphism of T cell receptors specific for 
alloantigens. 
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INTRODUCTION TO THE PAPERS 
The cellular basis of delayed type hypersensitivity (DTH) direc-
ted either to the particular thymus-dependent antigen, SRBC, or 
to non H-2 coded tissue antigens is described in the papers I, II, 
III and IV, added to this thesis. Low doses of SRBC, suspended in 
saline, were used as the immunizing antigen. Consequently, DTH-
related T cell functions could be studied under experimental con-
ditions in which the possible influence of persisting antigens was 
limited. The results obtained with the antigen SRBC, were compared 
with results from experiments using longer persisting antigens, 
viz. minor H-antigens, presented on viable H-2 compatible cells 
(paper IV). The genetic requirements for induction and expression 
of DTH to minor H-antigens were investigated in two different 
models, the graft-versus-host (GvH) assay and the host-versus-
graft (HvG) assay (paper V and VI). 
The first paper (appendix paper I) concerns a study of anamnes-
tic or secondary DTH to SRBC. In this paper the kinetics of 
secondary DTH to SRBC after optimal i.v. priming and booster was 
compared with the kinetics of the primary DTH after optimal i.v. 
immunization. The T cell dependence of the phenomenon of second-
ary DTH was also investigated. 
Appendix paper II further characterizes the T cells accounting 
for secondary DTH. By means of parabiosis experiments, it was 
tested whether DTH-related T memory cells are long-lived, poten-
tially circulating cells, which can persist in the absence of 
antigen. Furthermore, it was studied whether the DTH-related T 
memory cells accounting for secondary DTH were sensitive to sub-
cutaneous (s.c.) injection with ATS, which implies that they are 
recirculating cells {Levey and Medawar, 1967). The role of proli-
feration in the secondary DTH response was investigated by treat-
ment of primed mice with antimitotic agents before or after the 
booster injection. 
Appendix paper III deals with the contribution of short-lived 
(Tl) and long-lived (T2) precursor cells to primary DTH and 
DTH-related T memory. The methods used in this study were thymec-
tomy of adult mice (ATx) and ATS pretreatment. The results of 
this study were compared with those of Araneo et al. (1977) on 
the T helper cells. 
Appendix paper IV described the kinetics of primary and secon-
dary DTH to multiple minor H-antigens, or a single minor H-
antigen. These minor H-antigens were presented on viable cells, 
H-2 compatible with the recipient. It was also tested whether 
secondary DTH-responsiveness can be evoked to multiple minor 
H-antigen incompatible spleen cells which simultaneously present 
incompatible H-2 alloantigens. On the basis of the results 
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reported in this paper it was speculated that persistent DTH 
as observed in studies on tuberculin type DTH is dependent on 
the continuous antigen-driven differentiation of long-lived 
recirculating T memory cells into functionally short-lived DTH 
effector cells. 
In appendix paper V the role of the Mls locus coded H-antigens 
was studied in DTH assays, based on the HvG model as described 
in appendix paper IV and the GvH model, as described previously 
by Wolters et al. (1978). The latter authors described a DTH 
assay which is fit to measure the development of H-antigen in-
duced DTH effector T cells during a GvH reaction. 
In appendix paper VI the influence of H-2 compatibility of in-
jected allogeneic spleen cells on (1) induction of DTH-effector 
T cells and memory T cells, (2) the booster phase and (3) the 
elicitation of the DTH reactivity to minor H-antigens was exa-
mined with congenic mouse strains. The capacity of T cells, sens-
itized to multiple minor H-antigens, for mounting a local GvH 
reaction in different H-2 congenic mouse strains was investi-
gated with the immune lymphocyte transfer assay. 
SUMMARY 
Peripheral T cells with a particular immunological function (e.g. 
helper function, suppressor function, resistance to bacteria) can 
be subdivided according to their differentiation stage (Fig. 3}. 
Short-lived "virgin11 Tl cells are cells, which have recently 
originated in the thymus and they can differentiate into the long-
lived T2 cells. These, unprimed, T2 cells are mainly involved in 
the primary T cell immune response, since after immunization they 
can rapidly differentiate into the short-lived effector T cells. 
Priming of mice not only results in a primary immune response, 
but also in the formation of T memory cells which, upon restimu-
lation with the specific antigen, account for secondary immune 
responsiveness. These T memory cells are long-lived, potentially 
recirculating cells, and they do not perform an effector function, 
unless restimulated. It is not known, whether the unprimed T2 
cells are qualitatively different from the memory T cells accoun-
ting for secondary immune responsiveness. Memory might also be a 
quantitative phenomenon, resulting from the increase in the number 
of antigen-specific T2 cells. 
From the data provided by literature it appears that a few excep-
tions to this general plan of peripheral T cell differentiation 
may exist: 
1. T cells whose function it is to amplify the immunological 
function of T2 cells have the properties of Tl cells. These Tl 
cells probably do not differentiate into T2 cells before they 
have carried out amplifying function. 
2. T 11 memory 11 cells accounting for second set graft rejection 
across major H-differences are possibly non-recirculating 
effector cells with a long lifespan. 
3. T cells accounting for persistent tuberculin type DTH were 
thought to be long-lived T (memory} cells with an effector 
function. 
Our results suggest that the T cells involved in the transient 
state of DTH to SRBC or in the persistent state of DTH to minor 
H-antigens can be classified according to the above mentioned 
scheme of peripheral T cell differentiation, without evoking 
additional T cell populations with exceptional properties. 
H-2 complex coded antigens play a different role under GvH con-
ditions than under HvG conditions. During HvG reactions the K- and 
D-region coded products constitute the major target antigens of 
the cytotoxic reaction, whereas in GvH the I-region coded antigens 
are most important. These I-region coded antigens can strongly 
stimulate T lymphocyte proliferation in primary MLR. Similarly, 
Mls locus products can strongly stimulate a primary MLR. In this 
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respect, the Mls locus products stand in contrast to the other 
minor H-antigens which are not able to induce a primary MLR. In 
parallel with the comparatively strong GvH inducing capacity of 
I-region coded alloantigens, we found a similar capacity of sti-
mulatory Mls-locus antigens to produce DTH effector cells under 
GvH conditions. Under these conditions, the other minor H-
antigens only slightly contributed to the DTH response. 
Peripheral T cells generally recognize antigens in association 
with self-MHC-coded antigens. This also applies to DTH-reactive T 
cells. Data from the literature suggested that the region(s) of 
the H-2 complex involved in recognition of antigens by DTH-reac-
tive T cells is (are) determined by the type of immunizing anti-
gen. Our study with congenic mouse strains indicated that DTH 
reactivity to minor H-antigens was restricted by the K- and D-
region of the H-2 complex. 
In appendix paper I the kinetics of primary and secondary DTH to 
SRBC are compared. It was shown that secondary DTH was character-
ized by an earlier appearance of the state of DTH, an earlier 
peak reactivity and a somewhat increased intensity of the DTH 
response, as compared to the primary DTH response. Secondary DTH 
responsiveness could be elicited at a time when no detectable 
primary DTH was present, for up to at least one year after optimal 
i.v. priming. The capacity of secondary DTH could be adoptively 
transferred into lethally irradiated recipients by means of 
Thy-1.2+ spleen cells. The cellular basis of this secondary DTH 
responsiveness was further investigated by the experiments pre-
sented in appendix paper II. Parabiosis, for a three week period, 
of non-immunized mice and mice primed at least 2 months previously, 
resulted in the transfer of DTH-related T memory cells to the non-
immunized partners. The presence of antigen in the non-immunized 
partner can virtually be excluded, and the capacity of secondary 
DTH reactivity in these mice, at long intervals after termination 
of the parabiosis, indicates that DTH-related T memory cells are 
long-lived, potentially circulating cells, which can persist in 
the absence of antigen. S.c. treatment of i.v. primed mice with 
a dose Of ATS, which depletes the recirculating T cell pool, did 
not inhibit the expression of secondary DTH responsiveness in i.v. 
boosted mice. Secondary DTH reactivity in s.c. boosted mice was 
inhibited by this ATS treatment. The DTH-related T memory cells 
probably consist partly of non-recirculating sessile cells and 
partly of rapidly recirculating T cells. It was further demonstra-
ted that the T memory cells themselves do not perform a detect-
able effector function, but their progeny, which arises from them 
in an antigen-driven step accompanied with proliferation. 
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In appendix paper III the contribution of short-lived Tl and 
long-lived T2 precursor cells to primary DTH and DTH-related T 
memory was investigated. It seemed feasible that only one, long-
lived, population of recirculating T cells accounts for primary 
DTH. Furthermore, both Tl and T2 cells contribute to the popul-
ation of T memory cells accounting for secondary DTH. The pres-
ence of the thymus, and probably of Tl cells, seems to be re-
quired for the generation of antigen-reactive T2 cells. The gene-
ration of T2 cells can take place without deliberate immunization. 
It was postulated, on the basis of the experiments described in 
this paper, that Tl cells can compensate for the absence of T2 
cells during generation of T memory cells, but T2 cells cannot do 
so for the loss of Tl cells. Antigen stimulation might at first 
stimulate the more mature T2 cell pool to carry out their immun-
ological function. If necessary, the Tl cell pool can supplement 
the contribution of the T2 cell pool to the immune response. The 
possibility that the short-lived effector T cells can revert to 
T memory cells in the absence of antigenic stimulation was not 
investigated. 
In appendix paper IV it is shown that a single s.c. immunization 
of mice with viable allogeneic H-2 compatible spleen cells can 
induce a persistent state of DTH to multiple minor H-antigens as 
well as generating DTH-related T memory cells specific for these 
antigens. Boosting of such primed mice at long intervals after 
priming resulted in a secondary type DTH reactivity. Secondary 
DTH to semi-allogeneic H-2 incompatible spleen cells could not 
be induced. It was suggested in this paper that persistent DTH 
might be dependent on the continuous antigen-driven differentiat-
ion of long-lived recirculating T memory cells into functionally 
short-lived DTH effector cells. 
In appendix paper V it was demonstrated that under GvH conditions 
created with H-2 compatible, minor H-antigen incompatible mouse 
strain combinations, DTH-reactive cells were generated which were 
specific for Mls coded antigens. These cells only occurred if Mls 
locus antigens were involved which are stimulatory in primary MLR. 
The contribution of other minor H-antigens was minimal under these 
GvH conditions. In contrast, under HvG conditions the influence of 
the Mls locus coded antigens was negligable, while under these HvG 
conditions the other minor H-antigens played an essential role. 
It was concluded that the Mls locus resembles the I-region in that 
both are mainly involved in GvH reactions and primary MLR. 
The genetic requirements for (1) induction of DTH effector T cells 
and DTH-related T memory cells, (2) restimulation during the booster 
phase in secondary DTH and (3) the elicitation of DTH reactions 
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to minor H-antigens, were investigated in the experiments descri-
bed in appendix paper V. Optimal induction of primary DTH and 
DTH-related memory for minor H-antigens required identical H-2 
haplotypes in the immunizing cells and the recipient. Boosting 
was not strongly dependent on the H-2 haplotype of the cells 
used for booster injection. The expression of the DTH-reactivity 
to minor H-antigens was restricted by K- and D-region coded anti-
gens. Elicitation of a DTH reaction to minor H-antigens with full~ 
H-2 incompatible cells led to a comparatively weak, though signi-
ficant DTH reaction. Our results in addition to those obtained by 
other authors, provide support for the hypothesis that different 
T cell subpopulations (e.g. Lyt-1+ and Lyt-23+ cells) can mediate 
DTH reactivity. 
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SAMENVATTING 
Perifere T lymfocyten, die een bepaalde immunologische functie 
vervullen {b.v. helper functie, suppressor functie, resistentie 
tegen bacterien) kunnen worden ingedeeld op grand van hun diffe-
rentiatiestadium (Fig. 3). Kortlevende "virginale" Tl lymfocyten 
zijn cellen, die onlangs in de thymus zijn ontstaan, en deze Tl 
cellen kunnen verder differentieren tot de langlevende T2 cellen 
zonder dat er van opzettelijke immunisatie sprake is. T2 cellen 
leveren de belangrijkste bijdrage tot de primaire T cellulaire 
immuunresponse. Na immunisatie kunnen de T2 cellen snel differen-
tieren tot de kortlevende effect-:::>r T cellen, die de uiteindelijke 
immuunreaktie teweeg brengen. Immunisatie van muizen leidt niet 
alleen tot een primaire immuunresponse, maar ook tot de vorming 
van T memory cellen, die, na restimulatie met het specifieke 
antigeen, verantwoordelijk zijn voor de secundaire immuunresponse. 
Deze T memory cellen hebben een lange levensduur, zijn in staat 
tot recirculatie, en oefenen geen effector functie uit, tenzij 
wederom door het specifieke antigeen gestimuleerd. Het is on-
duidelijk, of de T2 cellen in het ongeimmuniseerde dier kwalita-
tief verschillen van de T memory cellen, die verantwoordelijk 
zijn voor de secundaire immuunresponse. Memory zou namelijk ook 
kunnen berusten op de toename, ten gevolge van de immunisatie, 
van het aantal antigeen-specifieke T2 cellen, welke cellen kwali-
tatief niet zouden verschillen van de "spontaan" gevormde T2 
cellen. 
Uit literatuurgegevens blijkt, dat mogelijk enkele uitzonderingen 
op dit algemene model van perifere T eel differentiatie bestaan: 
1. T cellen, die de immunologische functie van T2 cellen ver-
sterken, de z.g. amplifier T cellen, hebben de eigenschappen 
van Tl cellen. Deze Tl cellen hoeven waarschijnlijk niet te 
differentieren tot T2 cellen, alvorens hun "amplifier 11 functie 
uit te oefenen. 
2. T "memory" cellen, verantwoordelijk voor de "second set" 
transplantaatafstoting, waarbij verschillen in het H-2 com-
plex een rol spelen, zijn waarschijnlijk niet-recirculerende 
effector T cellen, met een lange levensduur. 
3. T cellen verantwoordelijk voor persisterende tuberculine type 
vertraagde overgevoeligheid {DTH) zouden langlevende T memory 
cellen zijn met een effector functie. 
Onze resultaten suggereren echter, dat zowel T cellen betrokken 
bij de kortlevende staat van DTH (Jones Mote type) als T cellen 
betrokken bij de persisterende staat van DTH (tuberculine type) 
geklassificeerd kunnen worden volgens het bovengenoemde schema 
van perifere T eel differentiatie {Fig. 3), zonder de noodzaak 
om een T eel populatie met uitzonderlijke eigenschappen te 
postuleren. 
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Antigenen gecodeerd door het H-2 complex spelen onder transplan-
taat-versus-gastheer (GvH) omstandigheden een andere rol dan 
onder gastheer-versus-transplantaat (HvG) omstandigheden (Tabel 
5). Tijdens HvG reakties vormen de door de K- en D-regio geco-
deerde weefselantigenen de voornaamste antigenen, waartegen de 
cytotoxische reaktie gericht is, terwijl daarentegen in de GvH 
reaktie de door de I-regio gecodeerde antigenen het belangrijkste 
zijn. Deze in de I-regio gecodeerde weefselantigenen veroorzaken 
een sterke proliferatie van T lymfocyten in de primaire gemengde 
lymfocytenkweek (MLR). Eveneens kunnen de weefselantigenen, geco-
deerd door de Mls locus een primaire MLR induceren. In dat opzicht 
verschillen de Mls locus gecodeerde antigenen van de andere "minor 
weefselantigenen, die niet in staat zijn T eel proliferatie in een 
primaire MLR teweeg te brengen. Parallel aan de krachtige GvH indu· 
cerende werking van in de I-regio gecodeerde weefselantigenen, 
vonden we, dat Mls locus gecodeerde antigenen onder GvH omstandig-
heden grote aantallen DTH effector cellen doen ontstaan, terwijl 
hierbij de overige "minor" weefselantigenen geen belangrijke rol 
spelen. 
Perifere T cellen herkennen in het algemeen antigenen in samen-
hang met een weefselantigeen gecodeerd door het eigen "major 
histocompatibility complex". Dit verschijnsel, in de muis genoemd 
H-2 restrictie, geldt ook voor T cellen betrokken bij de DTH res-
ponse. Gegevens uit de literatuur suggereren, dat het antigeen 
bepaalt, welke regio(nen) van het H-2 complex betrokken is (zijn) 
~ij de herkenning van het desbetreffende antigeen door de DTH-
reactieve T cellen (Tabel 6). Onze studie met congene muizestam-
men toonde aan, dat DTH voor "minor" weefselahtigenen onderhevig 
is aan restrictie door K- en D-regio gecodeerde weefselantigenen. 
In appendix paper I werd de kinetiek van de primaire en secun-
daire DTH met elkaar vergeleken. Gevonden werd dat secundaire DTH 
gekarakteriseerd is door een vervroegd ontstaan van de staat van 
DTH, een eerdere piek, en een enigszins verhoogde kracht van de 
DTH response, vergeleken met de primaire DTH. Een staat van secun-
daire DTH kon worden geinduceerd op een tijdstip waarop geen 
primaire DTH meer aantoonbaar was, en wel tot minstens 1 jaar na 
intraveneuze (i.v.) irnmunisatie met de optimale dosis SRBC. De 
capaciteit tot secundaire DTH kon adoptief worden overgedragen 
naar letaal bestraalde recipienten door middel van Thy-1.2+ milt-
cellen. De cellulaire basis van dit verschijnsel van secundaire 
DTH werd verder onderzocht in de experimenteD omschreven in appen-
dix paper II. Parabiose gedurende een periode van 3 weken, van 
niet-geimmuniseerde muizen en muizen, minstens 2 maanden eerder 
geimmuniseerd, had tot gevolg dat DTH-reactieve T memory cellen 
overgedragen werden naar de niet-geimmuniseerde partners. De aan-
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wezigheid van antigeen in de niet-geimmuniseerde partner kan in 
feite uitgesloten geacht worden. De capaciteit tot secundaire DTH 
in deze niet-geimmuniseerde dieren, lang na de beeindiging van de 
parabiose, toonde aan, dat de DTH-reactieve T memory cellen lang-
levende cellen zijn, die in de bloedsomloop kunnen voorkomen, ter-
wijl ze blijven voortbestaan in afwezigheid van antigeen. Subcu-
tane (s.c.) -behandeling van i.v. geimmuniseerde muizen met anti-
thymocyten serum {ATS}, dat de recirculerende T eel populatie uit-
schakelt, had nauwelijks invloed op het vermogen tot secundaire 
DTH na intraveneuze booster. De capaciteit tot een secundaire DTH 
response in muizen geboosterd via de s.c. route ging wel verloren 
door ATS behandeling. waarschijnlijk bestaan de DTH-reactieve T 
memory cellen deels uit niet recirculerende sessiele cellen, en 
deels uit snel recirculerende T cellen. Verder werd aannemelijk 
gemaakt, dat door de T memory cellen zelf geen effector functie 
wordt uitgeoefend, maar wel door hun nageslacht, dat onder invloed 
van antigenen uit de memory cellen voorkomt. In het geval van 
immunisatie met SRBC gaat dit laatste proces gepaard met prolife-
ratie van de memory cellen. 
In appendix paper III werd de bijdrage van kortlevende Tl en 
langlevende T2 voorlopercellen aan primaire DTH en de vorming 
van DTH-reactieve T memory cellen onderzocht. Het leek zeer waar-
schijnlijk, dat slechts een enkele, langlevende, populatie recir-
culerende T cellen een rol speelt in de primaire DTH. Verder 
zouden zowel T1 als T2 cellen bijdragen tot de vorming van DTH-
reaktieve T memory cellen, die de secundaire DTH bewerkstelligen. 
De aanwezigheid van de thymus, en vermoedelijk van T1 cellen, 
lijkt vereist voor de vorming van antigeen-reaktieve T2 cellen. 
De vorming van T2 cellen kan plaatsvinden zonder opzettelijke 
immunisatie. Op grand van de experimenten, die beschreven zijn in 
dit artikel, werd gespeculeerd dat T1 cellen kunnen compenseren 
voor de afwezigheid van T2 cellen tijdens de vorming van T memory 
cellen, maar dat T2 cellen dat niet kunnen bij een tekort aan T1 
cellen. Antigene stimulatie zou allereerst de rijpere T2 eel popu-
latie activeren tot het uitoefenen van hun immunologische functie. 
zo nodig kan de Tl eel populatie de bijdrage van de T2 cellen voor 
de immuunresponse aanvullen. De mogelijkheid, dat kortlevende 
effector T cellen kunnen "terugdifferentieren" tot T memory eel-
len, wanneer ze niet door antigeen gestimuleerd worden, werd niet 
in beschouwing genomen. 
In appendix paper IV is aangetoond, dat een enkele s.c. immunisa-
tie van muizen met levende allogene H-2 compatibele miltcellen 
een persisterende staat van DTH tegen "minor" weefselantigenen 
kan teweeg brengen, tezamen met de vorming van DTH-reactieve 
T memory cellen specifiek voor deze antigenen. Booster van der-
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gelijk geimmuniseerde dieren enkele maanden later .. leidde tot het 
optreden van een secundaire staat van DTH. Secundaire DTH tegen 
semi--allogene H-2 incompatibele miltcellen kon niet worden geindu-
ceerd. Op grand van de gegevens, beschreven in dit artikel werd 
gesuggereerd, dat persisterende DTH afhankelijk zou zijn van de 
voortdurende differentiatie, onder invloed van antigenen, van 
langlevende recirculerende T memory cellen tot functioneel kort-
levende DTH effector cellen. 
In appendix paper V werd aangetoond, dat GvH omstandigheden, ver-
kregen door bestraalde ontvangers te reconstitueren met allogene 
miltcellen uit H-2 compatibele donoren, kunnen leiden tot het ont-
staan van DTH-reactieve T cellen. Deze DTH-reactieve T cellen zijn 
alleen gericht tegen Mls locus gecodeerde antigenen, en dan alleen 
tegen die, welke in een primaire MLR een stimulatoire rol spelen. 
De bijdrage van de andere "minor" weefselantigenen was minimaal 
onder deze GvH omstandigheden. In tegenstelling hiermee was onder 
HvG omstandigheden de invloed van de Mls locus gecodeerde anti-
genen verwaarloosbaar. In dit laatste geval speelden de andere 
"minor" weefselantigenen een essentiele rol. Geconcludeerd werd, 
dat de Mls locus lijkt op de I-regio van het H-2 complex, omdat 
beide coderen voor weefselanti9enen, die een belangrijke rol spelen 
in GvH en MLR. 
De genetische vereisten voor (1) inductie van DTH-reactieve effec-
tor cellen en T memory cellen, (2) restimulatie tijdens de boos-
ter phase voor de secundaire DTH en (3) het oproepen van DTH 
reacties tegen "minor" weefselantigenen werd onderzocht in 
appendix paper VI. Voor optimale inductie van primaire DTH en 
memory voor "minor" weefselantigenen was H-2 identiteit van de 
immuniserende cellen met de recipient vereist. De booster phase 
is waarschijnlijk in mindere mate afhankelijk van het H-2 haplo-
type van de cellen, die gebruikt worden voor booster injectie. 
De expressie van de DTH voor "minor" weefselantigenen was alleen 
krachtig, wanneer de cellen, waarmee de DTH reactie werd opge-
roepen, en de recipient de K- en/of D-regio van het H-2 complex 
gemeen hadden. Het opwekken van een DTH reactie tegen "minor 11 
weefselantigenen met volkomen H-2 incompatibele cellen leidde tot 
een vrij zwakke, maar wel significante DTH reactie. Onze resul-
taten, in samenhang met die van andere auteurs, ondersteunen de 
hypothese, dat verschillende T eel subpopulaties (b.v. Lyt-1+ en 
Lyt-23+ cellen) een staat van DTH tot stand kunnen brengen. 
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Secondary Delayed-Type Hypersensitivity to Sheep Red Blood 
Cells in Mice: A long-lived Memory Phenomenon 
TnEonoRus H. VANDER KwAsT, JoHANNA G. 0LTHOF, AND RonBERT BENNER 
Department of Cell Biolog}' and Genetics, Erasmus UniversitJ,.', P.O. Box 1738, 
Rotterdam, The Netherlands 
Recch,cd August 2, 1977 
Immunization of mice ·with sheep red blood cells (SRBC) can induce the capacity 
to react with a secondary delayed-type hypersensitivity (DTH) immune response 
upon a booster injection of the antigen. In this paper the kinetics of secondary DTH 
after intravenous (iv) immunization with various doses of SRBC was studied by means 
of the foot swelling test. Dose-response studies sho\ved that maximal secondary DTH 
responsiveness was obtained by iv administration of a priming dose of 3 X 104 SRBC 
and a booster dose of 3 X 10~ SRBC 2 months later. Secondary DTH in such treated 
mice was characterized by an earlier appearance of the state of DTH, an earlier 
peak reactivity, and an increased intensity of the DTH response as compared to the 
primary DTH response. Up to 1 year after priming, a secondary DTH could be 
elicited, indicating the long-lived character of this memory phenomenon. With increas-
ing intervals between the priming and booster injection, a gradual shift to a later 
time, of the peak secondary DTH reactivity \Vas found. The capacity of primed mice 
to react with an increased intensity upon a booster injection could be adoptively trans-
ferred into lethally irradiated recipients by means of spleen cells obtained from primed 
mice. This phenomenon appeared to be highly dependent on Thy 1.2+ cells and on the 
booster dose of SRBC. The DTH reaction, evoked in such recipients, showed a pro-
longed time course. 
INTRODUCTION 
Secondary-type responsiveness for delayed-type hypersensitivity (DTH) has 
been described for a number of antigens including proteins ( 1), a contact sensitivity 
agent (2), Mycobacterium tuberculosis ( 3), Listeria monocytogenes ( 4), and 
sheep red blood cells (SRBC)· (5). Most authors did not study secondary DTH 
systematically but noticed a higher percentage of responder animals after two 
instead of one injection. Only Cro1-vle (6) carefully reviewed these data and de-
scribed some general properties of secondary DTH: a more rapid sensitization 
after the second application of the antigen as compared to the first exposure, an 
increase of the intensity of an already existing primary hypersensitivity, the finite 
period of its induction in primed mice, and the ability to transfer the property of 
accelerated sensitization to syngeneic recipients by means of spleen cells. It was 
proposed that the interval \'\·hich allows successful restimulation depends on (i) the 
route of immunization ( 6) and ( ii) the persistence of the state of primary DTH 
( 4, 6). This persistence of the state of DTH would depend on the presence of 
nonreplicating, vinblastin-resistant cells ( 4). 
Copyright© 1977 by Academic Press, Inc. 
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For the antigen SRTIC Lagrange a1Hl1fackaness (7), usi11g the iv inmtutlizatiott 
route, failed to demonstrate a secondary DTH response in primed normal mice. 
However, in previously splenectomized mice (8) or in mice that had been pre-
treated ,vith cyclophosphamide and Baci!lc Calmctte GuCri11, an increase of the in-
tensity of DTH 'Yas ohseryecl after iv injection of a hno:>ter do:;e of SRBC (7). 
Recently Tamura and Egashira ( 5) found that subcutaneous ( sc) priming and a 
subsequent booster injection with SRBC resulted in an accelerated DTH respon-
siveness. They did not study the other ahoYe-mentioned properties of secondary 
DTH. These authors concluded that priming of mice with SRBC induced DTH-
related memory cells. 
In cell-mediated immunity both short-lived and long-lived memory exist (9). 
An example of a short-lived memory phenomenon in cell-mediated immunity is 
the capacity of secondary-type mixed lymphocyte reaction ( XILR). A second-set 
skin graft rejection can be considered as a long-li,·ed memory phenomenon (9). 
In this paper we investigated the kinetics of secondary DTH after iv imnmniza-
tion with SRBC. Furthermore, the influences of antigen close and interval between 
priming and booster on the reaction pattern were studied. 
MATERIALS AXD ~IETHODS 
Ani11lals. (C57BL/Rij X CBA/Rij) Fl female mice, 20 to 30 weeks old, were 
used. In one transfer experiment male (C57BL/Rij X CBA/Rij) F1 mice 'vere 
used, as indicated in the text. The mice were purchased from the 1\-Ieclical Biologi-
cal Laboratory, Rijswijk, The Xetherlands, and the Laboratory Animals Center of 
the Erasmus Gniversity, Rotterdam, The 1\ etherlands. 
Antigen and immunization. Sheep red Llood cells were commercially ohtainecl, 
stored, and '"ashed as described preyiously (10). Primary and secondary immu-
nization was performed by iv injection of the SRBC in 0.5 ml of saline. The chal-
lenge dose '\"as administered sc in the instep of the right hind foot. 
Preparation of cell suspensions for adopti'l'C transfer. Single cell suspensions 
were prepared in a balanced salt solution as described in a pre\·ious paper from 
our laboratory ( 11). Bone marrow was collected from femurs and tibias. Lethally 
irradiated recipients were injected i\· with the appropriate cell suspension and 3 X 
10', 3 X 10', or 3 X 10' SRBC in a total Ynlume of O .. i mi. 
Antisera. The production of anti-Thy 1.2 .antisera and their use for the selective 
elimination of T cells in the spleen haYe Leen clescribe<l previously ( 11). 
Cell counts. Viable cells were counted in a hemocytometer using 0.2j'o trypan 
blue in phosphate-buffered saline (PBS) as diluent. 
Irradiation. The recipient mice recei\·ed 925 rad of \Yhole-hocly irradiation gen-
erated in a Philips-1\Iiiller J\IG 300 X-ray machine. Animals were irradiated in 
well-aerated circular Perspex cages. Physical constants of the irradiation were: 
250 kV (constant potential); 10 mA; added filtration of 1.0 nun of Cu; correction 
of irradiation for field inhomogeneity; focus-object distance, 53 em; close rate, 30-
35 radjmin. During irradiation the dose was measured with a Baldwin Ionex 
dosimeter. The recipient mice were injected iv \Yith the appropriate cell suspension 
24 hr after irradiation. 
Assay for dela}'ed-type hypersensitivity. DTH reactions were determined by 
measuring the difference in thickness of the hind feet 2-+ hr after sc injection of 
5 X 107 SRBC in the instep of the right hind leg. In transfer experiments the in-
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crease in foot thickness was also measured -+8 and 72 hr after challenge. The chal-
lenge dose was administered sc in a volume of 0.02 ml by means of a 29-gauge 
needle. The thickness of the left ancl right bind foot was measured with a footpad 
meter as described hy Bonta and \ T os ( 12), with some minor modifications. During 
measurement the mice were anesthetized with ether. 
A control group, consisting of nonimmnne mice challenged with SRBC in a man-
ner similar to the mice to be tested, was always included. The specific increase in 
foot thickness was calculated as the relative increase in foot thickness of the im-
mune mice minus the relatiYe increase in foot thickness of the control mice ( 10). 
The swelling in control mice varied between 15 and 207o. 
RESULTS 
Variation of the prillling dose. ( C57BL X CBA) F1 female mice vYere primed with 
either 3 X 10', 3 X 10', or 3 X 10' SRBC iv and boosted with 3 X 10' SRBC iv 
6 months later. Different groups of mice ·were challenged with 5 X 107 SRBC sc in 
the foot 2, 3, or 4 days after injection of the booster dose. At 24 hr after challenge, 
the DTH reaction was measured and expressed as the percentage increase of foot 
thickness. The mice primed iv \Vith 3 X 104 or 3 X 105 SRBC showed an almost 
equally high response on the second day after the booster injection, whereas mice 
primed ·with 3 X 106 SRBC showed a somewhat lower secondary DTH response 
(Fig. 1). The DTH response, evoked on the third and fourth day after booster 
injection, \vas inversely related to the priming dose. Apparently, priming with 
3 X 105 SRBC 6 months preyiously results in a diminished capacity for secondary 
DTH response in these mice, whereas this dose is optimal for induction of pri-
mary DTH (13, and our unpublished results). 
"ic spec1f1c mcrease 
foot thickness 
50 
30 
20 
10 
interval between booster and cha\lenge 
FIG. 1. Effect of variation of the priming dose on the secondary DTH response to SRBC. 
1.ficc \vere primed with either 3 X 104 (e--e), 3 X 105 (0--0), or 3 X 106 SRBC 
(A--A) and boosted with 3 X 105 SRBC 6 months later. Another 2, 3, and 4 days later 
different groups of mice were challenged. Vertical bars represent 1 SEM (n = 5). 
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T.\BLE 1 
Variation of Interval and Priming Dose on Secondary DTH to SRBC 
Priming dose 
PBS" 
3 X 10' SRBC 
3 X 10' SRBC 
3 X 10' SRBC 
Interval betwten priming and booster 
2 month,; 3 months 12 months 
1.2 ± 2.9b 0.2 ± 2.1 n.d.c 
9.5 ± 3.9 n.d. n.d. 
31.2 ± 1.4 31.4 ± 2.5 19.4 ± 2.5 
16.7 ± 4.4 20.0 ± 2.4 3.0 ± 3.0 
""PBS = phosphate-buffered saline. These mice were only immunized with 3 X 105 SRBC 
2 days before challenge. 
° Figures represent the mean ± 1 SE.M of five mice injected with 3 X 105 SRBC 2 days 
previouslv. 
c n.d. = not determined. 
Since the optimal dose for priming might depend on the interval between prim-
ing and booster, groups of mice p1·imed "\Yith varying doses of SRBC were boosted 
"\Yith 3 X 105 SRBC iv at various times after priming. Table 1 shmvs the results 
obtained with mice boosted 2, 3, or 12 months after priming with either 3 X 103 , 
3 X 10\ or 3 X lOco SRBC iY. All mice were challenged on the second day after 
booster injection. Since in normal mice no primary DTH response can be initiated 
2 days after immunization with 3 X 10;' SRBC j,-, the DTH reaction evoked on the 
second day after booster is a parameter for the leYel of secondary DTH. The prim-
ing dose of 3 X 10' SRBC appeared to be optimal at all intervals (Table 1). 
J{inetics of the sccondars DTH. Groups of mice \Yere primed with 3 X 10·• 
SRBC iv and boosted with different doses of SRBC iv 3 months later. Figure 2 
"!, spectf,c ,ncreose 
foot ~h,ck'less 
50l 
I,!J 
30 I 
20 
10 
c+-~~----~s-------~c-------'7,~ 
0 10 10 ~0 
dose of SHBC 
FIG. 2. Dose-response curve for secondary DTII, ohtaine(l in 11licc primerl \\"ith 3 X 101 SRHC 
iv 3 mouths previously. The mice were boosted \vith varying duscs of SH.BC ami cliallcngt'd 
2 days later. Vertical bars represent 1 SEM (n = 5). 
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FIG. 3. Kinetics of primary and secondary DTH to SRBC. Mice were primed for secondary 
DTH with 3 X 10{ SRBC and boosted with either 1 X lOt (D---0), 3 X 105 (0--0), 
or 1 X 105 SRBC (Ill --- Ill) 2 months later. A group of nonprimed mice of the same age 
was also immunized with 3 X 10" SRBC ( e--e) in order to induce an optimal primary 
DTH. DTH responses were determined at different days after the last immunization. Vertical 
bars represent 1 SE1vf. Each point is the mean of at least five mice. 
shows the dose~response curve v,rhen the mice \Vere challenged 2 days after booster 
injection. It was found that the booster dose of 1 X 10' SRBC evoked the strongest 
reaction \Vhen elicited on the second day after booster. 
To compare the course of the primary and the secondary DTH nonprimed mice 
and mice primed 2 months previously with 3 X 10' SRBC were immunized with 
3 X 10' SRBC. The DTH responses of these mice· were determined at different 
times after immunization (Fig. 3). Primary DTH could not be detected before 
the third day after immunization, reached a peak reactivity on the fourth day, and 
subsequently declined. Contrarily, secondary DTH was already detectable 48 hr 
after booster injection, peaked at about 72 hr, and subsequently declined. Generally 
the peak of the secondary DTH response reached a higher level than peak primary 
DTH responses to the same dose of antigen. J\iiice primed 2 months previously 
with 3 x 10' SRBC and boosted with either 1 x 10' SRBC or 1 x 10' SRBC 
showed a different reaction pattern (Fig. 3). A booster dose of 1 X 10' SRBC 
resulted into a shift of the peak response to Day 4, whereas after a booster dose of 
1 X 106 SRBC the peak response occurred by Day 2. Nevertheless, the strongest 
DTH response was obtained in mice boosted with 3 X 10' SRBC iv. 
Variation of the interval bet'lveen priming and booster. In order to study the 
kinetics of secondary DTH at different intervals after priming, mice were im-
munized iv with 3 X 10' SRBC and boosted with 3 X 10' SRBC at either 1, 3, 9, 30, 
60, or 90 days after priming. The response of primed mice which had not been 
boosted \Yas also measured. Boosting on the third clay after priming could already 
e1Jhauce the existing primary DTIT response (Fig. 4). At longer intervals between 
priming and hoosier the secondary DTH response further increased. A clear peak 
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"1. spe-c1fic increase-
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4 2 4 4 
mte-rval betwe-e-n booste-r and challenge-
FIG. 4. Effect of variation of the interval behwen priming and booster upon secondary DTH 
responsiveness. Mice \vere primed iv with 3 X 101 SRBC and boosted ·with 3 X 10~ SRBC 
iv at different intervals. DTH responses ·were evoked on different days after booster injection 
(graphs). Columns show the level of still-persisting primary DTH of similarly primed mice 2 
days after the indicated interval. These mice had only received the priming dose of 3 X 10'1 
SRBC. Vertical bars represent 1 SEU (n = 5). 
response on the third day after booster was obserYed, 1vhen a period of 60 days 
between priming and booster had passed. Thus, the kinetics of secondary DTH 
was strongly influenced by the interval between priming and booster. Also 3 months 
after priming, when primary DTH reactiYity due to priming could no longer be 
detected, a typical secondary DTH response could be induced (Fig. 4). 
Transfer of the capacity of secondary DTH. J\Tale (C57BL X CBA) F1 mice 
were primed iv with either 3 X 103 or 3 X 10-J. SRBC. Six months later, 5 X 107 
spleen cells from these mice were transferred together with 3 X lOG normal bone 
marrow cells and either 3 X 10", 3 X 10', or 3 X 10' SRBC into lethally irradiated 
recipients. As a control, normal spleen cells were transferred together with 3 X 10" 
bone marrow cells and the same doses of antigen. Four days after transfer, all re-
cipients were challenged. The DTH reactiYity 1vas determined 24, 48, and 72 hr 
after challenge. Also in these transfer experiments priming with 3 X 104 SRBC 
accounted for maximal DTH responsiveness upon subsequent transfer and booster 
with 3 X 10' SRBC (Fig. SA). Furthermore, it appeared that the DTH response 
in recipients of immune spleen cells \vas susceptible to the suppressive action of 
higher booster doses of antigen, whereas the DTH response in recipients of normal 
spleen cells was enhanced after boosting IYith high antigen closes (Figs. SB and C). 
In contrast to normal mice, in \vhich the DTH response at 48 hr after challenge is 
generally diminished to about 50% of the response measured at 24 hr (data not 
shown), irradiated recipients of normal or immune spleen cells showeJ a prolonged 
time course of the DTH response after challenge (Fig. 5). 
A subsequent experiment studied whether the uhscrvcd capacity to transf<.:r sec-
ondary DTH to irradiated recipients was dependent on the presence of Thy 1.2~ 
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FIG. 5. Transfer of the capacity of secondary DTH into irradiated recipient mice. Irradiated 
mice were injected iv with either 5 X 107 normal spleen "Cells (A--A) or 5 X 107 spleen 
cells from mice primed with 3 X 103 (0--0) or 3 X 10{ SRBC ( •--•) 6 months 
previously. Together with the spleen cells, 3 X 10° bone marrow cells and either 3 X 105 (A), 
3 X 10'\ (B), or 3 X 107 SRBC (C) \vere administered. Challenge of the recipients was 
performed 4 days after transfer, and DTH reactivity was determined at 24, 48, and 72 hr 
after challenge. Vertical bars represent 1 SEM ( n ::::: 5). Control mice which had only 
received 3 X lOG bone marrow cells and 3 X 10° SRBC did not show a significant foot swelling 
at 24, 48, and 72 hr after challenge. 
cells in the inoculum. Spleen cells from female mice, primed \vith 3 X 104 SRBC iv 
6 weeks previously, were treated either with normal mouse serum (NJ\.1S) and 
complement or with anti-Thy 1.2 antiserum and complement. A total of 2 X 107 of 
these cells were either supplemented or not with 2 X 107 normal spleen cells and 
injected iv together ·with 3 X 106 normal bone marrow cells and 3 X 105 SRBC 
T.\BLE 2 
Dependence of Secondary DTH Responsiveness on T fdemory Cells 
Immune 
spleen cells"' 
2 X 10' 
2 X 107 
2 X HF 
2 X 10' 
Treatment 
NMS + C" 
anti-Thy 1.2 + C 
X :VIS + C 
anti-Thy 1.2 + C 
Nonimmune 
spleen cells 
2 X 107 
2 X !0' 
2 X 107 
2 X 10' 
SRBC Response 
(%) 
3 X 105 56.7 ±3.7' 
3 X 10" 16.6 ± 2.4 
3 X 105 56.1 ± 6.6 
3 X 105 26.0 ± 2.8 
3 X 10" 21.2±1.7 
9.4 ± 1.7 
"Lethally irradiated recipients were injected with 3 X 106 normal bone marrow cells together 
with the indicated number of immune and nonimmune spleen cells and SRBC. Immune spleen 
celb were obtained from i!:iogeneic mice primed with 3 X 104 SRBC iv 6 weeks previously. 
11 :\i'dS =normal mouse serum; C = gui1u:a pig complement. 
~Figures represent the mean rcspon::;e ± 1 SEiVI. 
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into lethally irradiated mice. The mice were challenged on the fifth day after 
transfer and DTH reactivity was measured 2+, 48, 72, and 96 hr after challenge. 
Maximal responses have been listed in Table 2. It was found that typical secondary 
DTH responses \Yere elicited only after transfer of NJ\1S-treated immune spleen 
cells. Addition of normal spleen cells to anti-Thy 1.2-treated immune spleen cells 
could not restore the capacity of a typical secondary DTH. These results suggest 
that T cells, and not macrophages or B cells in the immune inoculum, are mainly 
responsible for secondary DTH responsiveness. 
DISCUSSION 
This study on DTH to SRBC reports the induction of a state of immunological 
memory for DTH reactivity in normal mice after priming by the iv immunization 
route. The failure of Lagrange .and l\{ackaness (7) to demonstrate a secondary 
DTH to SRBC using the same immunization route can be explained by the strong 
dependence of this phenomenon on the antigen dose used from priming (Fig. 1 and 
Table I) and the interval between booster and challenge (Fig. 3). In the case of iv 
antigen injection, secondary DTH can be most easily demonstrated after low prim-
ing doses (e.g., 3 X 104 SRBC) and a short interval between booster and challeng~ 
(e.g., 2 days). This strong dependence of secondary DTH on the priming dose of 
SRBC was not found by Tamura and Egashira (5). These authors immunized mice 
\Vith SRBC via the sc route. The variance between their and our results might indi-
cate that suppression of secondary DTH by high priming antigen doses occurs 
especiaiiy after iv immunization. This is consistent with reports in literature at-
tributing suppression of primary DTH mainly to the spleen (8, 14, IS). The dose-
response curve for the booster dose in secondary DTH on Day 2 (Fig. 2) is very 
much like the dose~response cune of primary DTH on Day 3 (data not shmvn), 
which suggests that a similar mechanism suppresses the expression of primary and 
secondary DTH. 
The DTH reaction elicited in irradiated recipients of both normal and immune 
spleen cells showed a remarkably prolonged time course (Fig. 5) as compared to 
the DTH reaction to SRBC e\·oked in normal mice, in which the foot swe11ing 
rapidly diminishes after 24 hr. This altered time course of DTH reactivity was 
also reported to occur in guinea pigs pretreated \vith cyclophosphamide before im-
numization with 1-fluoro-2,4-dinitrobenzene ( 15). Evidence was presented that 
cyclophosphamide treatment causes a depletion of the suppressor cell population 
acting at the effector cell level (16). In a previous study on DTH to SRBC we 
have shown that the DTH effector cells have a short-lived functional lifespan (10), 
and we suggested that continuous migration of DTH effector cells to the site of 
challenge was required for the establishment of a foot swelling reaction. Thus, the 
prolonged course of the DTH reaction observed in irradiated recipients might re-
flect the kinetics of the production of DTH-effector cells derived from the in-
jected inoculum. The adoptive transfer experiments also shmv that immune spleen 
cells are more sensitive to suppression by high antigen doses than normal spleen 
cells (Fig. 5), which can be attributed to the coexistence of both DTH-related 
memory cells and DTH-related suppressor cells. This latter population might have 
expanded or increased in reactivity due to the primary immunization. 
Variation of tile interval between pritlling aiJ(l l,uostcr showed that tile kinetics 
of secondary DTH changed with time. A dear peak reactivity on the third day 
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after a booster injection with 3 X 10' SRBC was found only 2 months and later 
after priming (Fig. 4). This shift of the peak res1\onse from Day 2 to Day 3 can 
be ascribed to a gradual increase of the number of DTH-rflated memory cells. 
Although the secondary DTH as a phenomenon is qualitatively different from 
primary DTH (Fig. 3), it remains questionable whether the T cells for primary 
DTH differ qualitatively from the DTH-related T memory cells. Once started, the 
courses of primary and secondary DTH are very much alike. The earlier appear-
ance of secondary DTH and higher peak reactivity might therefore be attributed 
to a larger number of antigen-specific DTH-related T cells. The earlier peak reac-
tivity during secondary DTH might then be due to the earlier occurrence of sup-
pression of the state of DTH in such mice. Although in this way the differences 
between primary and secondary DTH can be explained in quantitative terms, there 
is some evidence for qualitative differences as well. This can be deduced from com-
parison of the course of primary DTH to 3 X 10' SRBC with the course of sec-
ondary DTH to a booster dose of 1 X 10' SRBC. Both responses have an equally 
high peak reactivity on the same day (Fig. 3). However, the first appearance of the 
secondary DTH reactivity after booster with 1 X 10' SRBC is 1 day earlier, which 
might suggest that precursors for primary DTH are qualitatively different from 
the DTH-related memory cells. 
In cell-mediated immunity, as in humoral immunity ( 17, 18), both short-lived 
and long-lived memory has been described (9). Long-lived memory phenomena 
thus far reported are: the second-set skin graft rejection (19), its in vitro corre-
late, the secondary cell-mediated lympholysis (20); and the recall of resistance to 
M. tuberculosis (21), to L. monocytogencs (22), and to Salmonella enteritidis (23). 
The secondary mixed lymphocyte culture (J\IILC) was considered as a short-lived 
memory phenomenon only demonstrable for 3-5 weeks after induction of primary 
l\ILC according to some authors (24), but for about 5 months according to others 
(25). Crowle postulated, in his review on DTH in mice (6), that memory for 
secondary DTH would have a finite life time, depending on the persistence of the 
original state of hypersensitivity, just as once had been suggested for the second-
set skin graft rejection: The accelerated rejection v ..;ould be due to the persistence 
of effector cells (19). Since the secondary DTH to SRBC can be demonstrated in 
absence of a persistent primary DTH and even 1 year after priming with 3 X 10* 
SRBC, 'Ye suggest that secondary DTH represents a true long-lived memory 
phenomenon, waning only after a long time. In a following paper, evidence will be 
presented for the long-lived nature of the DTH-related T memory cells and their 
persistence in the absence of antigen (27). 
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Secondary delayed type hypersensitivity (DTH) to sheep red blood cells (SRBC) in mice 
is a long· lived memory phenomenon which is characterized by the accelerated reappearance 
of the state of DTH after a booster injection of the antigen. In this paper the nature of the 
DTH~related T memory cells accounting for secondary DTH was investigated. Parabiosis of 
primed and nonprimed mice for a period of 4 weeks resulted in an equally large secondary 
DTH responsiveness in both partners. This ability was maintained in both members for at 
least 6 months after termination of the parabiosis. These results indicate that (a) DTH~ 
related T memory cells are potentially circulating cells, and (b) the persistence of these 
memory cells is not dependent on the presence of the antigen which induced their genera-
tion. Subcutaneous (sc) injection of intravenously (iv) primed mice with a small dose of anti-
thymocyte serum before boosting did prevent the development of secondary DTH respon-
siveness in sc boosted mice, but not in iv boosted mice. Treatment of primed mice with 
vinblastine or azathioprine did not decrease the capacity of adoptive transfer of secondary 
DTH by means of spleen cells, but passive transfer of secondary DTH was completely 
abolished by this treatment. These results suggest that (a) SRBC-induced DTH-related T 
memory cells are nonproliferating, partially sessile, partially recirculating cells, and (b) these 
memory cells proliferate before they become DTH-related effector cells. 
INTRODUCTION 
In a previous paper it was shown that secondary delayed type hypersensitivity 
(DTH) to sheep red blood cells (SRBC) is a long-lived memory phenomenon, 
which can be demonstrated up to at least I year after priming (1). Secondary DTH 
has been described for a number of antigens but the cellular base of this phenome-
non has not yet been investigated (2). 
A stable and long-lived state of DTH has been observed after immunization with 
mycobacteria alone (3, 4), after immunization with antigen emulsified in an ad-
juvant containing mycobacteria (5, 6), and after pretreatment of mice with Bacillus 
Calmette-Guerin (BCG) before immunization (7). Such a persistent state of DTH 
can be considered as an expression of immunological memory and it was proposed 
that this classical DTH would be mediated by long-lived effector cells which would 
not require proliferation in order to establish DTH reactivity after passive transfer 
of these cells into a syngeneic recipient (8, 9). The cells that are responsible for 
the persistent state of DTH would be different from the DTH effector cells gener-
ated early after immunization with, e.g., BCG. This has been proposed by Lefford 
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and McGregor (4), who showed that during the early stage after immunization of 
rats with BCG the cells conferring protective immunity to tuberculosis were 
vinblastine-sensitive cells, whereas at a later moment these cells were vinblastine 
resistant and recirculating (10). The same results were obtained when mice were 
intravenously (iv) immunized with SRBC in saline 2 days after treatment with 
cyclophosphamide. Initially, the DTH to SRBC was mainly dependent on a vin-
blastine-sensitive pool of lymphocytes, but later on the DTH response was no 
longer influenced by vinblastine treatment (II). The persistence of the vinblastine-
resistant population might be independent of the antigen used for immunization, 
although this has not been shown conclusively (II). 
The aim of the experiments reported here is to investigate whether long-lived 
memory cells occur after iv priming with SRBC in saline and to further characterize 
these DTH-related T memory cells. 
MATERIALS AND METHODS 
Mice. (C57BL/Rij x CBA/Rij) Fl female mice, 12-16 weeks old, were used. 
They were purchased from the Laboratory Animals Centre of the Erasmus Univer-
sity, Rotterdam, and the Medical Biological Laboratory, Rijswijk, The Netherlands. 
Antigen and immunization. Sheep red blood cells were commercially obtained, 
stored, and washed as described previously (12). Primary and secondary im-
munization was done by iv injection of the SRBC in 0.5 ml of saline. The challenge 
dose of 5 x 107 SRBC was administered subcutaneously (sc) in the instep of the 
right hind foot. 
Parabiotic mice. Parabionts were joined unilaterally under Nembutal (Abbott 
S.A., Saint-Remy-sur-Avre, France) anesthesia (70 mg!kg body wt). The mice 
were united by suturing the peritoneum and abdominal wall muscles without leav-
ing a communication between the abdominal cavities. The connective tissue along 
the thorax was also sutured. In addition, the scapulae were joined. The skin was 
closed with linen thread from behind the ears to the femora. Parabiotic mice were 
separated from each other under Nembutal anesthesia 4 weeks after joining. Again 
the skin was closed with linen thread. 
Anti-thymocyte serum. Anti-mouse thymocyte serum (ATS) was prepared in 
rabbits as described previously (13). For elimination of recirculating Tcells a total 
volume of 0.2 ml ATS or normal rabbit serum (NRS) was administered sc on the 
back, in the armpits, and the groins. ATS and NRS were adsorbed once with mouse 
blood cells (I: I) before use. 
Vinblastine and azathioprine. Vinblastine sulfate (Eli Lilli and Co., Indianap-
olis, Ind.) was iv injected in a dose of 100 J.tg/recipient, dissolved in a volume of 0.2 
ml sterile saline. Azathioprine sodium (Imuran; Burroughs Wellcome and Co., 
London, England) was iv injected in a dose of 100 mg!kg body wt, dissolved in a 
volume of 0.25 ml distilled water. 
Preparation of cell suspensions. Single-cell suspensions were prepared in a 
balanced salt solution as described in a previous paper from our laboratory (14). 
Bone marrow was collected from femora and tibiae. Cells were counted in a Coulter 
Counter Model B. 
Irradiation. For adoptive transfer, the recipient mice received 900 rad whole-
body irradiation, generated in a Philips-Miiller MG 300 X-ray machine. Details 
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of the apparatus and the irradiation procedure have been described previously (1). 
The recipient mice were iv injected with the appropriate cell suspension in a total 
volume of 0.5 ml 24 hr after irradiation. 
RESULTS 
Secondary DTH Responsiveness of Nonprimed Mice after Parabiosis with 
Primed Mice 
To investigate the ability ofDTH-related T memory cells to circulate in the blood 
and to study their persistence in the absence of antigen, the technique of parabiosis 
was used. Within 6 days after joining the mice for parabiosis, blood cells can freely 
circulate from one partner to the other and within 4 weeks of parabiosis an equilib-
rium of the freely circulating cells between both partners can be expected (17). In 
the present study, mice, primed iv with 3 x 104 SRBC 2-3 months previously, 
were joined for parabiosis with nonimmune mice. As controls similarly primed and 
nonimmune mice were joined separately. Four weeks after the establishment of 
the parabiosis all parabionts were separated. Either 3 weeks, 3 months, or 6 months 
after separation all mice were iv immunized with 3 x 105 SRBC. The challenge 
injection was given 2 days later, as the response measured on the second day after 
a booster injection has been shown to be a reliable parameter for the secondary 
DTH responsiveness (1). The parabiosis of nonimmune mice with primed mice 
resulted in an equal capacity of secondary DTH of both partners, irrespective of 
the interval between separation of the parabionts and the booster injection (Table 
1). The secondary DTH responsiveness of these mice was as high as in immune 
mice that had been joined to other immune mice. The level of secondary DTH 
responsiveness did not decline with increasing interval between separation of the 
parabiotic mice and the moment of booster injection. N onimmune mice which had 
been joined together did not show a significant DTH response on Day 2 after im-
munization. 
TABLE I 
Transfer of DTH-Related Memory by Means of Parabiosis 
Interval between termination of parabiosis 
Parabiotic members and iv booster injection 
Parabiotic members that had been 
tested for DTH" joined to them 3 Weeks 3 Months 6 Months 
Normal Normal -4' n.d.c -2 
Immuned Immune 37 n.d. 31 
Normal Immune 31 34 37 
Immune Normal 27 30 31 
a Mice were iv injected with either 3 x 104 SRBC in 0.5 ml PBS or with 0.5 ml PBS alone, rested 
for 2-3 months, and joined for parabiosis with either normal or similarly primed mice. Four weeks later 
all pairs were separated, and at the indicated intervals the mice were injected with 3 x lOS SRBC iv in 
order to elicit a state of DTH. Two days later all mice were challenged and the subsequent DTH 
responses measured. 
b Figures represent the mean response of the group of mice indicated by the left column. Each group 
consisted of five to six mice. 
c Not determined. 
d Immune mice were iv primed with 3 x 104 SRBC at least 2 months before joining for parabiosis. 
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Sensitivity of DTH-Related T Memory Cells to Treatment with Anti-Thymocyte 
Serum 
Mice, primed with 3 x 104 SRBC iv 6-8 weeks previously, were injected sc 
with either 0.2 ml ATS or 0.2 ml NRS. These mice were boosted with 3 X 105 
SRBC iv either 2 days or 3 weeks later and another 2 days later they were chal-
lenged. The ATS treatment could not prevent the development of secondary DTH 
responsiveness (Table 2). In a further experiment, mice, primed with 3 x 104 
SRBC 8 weeks previously, were similarly treated with ATS or NRS. Ten days or 
4 weeks later they were boosted sc instead of iv using an antigen dose of I x 107 
SRBC, which is optimal for the sc route of immunization (data not shown). Another 
2 days later the mice were challenged. The subsequent DTH reactions were signifi-
cantly depressed in ATS-treated mice as compared to NRS-treated mice and 
resembled a primary DTH response to a sc immunization with I x 10' SRBC (Fig. 
lA). Similarly primed but nonboosted mice were not capable of a significant DTH 
response 12 weeks after priming (Fig. !B). 
Effect of Antimitotic Agents on the Passive and Adoptive Transfer of Secondary 
DTH Reactivity 
Mice primed with 3 x 104 SRBC iv and boosted 2 months later with 3 x 105 
SRBC iv were iv injected with 100 1-'g vinblastine in 0.2 ml phosphate-buffered 
saline (PBS) either l, 2, or 3 days after the booster injection. At 15 hr after injection 
of vinblastine, suspensions of the whole individual spleens were iv transferred into 
normal syngeneic recipients. These recipients were challenged with SRBC im-
mediately after this passive transfer ofT cells. The recipients of the spleen cells 
from vinblastine-treated mice did not show any DTH reactivity (Fig. 2). An iv injec-
tion of 100 mg/kg azathioprine at 48 and 24 hr before the passive transfer of the 
spleen cells also abolished DTH reactivity (Fig. 2). 
To test whether the T cells accounting for secondary DTH are sensitive to anti-
mitotic agents, mice, primed with 3 x 104 SRBC iv 8 weeks previously, were 
treated either by four daily iv injections of PBS or azathioprine (100 mg/kg), or by a 
single iv injection of vinblastine (100 1-'g/recipient), 15 hr before adoptive transfer. 
Spleen cells from these various groups of donor mice were iv injected into 900 R 
TABLE 2 
Sensitivity of DTH~Related T Memory Cells to Treatment with ATS 
Treatment 
NRS 
ATS 
Interval between treatment and 
iv booster injection11 
2 Days 
41 ± )b 
27 ± 2 
3 Weeks 
35 ± 6 
36 -= 6 
a Mice were iv primed with 3 x 104 SRBC 6-8 weeks before NRS or ATS treatment. Two days or 
3 weeks later they were boosted iv with 3 x 105 SRBC. Challenge was performed 2 days after the 
booster injection. 
b Figures represent mean 24 hr DTH responses ± 1 SEM (n = 5). In both groups DTH responses 
occurred at 24 hr after challenge. 
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FIG. l. The susceptibility of DTH-related T memory cells to in vivo treatment with ATS. Immune 
mice were sc treated with 0.2 ml ATS (Ill), or NRS (8:). Ten days (A) or4 weeks (B) later these mice were 
sc boosted with 1 x 107 SRBC. A group of nonimmune mice was immunized sc with 1 x 107 SRBC 
(0). Two days after the booster or immunization all mice were -challenged. One group of immune mice 
was not boosted, but only challenged (A). At 24, 48, and 72 hr after challenge the foot swelling was 
measured. Vertical bars represent 1 SEM (n = 5). 
irradiated mice together with 3 x 106 bone marrow cells and I X 105 SRBC as 
controls were used irradiated mice iv injected with 3 X 106 bone marrow cells and 
I x 105 SRBC. At 4 days after transfer all recipients were challenged and the DTH 
reactivity was determined. It appeared that neither vinblastine nor azathioprine 
treatment did affect the scondary DTH responsiveness (Table 3). 
DISCUSSION 
Both iv and sc immunization of mice with SRBC in saline can induce a transient 
state of primary DTH to this antigen (7, 16-18). This DTH reactivity can be con-
sidered as a Jones-Mote-type of DTH (12, 17), although recently it was shown 
that histological and other features of the DTH reactivity induced by iv immuniza-
tion with SRBC in saline are more similar to the tuberculin-type hypersensitivity 
(19). Convincing evidence exists that this transient state of DTH to SRBC is 
entirely mediated by functionally short-lived T effector cells (12, 18, 20). The life-
span of T effector cells in DTH reactivity induced by BCG or Listeria 
monocytogenes injection would depend on the interval between immuniza-
tion and challenge (21-23). Shortly after priming with these antigens the 
DTH reactivity is dependent on short-lived, nonrecirculating T effector cells (21, 
22), while it is assumed that a long-lived DTH-reactive effector cell population 
mediates the DTH reactivity to these antigens at longer intervals after immuniza-
tion (21, 23). Persisting antigen or a high antigen dose would be required to drive a 
particular T cell subclass through a differentiation step in order to become such a 
long-lived cell (18). 
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FIG. 2. The immunosuppressive action of vinblastine and azathioprine on the passive transfer of 
secondary DTH. Groups of donor mice were treated either I, 2, or 3 days after their booster with a single 
injection of 100 p.g of vinblastine (0) or PBS (8). At 15 hr after this treatment the individual spleens 
were transferred into normal syngeneic recipients. Two other groups of mice received two iv injections 
of either 100 mg/kg body wt azathioprine (Ill) or 0.25 ml PBS (0) on Days I and 2 after booster. At 24 hr 
after the last injection the individual spleens were transferred into normal syngeneic recipients. All 
recipients were challenged immediately after transfer and the 24-hr DTH response was determined. 
Vertical bars represent I SEM (n = 5). 
In a previous paper we have shown that priming of mice with a low dose ofSRBC 
in saline can induce T-cell memory for DTH to this antigen (1). Parabiosis of such 
SRBC primed and nonprimed mice results in an equal secondary DTH responsive-
ness in both groups of animals for at least 6 months after the termination of the para-
biosis (Table 1). It is unlikely that dissemination of the antigen from the one part-
ner, primed at least 8 weeks before parabiosis, to the other nonprimed partner ac-
counts for the presence and propagation of such a high level of secondary DTH 
responsiveness in the nonprimed mice, since the mice were primed with a very low 
dose of SRBC, and SRBC are rapidly degraded in mice, thereby losing their im-
munogenicity (24, 25). This indicates that the T cells responsible for secondary 
DTH are long-lived, potentially circulating cells. Their resistance to treatment with 
vinblastine or azathioprine (Table 3) suggests that they do not or hardly proliferate 
in the absence of the specific antigen, just as has been proposed for DTH effector 
cells specific for purified protein derivative (21), L. rnonocytogenes (23), and DTH ef-
fector cells induced by extremely high doses of SRBC (II). Based upon the results 
presented in this paper we suggest an alternative explanation for the resistance of 
DTH reactivity to vinblastine in these latter situations. Under influence of small 
amounts of persisting antigen long-lived memory cells might develop into DTH ef-
fector cells without additional proliferation, or, alternatively, a proportion of the 
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TABLE 3 
Susceptibility of DTH·Related T Memory Cells to Antimitotic Agents Tested 
in an Adoptive Transfer Systema 
Treatment of donor miceb 
PBS 
Azathioprine 
PBS 
Vinblastine 
Peak DTH response 
(%) 
51± y 
48 ± 4 
56± 4 
51 ± 3 
a Lethally irradiated recipients were injected iv with 3 x 106 normal bone marrow cells together with 
5 x 107 immune spleen cells and 1 x lOS SRBC. Four days after transfer the recipients were chal-
lenged and the foot swelling was read on the subsequent day in order to determine the peak DTH 
response. 
b Azathioprine was injected iv in a dose of 100 mg/kg body wt (on 4 consecutive days) into a group 
of three donor mice. Controls received PBS. The last injection was given at 24 hr before the adoptive 
transfer of the pooled spleen cells. A single iv injection of 100 J.Lg vinblastine was given to three 
donor mice at 15 hr before the adoptive transfer of the pooled spleen cells. Controls received a 
single injection of PBS. 
c Figures represent the mean peak response ± l SEM. Lethally irradiated recipients of 5 x l07 
nonnal spleen cells, in addition to 3 x 106 normal bone marrow cells and 1 x 10s SRBC, showed a 
peak response of 26%. 
long-lived memory cells might be in Gl-phase for a rather long time, before they 
give rise to DTH effector cells. After passive transfer these activated memory 
cells, which can not be affected by vinblastine treatment (26), may then further ma-
ture into DTH effector cells. Proliferation of DTH-reactive precursor cells is 
probably only required for optimal DTH responsiveness, as has been suggested by 
experiments on DTH reactivity to major histocompatibility antigens (27). This 
requirement for proliferative activity of precursors for DTH to SRBC might be due 
to the number of potentially reactive precursor cells, which is probably larger in 
case of histocompatibility antigens (28) and after infection with persistent antigens 
(29). In the case of secondary DTH to SRBC proliferation of memory cells seems 
to be essential for its expression (Fig. 2). 
Labeling studies (30, 31) and functional studies (15) have shown that during para-
biosis for a period of 4-5 weeks a nearly complete equilibrium of long-lived T and 
B cells can be established between both members. Whether an equilibrium of the 
DTH-related T memory cells indeed arises within this period, remains obscure, as 
it seems conceivable that at a certain level ofDTH reactivity a further increase will 
be suppressed (32). This is in harmony with the finding that the secondary DTH 
response of parabionts consisting of one primed and one nonimmune member was 
as high as in parabionts consisting of two immune mice (Table 1). 
It is generally thought that T memory cells performing helper functions in anti-
body formation, and those reactive to alloantigens belong to the recirculating pool 
of small lymphocytes (33, 34). Levey and Medawar (35) have shown that sc injected 
ATS acts on the recirculating lymphocytes, but not on the sessile cells in the 
lymphoid organs. Attempts to erase memory in order to restore the "virgin" state 
in primed mice have given conflicting results. Helper T memory cells are sensitive 
to ip injection of small doses of ATS (36), but abrogation of second set skin graft 
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rejection by A TS treatment has been difficult to achieve (37, 38). The finding that a 
single sc injection of a small dose of ATS did not prevent secondary DTH reactivity 
in mice iv boosted with SRBC (Table 2), suggests that a part of the DTH-related T 
memory population consists of sessile cells residing in the spleen. This parallels the 
observation that a part of the B memory cells is sessile or slowly recirculating and 
residing in the spleen (39). Subcutaneous boosting with SRBC of mice treated with 
ATS 4 weeks previously did not elicit a typical secondary DTH response, but only 
a primary type DTH reactivity (Fig. 1). Apparently sc treatment with ATS results 
in a long-lasting depletion of a subset of rapidly recirculating DTH-related 
memory cells. 
The experiments reported here suggest that nonreplicating T memory cells give 
rise to DTH effector cells, only when restimulated by antigen. The susceptibility 
of the passive transfer of secondary DTH to treatment with antimitotic agents (Fig. 
2) suggests that the development of secondary DTH to SRBC requires prolifera-
tion. Thus, the establishment of secondary DTH reactivity to SRBC is not funda-
mentally different from the situation in humoral immunity (40). In both cases the 
memory cells need to be restimulated by the antigen which initiated their genera-
tion, in order to become functionally active. 
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T1 and T2 Lymphocytes in Primary and Secondary Delayed Type 
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Rotterdam, The Netherlands 
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Peripheral T lymphocytes can be subdivided into two populations (T1 and T2 cells) 
based upon the short life span of T1 cells after adult thymectomy (ATx) and sensi-
tivity of T 2 ceiis to treatment with anti-thymocyte serum (ATS) in vi<N. The contri-
bution of the T 1 and T2 cells to primary and secondary delayed type hypersensitivity 
(DTH) to sheep red blood cells (SRBC) and to primary DTH to allogeneic cells was 
studied in mice. T!l cells \vere found to account for the development of the state of pri-
mary DTH responsiveness after intravenous immunization ·with SRBC and after sub-
cutaneous immunization with aiiogeneic cells. No clear cut evidence was found 
that in the presence of T2 cells DTH related T effector cells \vere generated from T1 
cells. In mice selectively depleted for T1 cells by ATx, the remaining T2 cells ·were 
capable to generate SRBC-specific T memory cells, but not in numbers as large as in 
non-thymectomized mice. On the other hand, T1 cells in mice depleted for T2 cells by 
ATS treatment, could give rise to normal numbers of SRBC-specific T memory cells. 
Apparently T1 cells can compensate for the absence of T2 cells during generation ofT 
memory cells, but T" cells cannot do so for the loss of T). cells. From the time curve 
showing the ATx-induced decline of the population of SRBC-specific T 2 cells, involved 
in primary DTH responsiveness, the half life was calculated to be 6 to 7 months. 
INTRODUCTION 
Both in cell mediated and humoral immunity T lymphocytes play an important 
role (1). Raff and Cantor proposed to subdivide T lymphocytes into two popula-
tions, namely T 1 and T2 cells (2). This subdivision \Vas indicated by studies of 
Cantor and Asofsky (3, 4), who showed synergism between peripheral blood lym-
phocytes and thymocytes, and bet\veen peripheral blood lymphocytes and anti-
lymphocyte serum (ALS) treated spleen cells in the Graft-vs-Host (GvH) reac-
tion. In these experiments the peripheral blood was used as .a source of T 2 cells, 
and thymocytes and ALS treated spleen cells as a source of T 1 cells. Pretreatment 
of mice with ALS or anti-thymocyte serum ( ATS) was found to enrich the spleen 
for T 1 cells by ·selective depletion of the pool of recirculating T ~ cells ( 5). Raff and 
Cantor suggested that 1\ cells are immature short-lived cells, sensitive to adult 
thymectomy (ATx), and that T2 cells are mature long-lived ce1ls, resistant to A Tx. 
0008-87 49/78/0391-0194$02.00/0 
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According to this proposal T:! cells would ht responsible for the primary type im-
mtmc responses. These T:! celb v.;nuld have matured from the]\ population under 
influence of environmental antigens (2) or independent of antigenic stimulation 
( 6). Thus, primary immune responsiveness would he relatively A Tx resistant. 
This thesis could he supported by previous studies on the effects of A Tx on anti-
body formation (7-9) and on GvH reactions (7, 8), Later studies on T helper 
function in antibody formation (10-13) .and skin graft rejection (14, 15) generally 
approved this model. On the other hand, some authors suggested that both T 1 cells 
and T:! cells contributed to the primary T helper function (11, 12), and in one 
study, using cell mediated lympholysis (C~IL) as a test system, it appeared that 
the capacity for primary C~!L fell shortly after ATx (10). The effects of ATx on 
the capacity to respond in a mixed lymphocyte reaction ("~TLR) are rather con-
flicting (10, 16-19). 
Concerning secondary type immunity, Raff and Cantor suggested that T mem-
ory formation vmuld depend on the presence of T 1 cells. Priming for a secondary 
type immune response would imply an antigen-driven differentiation of T 1 cells 
into T 2 cells. Again evidence for this theory vvas mostly obtained from studies on T 
helper function in antibody formation ( 10, 11, 13). This proposal was recently 
modified by Araneo et a!. ( 12), who demonstrated an involvement of both T 1 and 
T:! cells in the formation ofT memory cells for humoral immunity. 
In a previous paper it was shown that priming of mice with SRBC can result 
in the formation ofT effector cells vvith .a short functional life span (20), as well as 
long-lived T memory cells. These latter cells can give rise to a state of secondary 
DTH upon a booster immunization. 1 This system was used to evaluate whether 
Raff and Cantor's original proposal also holds for primary and secondary type cell 
mediated immunity to SRBC and allogeneic cells. 
tiATERIALS AND ~lETHODS 
Mice. (C57BL/Rij X CBA/Rij) Fl and Balb/c female mice were used. The 
Flmice were 6 or 12 ,,.,.-eeks old, the Balh/c mice 12 to 15 weeks. They were pur-
chased from the 1\Iedical Biological Laboratory, Rijswijk, The Netherlands, and the 
Laboratory Animals Centre of the Erasmus University, Rotterdam, The Netherlands. 
Antigen and i111mllni.zation. Sheep red blood cells (SRBC) were commercially 
obtained, stored and \\·ashed as described previously (20). Primary and secondary 
immunization ·with SRBC was performed by intravenous (iv) injection of the 
SRBC in 0.5 ml saline. To induce DTH to histocompatibility antigens, mice were 
sc immunized with 1 X 10' or 5 X 107 Balb/c spleen cells in 0.1 ml saline, equally 
distributed over both inguinal areas. The challenge dose of either 5 X 107 SRBC or 
1 X 10' Balb/c spleen cells was administered subcutaneously ( sc) in the instep of 
the right hind foot. 
Adult thymectomy. Adult thymectomy (ATx) and sham-thymectomy (ShTx) 
was ah~~.rays performed, when the mice \vere 6 vveeks old. The surgery was done as 
described by Miller (21). The mice were anesthetized by 70 mg/kg body weight 
Nembutal ( S. A. Abbott, Saint-Remy-sur-Avre, France). 
Thymus transplantation. The restorative effects of thymus transplantation on 
1 Kwast, Th.H. van der, H. de Ruiter, and R. Benner. Secondary delayed type hypersensitivity 
to sheep red blood cells in mice. Its dependence on long-lived memory cells. Submitted for 
publication. 
105 
YAN DF:R K\\'AST AND BENNER 
DTH in :\Tx mice wa:-; imTstigatcd hy transplantation ui a single thymus luhe llll-
der the kidney capsule oi micr, thymectomized (J months prt'vinusly. Thymus lnhes 
v-..·ere obtained from 300 rad irradiated syngeneic neonatal mice, within 24 hr after 
birth. The recipient mice were anesthetized by ?\T emlmtal. Irradiation of the neo-
natal mice v·:as done as described previously (22). 
Treatment zvith anti-th_i'IIIOC)'fe serum. ATS "\·\'as prepared according to the 
method of Jooste ct a!. (23) by two injections of N~ew Zealand \Vhite rabbits \Vith 
5 X 108 Balbjc thymocytes, with an interval of 2 weeks. One week after the second 
injection the rabbits were bled. For elimination ofT 2 cells a total volume of 0.2 ml 
unabsorbed antiserum was administered sc on the back, in the arm-pits, and the 
groins. 
Assay for Delayed TJ'Pe Hypersensitivif)'. DTH reactions were determined by 
measuring the differences in thickness of the hind feet 24 hr after sc injection of 
either 5 X 10' SRBC or 1 X 107 Balb/c spleen cells into the instep of the right 
hind foot. Details of this assay have been given in a previous paper (20). A control 
group consisting of non-immune mice challenged in the same way as the mice to be 
tested, was always included. The specific increase in foot thickness was calculated 
as the relative increase in foot thickness of the immune mice, minus the relative in-
OJ. spe-c. incre-ase-
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Frc. 1. Effect of ATx upon primary DTH responsiveness to SRBC. Six week old 'mice 
were thymectomized or sham-thymectomized and immunized with 3 X 106 SRBC iv at various 
times aftel- surgery, Another 3, 4, and 5 days later different groups of mice \Vere challenged 
with 5 X 107 SRBC sc into the instep of the right hind leg, and the 24 hr DTH responses \vere 
measured. Only the peak responses of both groups of mice are given. Generally these peaks 
were elicited on the 4th day after immunization. Hatched area represents the mean responses 
of the sham-thymectomized mice ± 1 SD. Closed circles represent the responses of the ATx 
mice. Each figure is the arithmetic mean of the response of 5 to 15 mice. Vertical bars repre-
sent 1 SEM. The decline of primary DTH responsiveness can be described by the reverse 
exponential function y = 33.4- 8.5 lnx. r 2 = 0.91. 
106 
T1 AND T2 CELLS IN DTH 
cn·a~l' in f'rHJl thickne:-;:-; nf the control tnicP. Tlw S\\·elling in control mice varied 
between 12 and 20o/c for SRBC, and between 25 and 287a for Balb/c spleen cells. 
RESULTS 
Primary DTH Responsiveness to SRRC at Different Inten•als After Adult 
Thy1nectomy 
To investigate the lifespan of the T cells \vhich give rise to primary type DTH 
responsiveness, mice vvere thymectomized or sham-thymectomized at 6 weeks of age. 
At different intervals after surgery groups of mice were immunized with 3 X 105 
SRBC iv, -..Yhich is an optimal dose for induction of primary DTH reactivity. These 
mice were challenged 2, 3, 4, or 5 days after priming in order to determine the peak 
response as the parameter for the height o£ primary type DTH responsiveness. 
Independent of the interval between thymectomy and immunization the first DTH 
reactivity could be demonstrated on Day 3, while the peak response \vas generally 
found to occur on Day -+. Up to 1 year after surgery the primary DTH responsive-
ness remained at the same level in ShTx mice. In A Tx mice a gradual decline of 
primary DTH responsiveness \vas observed (Fig. 1). Two functions can describe 
this decline, namely a reverse exponential function (y = 33.4 - 8.5 lnx; r 2 = 0.91), 
and a linear function (y = 32.1 - 1.9x; r 2 = 0.87). The first function suggests an 
at random inactivation of a single long-lived population, whereas the second func-
tion indicates the participation of two populations of T cells in primary DTH re-
sponsiveness, one being "Short-lived and one being long-lived. In this latter case the 
contribution of the short-lived T 1 cells could be calculated to be about 25)1o. 
Since A Tx might affect the dose-response relationship, groups of mice were primed 
•1, specifiC increase 
footpad thickness 
50 
dose of SRBC 
FIG. 2. Effect of ATx upon the primary DTH responsiveness to various doses of SRBC. 
Six \veek old mice -..-vere thymectomized or sham~thymectomized, and immunized with various 
doses of SRBC iv 6 months later. Another 3, 4, and 5 days later different groups of mice were 
challenged and the 24 hr DTH responses were measured. Only the peak responses of both 
groups of mice are given. These peaks were elicited on the 4th day after immunization. ( 0) 
Sham-thymectomized mice, and ( 0) thymectomized mice. Each figure is the arithmetic mean of 
the response of 5 mice. Vertical bars represent 1 SEM. 
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months between surgery and priming 
FIG. 3. Effect of A Tx upon the generation of memory cells required for secondary DTH 
responsiveness to SRBC. Six week old mice were thymectomized or sham~thymectomized. and 
primed with 3 X 10' SRBC iv at various times after surgery. At 6 to 8 weeks after this optimal 
dose the mice \Vere boosted with 3 X 10n SRBC iv. Another 2 days later these mice were 
challenged, and the 24 hr DTH responses were measured. Hatched area represents the mean 
secondary DTH responses of the sham~thymectomized mice ± 1 SD. Closed circles represent 
the responses of ATx mice. Each figure is the arithmetic mean of 5 to 10 mice. Vertical bars 
represent 1 SE11. From 6 weeks after ATx onwards, the decline of the capacity to generate 
DTH-related T memory cells might be described by the function y:::: 25.9- l.Sx. r 2 = 0.84. 
with either 3 X 10', 3 X 10'\ 3 X 10', or 3 X 10' SRBC 6 months aiter ATx and 
ShTx. Four days after immunization the peak primary DTH reactivity was deter-
mined. For both groups of mice the dose of 3 X 10' SRBC appeared to be optimal 
(Fig. 2). A Tx apparently did not affect the suppression which normaU.y occurs after 
iv immunization with higher doses of SRBC. 
Decline of the Capacity to Generate DTH Related T J[cmory Cells After Adult 
Thymectomy 
The lifespan of the precursors of the T memory cells ·which account for secondary 
type DTH responsiveness, ·was investigated in mice iv primed with 3 X 104 SRBC 
at varying intervals after ATx or ShTx. At 6 to 8 weeks after injection of this 
optimal dose (22) the mice were boosted with 3 X 10' SRBC iv. The challenge 
dose was administered 2 days later, since the response measured on the second day 
after the' booster injection has been shown to he a good parameter for the secondary 
DTH responsiveness (22). No significant decline of the capacity to generate T 
memory cells for secondary DTH responsiveness \Vas observed up to 1 year after 
ShTx, whereas in A Tx mice, already 6 weeks after surgery, a greatly diminished 
capacity of secondary DTH responsiveness was found (Fig. 3). The subseqent 
decline of the capacity to generate T memo~y cells for secondary DTH reactivity 
was rather gradual. 
108 
T1 AND Tz CELLS JN DTH 
TABLE I 
Recovery of the Primary and Secondary DTH Responsiveness in Adult 
Thymectomized Mice After Thymus Transplantation 
Surgery" 
ShTx + Thym 
ATx + Thym 
ATx + Sh+Thym 
Primary response 
49.3 ± 6.6" 
37.0 ± 11.2 
14.3 ± 4.6 
Secondary response 
37.7 ± 4.5 
33.1 ± 4.0 
12.1 ± 3.0 
" Thymus transplantation (Thym) or sham+transplantation (Sh+ Thym) was performed at 6 
months after thymectomy of adult mice. Three months later these mice were primed either for 
primary DTH (3 X 105 SRBC) or for induction ofT memory cells for secondary DTH (3 X 104 
SRBC). At 3, 4, or 5 days after immunization for primary DTH these mice were challenged. Only 
the peak responses of these mice are given. These peaks were elicited on the 4th day after im-
munization. At 2 months after priming for secondary DTH the mice were boosted with 3 X 105 
SRBC iv, and challenged 2 days later. The 24 hr DTH responses are given. 
b Figures represent the mean response ± 1 SEM of 4 or 5 mice. 
The Restorative Capacity of Thymus Transplantation on DTH in Adult Thymec-
tomi:.:cd }If ice 
It was studied whether the decline of the capacity of primary and secondary 
DTH responsiveness after A Tx is a reversible phenomenon. Therefore, 300 rad 
irradiated syngeneic neonatal thymus lobes were transplanted under the kidney 
capsule of ATx and ShTx mice, 6 months after surgery. At 14 days and 3 months 
after transplantation or sham-transplantation the different groups of mice \vere im-
munized with 3 X 10" SRBC iv. Three, 4 and 5 days later the DTH responsiveness 
\vas determined. At 14 days after thymus transplantation no recovery of the 
primary DTH responsiveness was found (data not shown), \vhereas 3 months 
after thymus transplantation the mice were capable of an almost normal DTH re-
sponsiv-eness (Table 1). These results suggest that the decrease of primary DTH 
responsiveness after A Tx is due to the loss of T cells and not to a lack of thymic 
hormones. Thymus transplantation also almost completely restored the capacity 
of generation of T memory cells in A Tx mice, \vhen assayed 3 months after 
transplantation. 
TABLE 2 
Primary DTH Responsiveness After Depletion of T 2 Cells by ATS Treatment 
Protocol 
2 days 4 days 
NRS ~ 3 X 105 SRBC iv ~challenge 
2 days 4 days 
ATS --------7 3 X 105 SRBC iv~ challenge 
3 days 4 days 
ATS ~ 3 X 105 SRBC iv ~challenge 
"Figures represent the mean ± 1 SEM of 5 mice. 
% specific increase 
foot thickness 
37.7 ± 3.5" 
7.8 ± 0.5 
25.7 ± 4.9 
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TABLE 3 
Thymic Dependence of the Recovery of Primary DTH Responsiveness After 
Depletion of T 2 Cells by ATS Treatment 
Protocol 
3 days 3 weeks 4 days 
NRS _______,. NRS-+ 3 X 105 SRBC iv----+ challenge 
3 days '3 weeks 4 days 
ATS _______,.ATS -+3 X 105 SRBC iv----+ challenge 
6 weeks 3 days 3 days 4 days 
ATx-+ ATS _______,. ATS-+ 3 X 10s SRBC iv----....)- challenge 
6 weeks 3 days 3 weeks 4 days 
ATx-+ ATS _______,. ATS -+ 3 X 105 SRBC iv ----+ challenge 
" Figures represent the mean ± 1 SEM of 5 mice. 
% specific increase 
foot thickness 
51.6 ± 2.9• 
41.9 ±4.7 
-1.6 ± 2.2 
5.8 ± 3.1 
Effect of Selective depletion of T 2 cells by ATS-trcatment on primary and sec-
ondary DTH responsiveness 
The role ofT~ celb in primary and secondary DTH responsiveness was investi-
gated by sc injection of mice with 0.2 ml A TS. Treatment of normal mice with 
a single close of 0.2 ml ATS sc, 2 days before iv immunization with SRBC, largely 
abolished their capacity of primary DTH responsiveness. Ho·wever, 3 days after 
A TS-treatment the capacity of primary DTH responsiveness had been largely re-
covered (Table 2). l\1ice, thymectomized 6 \veeks previously, and treated by hvo 
sc injections of 0.2 ml ATS v .. ·ere found to be incapable of recovery of primary 
DTH responsiveness, even \vhen tested 3 weeks after treatment \Vith A TS (Table 
3). Thus, the presence of the thymus is required for recovery of primary DTH 
responsiveness in A TS treated mice. 
In another experiment the effect of selective elimination of T:!. cells was investi-
gated for the capacity to generate DTH related T memory cells. Therefore, mice 
were primed with 3 X 104 SRBC iv 2 clays after treatment \Vith ATS. Three weeks 
later the mice were boosted with 3 X 105 SRBC iv, and challenged another 2 days 
later. It was found that the secondary DTH responsiveness in the A TS treated 
mice was equally high as in non-treated control mice (Table 4). 
Effect of Adult ThJ'lllCCfOiliJ' on Primary DTH Responsiveness to .·-lllogeneic 
S plcen Cells 
Groups of ATx and ShTx mice were sc immunized with either 1 X 10' or 5 X 107 
Balb/c spleen cells, 1 month or 7 months after surgery. Challenge \\"as performed 
TABLE 4 
Capacity of Memory Induction in Mice Depleted ofT~ Cells by ATS Treatment 
Protocol 
3 weeks 2 days 
3 X 104 SRBC iv ----7 3 X 105 SRBC iv----+ challenge 
2 days 3 weeks _ 2 days 
ATSb _______,. 3 X 104 SRBC iv ~ 3 X 105 SRBC iv----+ challenge 
a. Figures represent the mean ±1 SEM of 5 mice. 
% specific increase 
foot thickness 
39.6 ± 2.1"" 
44.3 ± 3.5 
b The same dose of ATS administered 2 days before immunization with 3 X 10s SRBC iv re-
duced the 4th day primary DTH response from 37.7 to 7.8% (Table 1). 
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TABLE 5 
Effect of Adult Thymectomy on Primary DTH Responsiveness 
to Allogeneic Spleen Cells 
Interval" ] mmunization dose Surgery 
ShTx 
1 month 1 X 107 22.2 ± 3.2h 
7 months 1 X 10' 23.6 ± 4.5 
7 months 5 X 107 31.8 ± 1.5 
a The interval between surgery and immunization has been given. 
b Figures represent the mean ± 1 SEM of 5 mice. 
ATx 
16.8 ± 3.6 
23.7 ± 2.9 
25.8 ± 2.5 
on these mice 6 days after immunization, since at this interval the DTH reactivity 
appeared to be maximal (data not shown). It was found that ATx hardly affected 
the primary DTH 1-esponsiveness to allogeneic spleen cells, both after priming with 
a suboptimal (I X 10') and an optimal (5 X 10') dose of Balbjc spleen cells (Ta-
bleS). 
DISCUSSION 
In studies on the influence of ATx on the capacity of GvH reactivity (7, 8), T 
helper function in antibody formation (7-13), and skin graft rejection (14, 15), 
it was generally found that primary immune responsiveness gradually declined 
after ATx. For DTH Kappler eta/. ( 11) reported a rapid initial fall of the capacity 
of primary DTH responsiveness to SRBC after ATx, but other authors found an 
increase in DTH responsiveness to methylated human serum albumin after ATx 
(24). The explanation for these contradictory results probably is, that the sup-
pression of DTH responsiveness to the latter antigen, in contrast to SRBC (Fig. 
2), is regulated mainly by short-lived T cells. The experiments reported here show 
that primary DTH responsiveness to SRBC declines according to a reverse ex-
ponential function, namely, y = 33.4 - 8.5 lnx (Fig. 1). In such a function only one 
long-lived population of T lymphocytes needs to be hypothetized to explain the 
decline of the capacity of primary DTH after ATx. This is in agreement with the 
original proposal of Raff and Cantor (2), who suggested that the primary 
immune response is completely dependent on long-lived T 2 ceUs. The reverse 
exponential decline indicates an at random inactivation of T2 cells. From this 
function (y = 33.4 - 8.5 lnx) the maximal lifespan of the population of T 2 
cells specific for SRBC can be extrapolated to be approximately 50 months. The 
half life of these cells can be calculated to be about 6 to 7 months. From the decline 
of the capacity to induce DTH related T cell memory in A Tx mice, it can be 
concluded that the long-lived T cells can also contribute to T memory formation. 
The observed gradual decline of primary DTH responsiveness to SRBC after 
ATx is at variance with the data published by Kappler et al. (11), who found a 
rapid decrease of the primary DTH responsiveness. This difference is probably due 
to the rather young age of 4 to 5 weeks that these authors thymectomized their 
mice. Our data ·were ohtained ·with mice which were thymectomized at an age of 6 
weeks when the capacity of DTH-reactivity to SRBC had been fully developed 
(25). 
The rapid initial fall of the capacity of secondary DTH responsiveness after ATx 
111 
VAN DER KWAST AND RENNER 
(Fig. 3 J suggests that T 1 cells are required for the production of long-lived T 
memory ceJls in numbers comparable to normal mice. These latter cells \vere sug-
gested to belong to the T 2 cell pool 1 ( 26). The slow further decrease of the capacity 
to gen(:rate DTH related T memory celis after A Tx, subsequent to the rapid initial 
faU (Fig. 3), suggests that T 2 cells can also give rise toT memory cells. Presum-
ably, there is an additive contribution of short-lived and long-lived precursors in the 
formation of DTH related T memory cells for SRBC, although it cannot be excluded 
theoretically that T 1 cells have an amplifying effect on the T 2 cells. These data lead 
us to modify Raff and Cantor's original concept on T memory formation (2), and 
to suggest that both T 1 and T 2 cells can give rise to T memory cells for DTH. Re-
cently, it has been shown that this also holds for humoral immunity ( 12). VVe ex-
tend this concept by suggesting that the proportion in which T 1 cells and T 2 cells 
contribute to T memory development is only determined by the number of antigen-
specific T 2 cells already present in the animal. This number of T 2 cells may be 
dependent on the type of antigen chosen for immunization, the environmental anti-
gens of the individual, and on the level of "spontaneous" conversion of T 1 cells 
into T 2 cells. This "spontaneous'' conversion may be either fully antigen-inde-
pendent, or due to self recognition (6). In addition we postulate that T 2 ce11s can 
give rise to new T 2 cells ·without deliberate immunization. From Fig. 1 it appears 
that for the antigen SRBC, this occurs at a rate too small to compensate for the 
natural decline of the pool of T, cells. The calculated half life of the SRBC specific 
T 2 cell population of about 7 months, would then be an overestimation. This can 
explain the discrepancy between this data and the half life of 4 to 6 months cal-
culated from experiments in ·which long lived T cells are labeled by means of (3 H]-
thymidine (27). 
From the effect of ATx (Fig. 2) anJ ATS (Table 2) upon primary DTH re-
sponsiveness to SRBC, it can be concluded that in normal mice the conversion of T 1 
cells into T ~ cells occurs at a large scale without intentional immunization. This 
mechanism fully compensates for the natural decline of the T 2 cell population (Fig. 
1) up to at least 1 year of life, and for the depletion of the T, cell pool by A TS-
treatment (Table 2). However, the capacity of primary DTH responsiveness to 
histocompatibility antigens is not or only slightly influenced by A Tx (Table 5), 
and can thus be maintained independent of T 1 cells. A spontaneous clonal expan-
sion of the population of T 2 ceJls might account for this observation but it is also 
conceivable that the DTH reactivity to histocompatibility antigens is not per sc 
linearly related to the number of reactive T:! cells. Possibly for these antigens the 
number of T 2 ce1Is is larger than required for maximal DTH responsiveness, so 
that a decline of the number of T:! cells will not be directly reflected in the height 
of the DTH response. 
In conclusion, these ·in vivo experiments on DTH suggest that (a) DTH re-
lated T effector cells (generated after primary immunization with SRBC and histo-
compatibility antigens) are derived from T 2 cells, (b) T:! cells can give rise to DTH 
related T memory cells, similarly as has been shown recently for T helper memory 
(12), and (c) T 1 cells can supplement this contribution ofT, cells. 
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PRIMARY AND SECONDARY DELAYED TYPE HYPERSENSITIVITY TO MINOR 
HISTOCOMPATIBILITY ANTIGENS IN THE MOUSE 
Th.H. van der Kwast, J.G. Olthof and R. Benner 
Department of Cell Biology and Genetics, Erasmus University, 
P.O. Box 1738, Rotterdam, The Netherlands. 
SUMMARY 
Immunization of mice with viable allogeneic H-2 compatible spleen 
cells can induce a persistent state of delayed type hypersensitivity 
(DTH) to these alloantigens, as measured with the footpad swelling 
test. Boosting of such mice, 2-4 months after priming, induced a 
typical secondary type DTH reactivity. The capacity of secondary 
DTH to non H-2 alloantigens could be adoptively transferred from 
primed mice into irradiated syngeneic hosts by means of nylon-wool 
non-adherent, Thy-1.2+ spleen cells. Vinblastine treatment of the 
donor mice did not affect the adoptive DTH responsiveness. These 
results suggest that a population of long-lived T memory cells 
contributes to secondary type DTH responsiveness to non H-2 allo-
antigens. The phenomenon of persistent DTH is discussed in the 
light of these results. The hypothesis is put forward that persis-
tent DTH is dependent on the continuous antigen-driven differen-
tiation of long-lived, recirculating T memory cells into non-
recirculating, functionally short-lived DTH effector cells. 
INTRODUCTION 
Allogeneic skin grafts or tumor grafts can induce a state of 
delayed type hypersensitivity (DTH) to histocompatibility (H) 
antigens in many species, including mice (1). In hamsters (2) and 
mice (3) subcutaneous (s.c.) injection of viable allogeneic lymph-
oid cells can also evoke DTH reactivity to H-antigens. Histologi-
cally the reaction which is elicited in immune mice by the s.c. 
injection of intact lymphoid cells, crude membrane extracts or 
soluble antigens into the footpad appears to be of a typical DTH 
type (4,5). Kon and Klein (5) showed that such a DTH assay can 
detect both H-2 and non H-2 alloantigens in mice immunized by a 
H-2 or non H-2 incompatible skin graft, respectively. Earlier 
studies of Brent et al. (4) indicated that transplantation of 
allogeneic skin in guinea-pigs induced a state of DTH, which could 
also be demonstrated at long intervals after the rejection of the 
skin. These authors ascribed this phenomenon to a long-lived effec-
tor cell population. These cells were suggested to be responsible 
for the accelerated rejection of a second allogeneic graft as well. 
However, the contribution of long-lived memory cells to both the 
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pe~sistent state of DTH and the second set reaction was not ex-
cluded. 
Painting of mice with contact chemicals (6), injection of myco-
bacteria (7) or of antigens emulsified in Freund complete adjuvant 
(FCA) (6,8), can also induce a stable and persistent state of DTH 
to the specific antigen. Boosting of such primed mice generally 
results in the occurrence of an anamnestic or secondary DTH (6,7,9). 
This latter phenomenon is characterized by an initial disappearance 
of DTH reactivity followed by a rapid rise till above the level of 
DTH reactivity previous to the booster injection (7,9). Secondary 
DTH could also be demonstrated in mice, primed intravenously (i.v.) 
with a low dose of sheep red blood cells (SRBC) suspended in saline 
(10). The secondary DTH reactivity to SRBC was shown to be dependent 
on the presence of non-proliferating, long-lived T memory cells 
which can persist in the absence of antigen {11). 
In this paper we describe the inducibility and kinetics of primary 
and secondary type DTH reactivity to minor H-antigens in the mouse. 
Furthermore, this paper deals with the nature and specificity of 
the DTH related memory cells induced by priming with multiple 
minor H-antigens. 
MATERIALS AND METHODS 
Mice 
Female BALB/c (H-2d), DBA/2 (H-2d), C57BL/LiA (H-2be) and 
(C57BL/LiA x C3Hf) F 1 (H-2be/k) mice were purchased from the 
Radiobiological Institute TNO, Rijswijk, The Netherlands. Female 
C3Hf (H-2k) and (C57BL/LiA x CBA/Rij) Fl (H-2befq) mice were obtained 
from the Laboratory Animals Centre of the Erasmus University, 
Rotterdam, The Netherlands. Female AKR/FuRdA (H-2k) , (AKR/FuRdA x 
C3Hf) F1 (H-2k/k) and (BALB/c x C3Hf) Fj (H-2d/k) mice were bred 
at our department. The age of all mice ranged between 12 and 20 
weeks. 
Preparation of cell suspensions 
Spleens were removed, brought into a balanced salt solution (BSS) 
and squeezed through a nylon gauze filter to give a single cell 
suspension. Bone marrow was collected from femora and tibiae, and 
a single cell suspension of bone marrow cells in BSS was prepared 
as described previously (12). Nucleated cells were counted with a 
Coulter Counter Model B. Viable nucleated cells were counted in a 
haemocytometer using 0.2% trypan blue in BSS as a diluent. 
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Antigen and immunization 
Primary and secondary immunization was performed with the appro-
priate allogeneic spleen cells, suspended in a volume of 0.1 ml. 
The priming and booster dose was 1 x 107 spleen cells, unless 
stated otherwise. A total volume of 50 ~l of this spleen cell 
suspension was s.c. injected by means of a 28 gauge needle in 
each of both inguinal areas. Ultrasonic disruption of spleen cells 
suspended in BSS was performed in an ice bath with a MSE 100 W 
ultrasonic desintegrator, 20 kc/sec, for 3 bursts of 30 sec with 
an interval of 30 sec. Skin grafting was performed according to a 
modification of the method of Billingham and Silvers (13). The 
skin was removed aseptically from the donor and freed of the panni-
culus carnosus by cautious scraping with a scalpel. The recipient 
was anaesthetized with Hypnorm (Philips Duphar BV, Amsterdam, The 
Netherlands) and the panniculus carnosus of the graft bed was kept 
undamaged while removing the back skin. 
Selective depletion of T lymphocytes or B lymphocytes 
The method described by Julius et al. (14) for the depletion of B 
lymphocytes was used. After incubation for 45 min at 37°C on pre-
washed nylon wool (Fenwal Laboratories, Morton, Grove, Illinois) 
approximately 90% of the recovered lymphoid cells were T lymphocytes 
as shown by indirect membrane fluorescence staining using a spe-
cific rabbit anti-mouse thymocyte serum and a FITC-conjugated goat 
anti-rabbit immunoglobulin antiserum (15). Anti-Thy 1.2 treatment 
to eliminate T cells was performed as described in a previous 
paper of our laboratory (12). 
Irradiation 
The recipient mice received 800 rad of whole body irradiation as 
described in a previous paper {10). The recipient mice were i.v. 
injected with the appropriate number of spleen cells and 3 x 106 
bone marrow cells suspended in 0.5 ml BSS within 4 hr after irra-
diation. 
Vinblastine treatment 
At 24 hr and 12 hr before adoptive transfer Vinblastine sulphate 
(Eli Lilli & Co., Indianapolis, Ind.) was i.v. injected in a dose 
of 100 ~g/recipient, dissolved in a volume of 0.1 ml sterile saline. 
This dose is sufficient to abolish passive transfer of DTH react-
ivity (11). 
Assay for delayed type hypersensitivity 
DTH reactions were determined by measuring the difference in thick-
ness of the hind feet 24 hr after s.c. injection of 8 x 106 spleen 
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cells in the instep of the right hind leg. In adoptive transfer 
experiments the increase in foot thickness was also measured 48, 
72, 96 and 120 hr after challenge. The challenge dose was adminis-
tered s.c. in a volume of 20 ~1 by means of a 28 gauge needle. 
The thickness of the left and right hind foot was measured with a 
footpad meter as described by Bonta and De Vos (16), with some 
minor modifications. During measurement the mice were anaesthetized 
with ether. 
A control group, consisting of non-immune mice challenged with the 
same spleen cells as the mice to be tested, was always included. 
The specific increase in foot thickness was calculated as the 
relative increase in foot thickness of the immune mice minus the 
relative increase in foot thickness of the control mice. The swel-
ling in control mice ranged between 15 and 28%. 
Fig. 1 
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Dose-response curve for primary DTH to multiple non H-2 alloanti-
gens. C3Hf mice were injected s.c. with varying doses of AKR spleen 
cells and challenged on Day 5 after immunization (A). DBA/2 mice 
were similarly immunized with varying doses of BALB/c spleen cells 
and challenged on Day 5 (B). vertical bars represent 1 SEM (n = 5). 
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RESULTS 
Dose-dependence of the primary DTH response to multiple non H-2 
alloantigens 
C3Hf mice were immunized s.c. with either 105, 106, 107 or 3 x 107 
viable allogeneic H-2 compatible AKR spleen cells and challenged 
with AKR spleen cells by s.c. injection into the right hind leg 
5 days later. DBA/2 mice were similarly immunized with different 
doses of viable H-2 compatible BALB/c spleen cells, and challenged 
with BALB/c spleen cells 5 days later. In both mouse strain combi-
nations the maximal 24 hr DTH response was found after immunization 
with 1 x 107 allogeneic H-2 compatible spleen cells (Fig. 1). 
Induction of primary and secondary DTH responsiveness to multiple 
non H-2 alloantigens by injection of viable spleen cells 
To investigate the kinetics of primary and secondary DTH reactivity 
to multiple non H-2 alloantigens, groups of BALB/c, DBA/2 and C3Hf 
mice were s.c. immunized for primary DTH, or primed and boosted 
for secondary DTH by injection of DBA/2, BALB/c and AKR spleen cells, 
respectively. All immunizations were done by s.c. injection of 
1 x 107 viable nucleated spleen cells. The interval between priming 
and boosting for secondary DTH was at least 3 months. At varying 
intervals after primary immunization or booster injection groups of 
mice were challenged wi-th the specific antigen. In all three strain 
combinations it appeared that the course of the secondary DTH res-
ponse differed considerably from the primary DTH response (Fig. 2A, 
Band C). Primary DTH reactivity to non H-2 alloantigens became 
detectable from Day 3 onwards, with a clear peak reactivity on 
Day 5 after immunization. Thereafter the level of primary DTH 
reactivity declined to reach a plateau level which persisted for 
at least 3 months (points not shown in figures). The secondary 
DTH responsiveness had similar characteristics for all three mouse 
strain combinations. At 24 hr after booster injection the DTH 
reactivity had disappeared, but by Day 3 after booster the DTH 
response of the boosted mice reached its peak and surpassed the 
level of pre-existing DTH in primed mice. 
To test whether a similar difference exists in primary and secondary 
DTH to H-2 incompatible spleen cells, C3Hf mice were immunized for 
primary and secondary DTH with the dose of 1 x 107 (BALB/c x C3Hf) 
F1 spleen cells. At varying intervals after primary and secondary 
immunization different groups of mice were challenged with (BALB/c x 
C3Hf) F 1 spleen cells and the DTH reaction was determined. The 
kinetics of the primary and secondary DTH response to these H-2 
incompatible cells did not differ to the same extent as observed 
for allogeneic H-2 compatible spleen cells. Furthermore, the 
kinetics of the response to H-2 incompatible spleen cells was 
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different from that to allogeneic H-2 compatible spleen cells. The 
most striking difference was the slow development of DTH reactivity 
and the lower peak reactivity attained in case of immunization with 
H-2 incompatible spleen cells (Fig. 2D). 
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Fig. 2 
Primary and secondary DTH responsiveness to allogeneic H-2 compa-
tible or H-2 incompatible spleen cells. The time course of the 
primary DTH ( 0) and secondary DTH (CD ) response of DBA/2 mice to 
H-2 compatible BALB/c spleen cells (A), of BALB/c mice to H-2 com-
patible DBA/2 spleen cells (B) , of C3Hf mice to either H-2 compa-
tible AKR spleen cells (C) or to H-2 incompatible (BALB/c x C3Hf)F 1 
spleen cells (D) was followed. In all strain combinations the 
priming and booster dose was 1 x 107 viable spleen cells. The per-
sistent primary DTH reactivity at the moment of booster, at least 
3 months after priming, was also determined. Vertical bars repre-
sent 1 SEM (n = 5) . 
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Priming for secondary DTH to multiple non H-2 alloantigens by 
injection of crude membranes or skin grafting 
To exclude a role of persisting viable spleen cells in the ability 
of primed mice to respond with a secondary type DTH response, C3Hf 
mice were either grafted with dermis obtained from AKR mice or 
injected s.c. with ultrasonically disrupted AKR spleen cells. 
Primary DTH responsiveness to viable and ultrasonically disrupted 
AKR spleen cells was determined at varying intervals after the 
immunization. The ultrasonically disrupted spleen cells gave rise 
to very weak DTH reactivity (Table 1). Booster injection with 
1 x 107 viable AKR spleen cells caused a clear secondary DTH res-
ponse in both cases, as measured on Day 3 after booster (Table 1). 
TABLE 1 
INDUCTION OF DTH-RELATED MEMORY IN C3Hf MICE BY AKR SKIN GRAFTING 
OR INJECTION WITH ULTRASONICALLY DISRUPTED AKR SPLEEN CELLS 
Priming Interval a day of specific Booster 
challenge DTH response 
Viable cellsa 3 6.5 + 2.0 
Skin graft 90 days viable cells 3 31.1 + 4.0 
U.D. cells b 5c 9.8 + 1.0 
U.D. cells 24 6.5 + 2.7 
Viable cells 24 33.7 + 2.0 
U.D. cells 21 days viable cells 3 30.7 + 1.8 
U.D. cells 90 days viable cells 3 45.7 + 2.9 
a. The priming dose and booster dose of viable cells was always 
1 x 107 spleen cells. 
b. The dose of ultrasonically disrupted (U.D.) spleen cells was 
equivalent to 1 x 107 viable cells. 
c. The DTH reactivity after immunization with U.D. cells is shown 
on the 5th day when maximal responsiveness was found. 
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Primary and secondary DTH responsiveness to the maZe specific H-Y 
ant-igen 
To study the capacity of primary and secondary DTH to a single non 
H-2 antigen the H-Y antigen was chosen. Therefore (C57BL x CBA) F1 
female mice were s.c. immunized for primary and secondary DTH by 
1 x 107 sYngeneic male spleen cells. At varying intervals after 
primary and secondary immunization various groups of mice were 
challenged with syngeneic male spleen cells, and the 24 hr DTH 
reaction was measured. It appeared that a single immunization with 
the male specific H-Y antigen could induce DTH effector cells 
(Fig. 3). The difference in time course of the primary and secon-
dary DTH reactivity to H-Y antigen revealed that s.c. priming with 
male spleen cells in addition induced DTH related memory for the 
H-Y antigen. 
Fig. 3 
"lo specific increase 
foot thickness 
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Primary ( 0) and secondary ( 0) DTH responsiveness to H-Y antigen. 
Female (C57BL x CBA) F 1 mice were immunized for primary DTH or 
primed and boosted for secondary DTH by s.c. injection of 1 x 107 
syngeneic male derived spleen cells. DTH reactivity was determined 
at different days after the last immunization. vertical bars re-
present 1 SEM (n = 5). 
Adoptive transfer of secondary DTH to non H-2 aZZoantigens with 
T ceUs 
The cellular basis of secondary DTH responsiveness to non H-2 allo-
antigens was investigated by means of adoptive transfer experiments. 
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Fig. 4 
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Dependence of secondary DTH responsiveness to multiple non H-2 
alloantigens on T memory cells. Lethally irradiated C3Hf mice 
were injected with 3 x 106 syngeneic bone marrow cells together 
with 2 x 107 viable immune or non immune ( 0) spleen cells. Immune 
spleen cells were obtained from C3Hf mice primed s.c. with 1 x 107 
AKR spleen cells 2 months previously, and were enriched for T cells 
by nylon wool incubation (A) , depleted from T cells by anti-Thy 
1.2 serum treatment (B), or were treated with normal mouse serum 
(.6.). All recipients were s.c. immunized with 3 x 105 AKR spleen 
cells immediately after adoptive transfer, and challenged 4 days 
later. At different intervals after challenge the specific increase 
of foot thickness was determined. Vertical bars represent 1 SEM 
(n = 5). 
C3Hf mice, primed s.c. with 1 x 107 AKR spleen cells 2 months pre-
viously, were used as donor mice of spleen cells. A number of 2 x 107 
viable spleen cells was adoptively transferred into 800 R irradiated 
C3Hf mice after selective depletion of Thy-1.2+ cells by in vitro 
anti-Thy-1.2 serum treatment, or after T cell enrichment by incuba-
tion on nylon wool. Furthermore, one group of recipients received 
normal mouse serum treated spleen cells from primed C3Hf mice, and 
another group was injected with 2 x 107 spleen cells derived from 
non-primed C3Hf mice. Control mice did receive spleen cells. All 
groups of recipients were reconstituted with 3 x 106 C3Hf derived 
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bone marrow cells and immunized s.c. with 3 x 105 AKR spleen cells. 
on Day 4 after transfer and immunization all mice were challenged 
and during the following days the foot swelling was measured. 
The results indicate that the secondary DTH reactivity was strongly 
affected by anti-Thy-1.2 antiserum treatment of the spleen cells, 
whereas the ability of secondary DTH response was unaffected when 
nylon wool purified T cells were transferred (Fig. 4). 
In a similar set up the proliferative activity of DTH-related 
memory was investigated. This was done by studying the vinblastine 
sensitivity of the pool of T cells responsible for the adoptive 
transfer of secondary DTH. BALB/c mice, primed s.c. with 1 x 107 
viable DBA/2 spleen cells 4 months previously, received at 24 and 
12 hr before adoptive transfer either 100 ~g vinblastine or 0.1 ml 
BSS i.v. Thereafter 5 x 107 spleen cells from these groups of donor 
mice were i.v. injected into 750 R irradiated BALB/c mice together 
with 3 x 106 BALB/c derived bone marrow cells. Furthermore, one 
group of recipients received spleen cells from unprimed donors and 
another group was injected i.v. with bone marrow cells only. All 
groups were immunized s.c. with 3 x 105 DBA/2 spleen cells imme-
diately after cell transfer, and challenged 5 days later. It appeared 
that vinblastine treatment did not diminish the capacity of secondary 
DTH responsiveness to DBA/2 spleen cells (Table 2). 
Specificity of DTH-related memory for the multiple non H-2 allo-
antigens used for its induction 
In order to investigate the specificity of the DTH-related memory 
for multiple non H-2 alloantigens, female (C57BL x C3Hf) F1 mice 
were primed s.c. with 1 x 107 viable female AKR spleen cells. Two 
months later these mice were boosted with either 1 x 107 male 
AKR spleen cells or 1 x 107 male (C57BL x C3Hf) F1 spleen cells. 
Challenge of these mice with the antigen used for booster injec-
tion was performed on Day 3. One group of primed (C57BL x C3Hf) 
F1 mice was challenged with AKR spleen cells without a previous 
booster. injection with this antigen. Furthermore, primary DTH 
reactivity to female AKR and male (C57BL x C3Hf) F 1 spleen cells 
was induced, and assayed on Day 3 or 6 after immunization. The 
data presented in Table 3 show that (C57BL x C3Hf) F 1 mice are 
indeed capable of DTH reactivity to H-Y antigen, but priming of 
these mice with female AKR spleen cells could not induce the 
capacity of secondary DTH responsiveness to H-Y antigen upon 
booster injection with syngeneic male spleen cells. 
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TABLE 2 
SUSCEPTIBILITY OF DTH-RELATED T MEMORY CELLS TO TREATMENT WITH 
VINBLASTINE 
Treatment of 
donor micea 
PBS 
Vinblastine 
5 X 
5 X 
5 X 
b Transferred cells 
107 non immune spleen cells 
107 immune spleen cells 
107 immune spleen cells 
DTH reactivityc at 
48 hr 72 hr 
-1.0+1.1 14.0+3.8 
18.8+1.3 33.4+1.8 
21.4+1. 7 37.0+2.1 
a. BALB/c mice primed 4 months previously with 1 x 107 DBA/2 
spleen cells, were injected twice with either 100 ~g Vinblastine 
or 0.1 ml PBS. These injections were given at 24 hr and 12 hr 
before adoptive transfer. 
b. Together with the spleen cells 3 x 106 syngeneic bone marrow 
cells were injected i.v. into the 750 R irradiated BALB/c 
hosts. Immediately after transfer all recipients were immunized 
s.c. with 3 x 105 DBA/2 spleen cells. 
c. Five days after adoptive transfer and immunization all mice 
were challenged. At 24, 48, 82 and 96 hr after challenge the 
specific increase of foot thickness was determined. Figures 
represent the mean responses ~ 1 SEM (n = 4) at 48 and 72 hr. 
The peak response of the groups of mice receiving immune spleen 
cells occurred at 72 hr after challenge. 
DISCUSSION 
In this paper a stable and persistent state of DTH to non H-2 
alloantigens has been described, which was induced by a single 
s.c. injection of mice with viable allogeneic H-2 compatible 
spleen cells, suspended in saline. The time course of this DTH 
resembled the state of DTH to purified protein derivative of 
tuberculin (PPD) after immunization with viable mycobacteria (7). 
S.c. injection of viable allogeneic H-2 compatible spleen cells 
might lead to a condition in which a part of the injected cells 
remains intact in the host for a rather long time period. The 
experiments of Jacobsson et al. (17) indeed suggested that semi-
allogeneic H-2 compatible cells can survive in a normal host for 
at least 2 weeks, in. contrast to H-2 incompatible cells. The 
existence of long-lived DTH related T memory cells requiring 
125 
til 
TABLE 3 
SPECIFICITY OF DTH-RELATED MEMORY INDUCED BY MULTIPLE NON H-2 ALLOANTIGENS 
. . a Pr1m1..ng Booster Challenge Day of challenge 
AKR ~ - AKR ~ 3 
AKR ~ - AKR ~ 55 
AKR ~ AKR ~ AKR ~ 3 
(C57BL x C3H)F
1 
cJ' - (C57BL x C3H)F 1 d' 3 
(C57BL x C3H) F 
1 
d' - (C57BL X C3H) F 
1 
d' 6 
(C57BL X C3H)F
1 
d' (C57BL X C3H)F
1 
d' (C57BL X C3H)F
1 
d' 3 
AKR ~ (C57BL x C3H) F 
1 
d' (C57BL X C3H) F 1 d' 3 
Specific DTH responseb 
17.2 + 1.6 
18.5 + 2.7 
46.8 + 4.6 
-
-0.2 + 1. 5 
-
16.1 + 1.7 
-
13.2 + 1.4 
2.0 + 1.5 
a. Female (Black x C3H)F 1 mice were immunized for primary and secondary DTH reactivity by 
s.c. injection of 1 x 10? viable spleen cells as indicated in the table. The interval 
between priming and boosting for secondary DTH was 2 months. 
b. Figures represent the mean specific increase of foot thickness + 1 SEM (n = 5). 
antigenic restimulation in order to become able to perform an 
effector function has been demonstrated in our previous paper 
on secondary DTH to SRBC (11). The adoptive transfer experiments 
presented in this paper suggest that such a population of hardly 
proliferating, long-lived T memory cells is also present in mice 
which show a persistent level of DTH, and have the capacity of 
secondary DTH responsiveness to multiple non H-2 alloantigens 
(Table 2). Similarly, after immunization with viable mycobacteria, 
not only non-recirculating DTH-related T effector cells are 
generated (18), but also a population of recirculating cells which 
can differentiate into such DTH effector cells (19). A stable and 
persistent state of DTH has never been observed after short las-
ting immunization with non-viable agents alone (20) , although such 
immunization procedures can induce a long-lasting capacity to 
react upon reimmunization with secondary DTH reactivity (10). 
These data together lead us to hypothesize that a persistent state 
of DTH is dependent on the continuous antigen-driven differen-
tiation of long-lived, recirculating T memory cells into non-re-
circulating, functionally short-lived DTH effector cells. According 
to this hypothesis the persistence of immunogenic material is 
required for the persistence of DTH reactivity. 
It cannot be excluded, however, that the increase in DTH reactivity 
during anamnestic DTH can also be mediated by the progeny of effector 
cells undergoing an extra proliferation cycle upon booster injection 
with minor H-antigens. The sudden disappearance of DTH reactivity 
24 hr after the booster injection might reflect the recruitment of 
these effector cells either to the injection site or to the regional 
lymph nodes, where this further proliferation might take place. DTH-
related memory for non H-2 alloantigens could also be found in piimed 
mice at a moment when they hardly show DTH reactivity to these anti-
gens (Table 1). Obviously the absence of a detectable number of DTH 
effector cells doesn't preclude DTH-related memory. 
Combined in vivo and in vitro experiments provided evidence that allo-
reactive T cells, stimulated in.vitro in a mixed lymphocyte reaction 
(MLR) with H-2 incompatible spleen cells can revert into long-lived 
small lymphocytes after the injection into syngeneic recipients (21). 
Upon in vitro restimulation with the specific H-2 alloantigens these 
small lymphocytes gave rise to cytotoxic T lymphocytes in an accele-
rated fashion as compared to the generation of cytotoxic T lymphocytes 
in a primary MLR (21). On the other hand, MLR and in vitro induced 
cytotoxicity to single or multiple non H-2 alloantigens could gener-
ally be induced only after in vivo priming of mice with the specific 
non H-2 alloantigens (22-24). Therefore, MLR and in vitro induced 
cytotoxicity to non H-2 alloantigens might require either a quan-
titative or a qualitative change in the population of precursor cells 
reactive to these antigens {25). The discrepancy in time course 
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between primary DTH and the appearance of cytotoxicity to minor 
H-antigens in vivo (23,26) suggests that T cells mediating DTH to 
non H-2 alloantigens and T cells performing cytotoxic functions to 
these antigens either belong to a different subpopulation or repre-
sent a different stage of differentiation of the same cell line. 
While T cells recognizing non-self H-2 antigens in association with 
multiple minor H-differences are more numerous than T cells that 
recognize multiple minor H-antigens (27,28), immunization with H-2 
alloantigens always gives rise to a slowly developing and relatively 
weak DTH reactivity as compared with non H-2 alloantigens (Fig. 2D; 
other data not shown). It was shown by Hallet al. (29,30) that a 
primary allograft incompatibility for major H-antigens greatly 
increased the potency of alloreactive cells upon adoptive transfer 
to reject an allogeneic skin graft. However, neither the second 
set rejection of H-2 incompatible grafts (31) nor secondary DTH 
responsiveness to H-2 incompatible cells (Fig. 2D) are markedly 
different from the primary responses to major H-antigens, in 
contrast to responses to non H-2 antigens (31; Fig. 2A-C). Experi-
ments are in progress to reveal the underlying cause of this dis-
crepancy. 
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DIFFERENTIAL RESPONSIVENESS TO MLS LOCUS ANTIGENS IN GP~FT-VERSUS­
HOST AND HOST-VERSUS-GRAFT REACTIONS 
E.A.J. Wolters> N.H.C. Brons> Th.H. van der Kwast and R. Benner 
Department of Cell Biology & Genetics> Erasmus University> 
P.O. Box 1?38, Rotterdam> The Netherlands. 
SUMMARY 
After (semi-)allogeneic transplantation of lymphoid cells into 
lethally irradiated mice, the development of anti-host directed T 
effector cells can be demonstrated by means of a simple delayed 
type hypersensitivity (DTH) assay. Using this assay we have shown 
that in H-2 compatible combinations, Mls locus antigens can induce 
the generation of such T effector cells during a graft-versus-host 
(GvH) reaction~ Other non H-2 alloantigens are probably of minor 
importance. The capacity of Mls locus antigens to induce distinct 
anti-host DTH reactivity correlated with the capacity to induce 
an one-way mixed lymphocyte culture (MLC) response. Mlsa and Mlsc 
locus antigens initiated both a positive HLC response as well as 
distinct GvH-related DTH reactivity. On the other hand, in the 
combination DBA/2 versus (BALB/c x DBA/2) F1, the Mlsb locus 
antigens were not able to initiate in-vitro proliferation, a lack 
of response which coincided with a marginal and short-lasting 
GvH-related DTH reactivity. 
In contrast, the host-versus-graft (HvG). DTH reaction of BALB/c 
and DBA/2 mice to subcutaneously injected (BALB/c x DBA/2) F 1 
spleen cells was equally strong. Here, antigens other than those 
coded for by the Mls locus were mainly responsible for the anti-
graft DTH response. These results suggest that T effector cells 
generated in GvH and HvG reactions are specific for largely differ-
ent sets of minor histocompatibility antigens, with a selective 
stimulation by Mls locus antigens under GvH conditions. 
INTRODUCTION 
It is not only the major histocompatibility complex (MHC) of the 
mouse which encodes for antigens that stimulate T lymphocytes to 
strong proliferative responses in a mixed lymphocyte culture (MLC) 
test. The products of the Mls locus, which is neither linked to, 
nor part of the MHC, can also strongly stimulate in a MLC test 
( 1) . 
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Injection of lymphocytes into Mls locus incompatible neonatal F1 
recipients did not give rise to splenomegaly (2) , probably due to 
non-expression of Mls locus determinants on neonatal cells (3). 
Testing of MHC compatible, Mls locus incompatible lymphocytes in 
a popliteal lymph node assay, showed a graft-versus-host (GvH) 
reactivity (2,4). 
In the host-versus-graft (HvG) popliteal lymph node assay, CBA/H 
x (CBA/H x DBA/2) F 1 backcross derived cells, injected into paren-
tal CBA/H mice, induced an equally large proliferative response 
to H-2 identical, Mls locus compatible and to H-2 identical, Mls 
locus incompatible donor cells (2). In a comparable approach, 
Festenstein et al. (5) have shown that parental mice rejected 
skin grafts from Mls locus identical backcross mice in about the 
same time as skin grafts from Mls locus different backcross mice. 
Eichwald and Weissman (6) parabiosed MHC identical, but Mls locus 
different, BALB/c and DBA/2 mice. After some time the DBA/2 partner, 
but not the BALB/c, showed symptoms of severe parabiotic intoxicati-
on. Nisbet and Edwards (7), however, parabiosed BALB/c parents to 
BALB/c x (BALB/c x DBA/2) Fj backcross mice, both in Mls locus 
compatible and in Mls locus incompatible combinations~ These authors 
found an equal mortality in both groups, indicating that differences 
at Mls loci are not implicated in mortality~ Thus, the role of 
incompatibilities outside the MHC in the development of T effector 
cells for GvH and HvG reactivity is still unclear. 
Recently, we have developed a simple delayed type hypersensitivity 
(DTH) assay which is appropriate for measuring the development 
of histocompatibility antigen-induced T effector cells during a 
GvH reaction {8,9)~ The assay is based upon secondary transfer of 
lymphoid cells from animals undergoing a GvH reaction, and subse-
quent testing of the secondary recipients for DTH reactivity to 
the histocompatibility antigens which evoked the GvH reaction~ 
Using this assay we have now studied the capacity of Mls locus 
antigens to induce such DTH T effector cells after (semi-)allogeneic 
spleen cell transplantation into lethally irradiated mice. The 
results are correlated with the capacity of the same antigens to 
induce DTH related T effector cells during a HvG reaction. 
MATERIALS AND METHODS 
Animals 
BALB/c (H-2d, Mlsb) female mice and DBA/2 (H-2d, Mlsa) male mice 
were purchased from the Medical Biological Laboratory TNO, Rijswijk 
(ZH), The Netherlands. (BALB/c x DBA/2) F! (H-2d/d, Mlsb/a) female 
mice were obtained from the Radiobiological Institute TNO, Rijswijk 
132 
(ZH), The Netherlands. B10.D2 (H-2d, Mlsb) male mice were kindly 
provided by the Central Laboratory of the Netherlands Red Cross 
Blood Transfusion Service, Amsterdam, The Netherlands. C3H/f (H-2k, 
Mlsc) male mice and (C57BL/Rij x CBA/Rij) F1 (H-2b/q) female mice 
were bred at the Laboratory Animals Centre of the Erasmus Univer-
sity, Rotterdam, The Netherlands. (BALB/c X C3H/f) F 1 (H-2d/k, 
Mlsb/c) female and AKR/FuRdA (H-2k, Mlsa) male mice were bred in 
our own department. The age of the mice ranged between 15 and 30 
weeks. When mice from either sex were used in anyone experiment, 
the combinations were always chosen in such a way that anti-H-Y 
responses were impossible. 
Preparation of cell suspensions 
Mice were killed with carbon dioxide. Immediately after killing, 
the spleens were removed and placed in a. balanced salt solution 
(BSS). This solution was prepared according to Mishell and Dutton 
(10). The spleens were minced with scissors and squeezed through 
a nylon or stainless steel filter to give a single cell suspension. 
Nucleated cells were counted with a Coulter Counter Model B. 
Irradiation 
The recipient mice received 850 rad whole body irradiation, gener-
ated in a Philips Muller MG 300 X-ray machine as described pre-
viously (8). 
Acute GvH reaction 
Acute GvH reactions were elicited by intravenous (i.v.) injection 
of 5 x 107 nucleated spleen cells into lethally irradiated reci-
pient mice within 4 hr after irradiation. The cells to be injected 
were suspended in a volume of 0.5 ml of BSS. 
Immunization 
Primary immunization with histocompatibility antigens was performed 
with 1 x 107 spleen cells in a volume of 0.1 ml of BSS. The cells 
were injected subcutaneously (s.c.), and equally distributed over 
both inguineal areas by means of a 28-gauge needle. 
Mitomycin C treatment 
Treatment of spleen cells with 25 or 100 ~g mitomycin C (Kyowa 
Hakko Kogyo Co. Ltd., Tokyo, Japan) per ml was carried out as 
described previously (8). 
Estimation of cell proliferation in-vitro 
Washed cell suspensions were filtered through sterile nylon wool 
1~ 
in order to remove clumps and tissue debris, and cultured in 
RPMI 1640 supplemented with Penicillin (100 U/ml), Streptomycin 
(100 ~g/ml), L-glutamine (2 mM) and 10% fresh normal mouse serum. 
Cultures were set up in Costar 3596 flat bottom wells (Cambridge, 
Mass., U.S.A.). 5 x 105 (100 ~l) responder cells (R) and 5 x 105 
(100 ~l) stimulator cells (S) (treated with 25 ~g mitomycin 
C per ml) were dispersed into each well, so that quadruplicate 
cultures were plated for each combination. Control cultures con-
sisted of 1 x 106 responder cells or 1 x 106 stimulator cells 
alone. Cultures were incubated at 37°C in a humidified atmosphere 
of 5% C02 in air. Seventeen hours prior to termination, 1 ~Ci of 
3H-methyl-thymidine (spec. act. 5Ci/mM; The Radiochemical Centre, 
Amersham, England) was added to each well. The cells were harvest-
ed from the culture wells with a semi-automatic sample precipitat-
or (Cryoson, Midden Beemster, The Netherlands) and counted in a 
liquid scintillation counter (Packard, Model 3375). Specific 
counts per minute (cpm) were 
5 5 
spec.cpm=cpm(5x10 R + 5x10 
calculated as: 6 
cpm (1x10 
S) -
6 R) + cpm (1x10 S) 
2 
The activity of 1 x 106 R cells ranged from 500 to 2500 cpm, 
and the activity of 1 x 106 S cells ranged from 100 to 600 cpm 
in the various experiments. Background activity was 35 cpm. 
Estimation of cell proliferation in-vivo 
The method described by North et al. (11) was used. Briefly, 4 
days after s.c. immunization with 1 x 107 allogeneic or syngeneic 
spleen cells (treated with 25 ~g mitomycin C per ml), the mice 
were injected i.v. with a dose of 20 ~Ci 3H-methyl-thymidine, 
spec. act. 5Ci/mM. Thirty min. later their inguinal lymph nodes 
were taken out and homogenized in 5% ice-cold trichloracetic 
acid (TCA) . Each homogenate was extracted twice for 1 hr with 
20 ml cold 5% TCA. Thereafter the homogenate was extracted in 
6 ml of 5% TCA at 90°C for 1 hr. After cooling, 1 ml of the super-
natant was added to 9 ml scintillant consisting of 3 ml Triton 
X-100 and 6 ml toluene containing 4 mg PPO per liter and counted 
in a liquid scintillation counter (Packard, Model 3375). Radio-
activity was corrected for background and quenching and expres-
sed as cpm. Background activity was 35 cpm. 
Assay for delayed type hypersensitivity 
The delayed type hypersensitivity (DTH) assay for measuring anti-
host immune reactivity after allogeneic spleen cell transplantat-
ion has been described in detail in a previous paper (8). Briefly, 
a number of cells equivalent to one whole spleen from an irra-
diated and allogeneically reconstituted recipient mouse was 
transferred i.v. into a normal secondary recipient at different 
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intervals after reconstitution. This secondary recipient was syn-
geneic to the original spleen cell donor mouse. The secondary 
recipient mice were challenged into the right hind foot with 
2 x 107 spleen cells (treated with 100 ~g mitomycin C per ml), 
syngeneic with the original recipient. The DTH response to this 
challenge was measured as the difference in thickness of the 
hind feet 24 hr later. The specific increase in foot thickness 
was calculated as the relative increase in foot thickness of the 
immune mice minus the relative increase in foot thickness of 
control mice which only received the challenge. The swelling of 
challenged control mice ranged between 12 and 22%. 
RESULTS 
Kinetics of MLC responses to Mls locus antigens 
The capacity of the Mls locus antigens of our mice to induce pro-
liferation was tested in an one-way mixed lymphocyte culture (MLC) 
reaction. The following combinations were tested: BALB/c (H-2d, 
Mlsb) and DBA/2 (H-2d, Mlsa) versus (BALB/c x DBA/2) Fj, and 
AKR/FuRdA (H-2k, Mlsa) versus C3H/f (H-2k, Mlsc) and vice versa. 
Stimulator cells were treated with 25 ~g mitomycin C per ml, but 
not irradiated with 3000 rad, because this latter treatment reduced 
the response to Mls locus antigens to a large extent (data not 
shown). Stimulation with spleen cells from mice irradiated in vivo 
with 850 rad reduced the responsiveness as well, although to a 
smaller extent (data not shown). 
As can be seen in Fig. 1A, BALB/c spleen cells could strongly pro-
liferate in a MLC test upon stimulation with (BALB/c x DBA/2) F1 
spleen cells, with a maximum response on day 4 of culture. In 
contrast, DBA/2 spleen cells were not stimulated to proliferate by 
(BALB/c x DBA/2) F 1 spleen cells. Both BALB/c and DBA/2 spleen cells 
did proliferate upon stimulation with H-2 incompatible (C57BL/Rij x 
CBA/Rij) F1 spleen cells, with a maximum response on day 3. These 
results confirm that Mlsa locus antigen strongly stimulates proliferat-
ion of Mlsb locus positive cells, but not the other way around. 
Fig. 1B shows that C3H/f spleen cells are strongly stimulated to 
proliferate by AKR spleen cells with a maximum response at day 4. 
Iri the opposite direction, AKR spleeri cells were equally well 
stimulated by C3H/f spleen cells until about day 2. However, the 
maximum response, reached on day 3, was lower. In a fully histo-
incompatible combination, AKR spleen cells appeared to be fully 
capable of proliferating, with a maximum response on day 3. These 
results show that during the first 2-3 days of culture both Mlsa 
and Mlsc locus antigens strongly stimulate proliferation. However, 
after continued cultivation Mlsa locus antigen can induce a higher 
level of proliferation than Mlsc. 
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Fig. 1 
Kinetics of 3H-thymidine incorporation in one way MLC after stim-
ulation with Mls antigens. Responder (R) and stimulator (S) cells 
were always spleen cells. s cells were treated with 25 ~g mito-
mycin C per ml. 
(A) BALB/c (R) - (BALB/c x DBA/2) F1 (S) ( 0); DBA/2 (R) - (BALB/c 
x DBA/2) F 1 (S) (A). For comparison the response of BALB/c and 
DBA/2 cells in an H-2 incompatible combination is shown: BALB/c 
(R) - (C57BL/Rij x CBA/Rij) F1 (S) ( 8); DBA/2 (R) - (C57BL/Rij x 
CBA/Rij F1 (S) ( 41.). (B) AKR/FuRdA (R) - C3H/f (S) ( 0); C3H/f (R) 
- AKR/FuRdA (S) (A). For comparison the response of AKR/ 
FuRdA cells in an H-2 incompatible combination is shown: AKR/FuRdA 
(R) - (BALB/c x C3H/f) F1 (S) ( 8). Each experimental point 
represents the arithmetic mean of three separate experiments. 
Values are corrected for background (35 cpm). 
Cellular changes in the spleen after Mls locus differing spleen 
cell transplantation 
The cellular changes in the spleen of lethally irradiated (BALB/c 
x DBA/2) F1 mice inoculated with either 5 x 107 BALB/c, DBA/2 or 
(BALB/c x DBA/2) F! spleen cells were studied. After reconstitution 
with BALB/c and especially with DBA/2 spleen cells, an earlier in-
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crease of cellularity was found as compared to syngeneically recon-
stituted mice (Fig. 2). At 12-16 days after irradiation and BALB/c 
spleen cell reconstitution, a pronounced splenomegaly was observed, 
which was not found after DBA/2 and syngeneic spleen cell recon-
stitution .. 
Fig. 2 
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Recovery of the number of nucleated cells in the spleen of lethally 
irradiated (BALB/c x DBA/2) F1 mice, reconstituted with either 
5 x 107 BALB/c ( 0), DBA/2 (.6.) or (BALB/c X DBA/2) F 1 ( !J) spleen 
cells. The figure representing the value 0 days after irradiation 
was obtained from non-irradiated (BALB/c x DBA/2) F 1 control mice. 
Each experimental point represents the arithmetic mean of 4 mice. 
Development of GvH-related DTH reactivity after irradiation and Mls 
locus incompatible spleen cell transplantation 
At various intervals after irradiation of (BALB/c x DBA/2) F1 mice 
and reconstitution with 5 x 107 BALB/c or DBA/2 spleen cells, the 
recipient spleens were transferred into normal BALB/c and DBA/2 
mice respectively. Immediately therafter, these secondary recipients 
were challenged with 2 x 107 DBA/2 or BALB/c spleen cells respect-
ively. Similarly, the capacity of BALB/c and DBA/2 spleen cells to 
mount an anti-host DTH reactivity in an allogeneic H-2 incompatible 
combination was tested. Ther.efore, (C57BL/Rij x CBA/Rij) F1 mice 
were chosen as recipients. Fig. 3 shows that BALB/c spleen cells 
were capable of giving rise to an anti-host DTH reactivity in the 
lethally irradiated H-2 compatible, Mls locus different (BALB/c x 
DBA/2) F1 host. The maximum response occurred on day 4-6 after 
reconstitution. Thereafter the response gradually decreased .. The 
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anti-host DTH reactivity appeared to be directed against the Mlsa 
locus antigen, since after challenge with B10.D2 (H-2d, Mlsb) spleen 
cells no significant DTH response was found (Table 1, upper part), 
although extensive cross-reactivity exists between other non H-2 
alloantigens of DBA/2 and B10.D2 mice (12). DBA/2 spleen cells, 
however 1 did not cause such a strong anti-host DTH response in the 
Mls locus differing (BALB/c x DBA/2) F 1 host. Only during the first 
4 days could a low response be detected. In contrast, in an allo-
geneic, H-2 incompatible combination both BALB/c and DBA/2 spleen 
cells were capable of strong anti-host DTH reactivity, with a 
maximum at 5 days after reconstitution 1 and a sharp decrease 
thereafter. 
Fig. 3 
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Development of anti-host DTH reactivity in the spleen of lethally 
irradiated (BALB/c x DBA/2) F1 mice, inoculated with 5 x 107 
BALB/ c ( 0) or DBA/2 (b.) spleen cells and in the spleen of 
lethally irradiated (C57BL/Rij x CBA/Rij) F1 mice, inoculated with 
5 x 107 BALB/c ( 0) or DBA/2 (A) spleen cells. Each experimental 
point represents the arithmetic mean + 1 SEM of two different 
experiments (n=10). 
138 
~ 
l!l 
TABLE 1 
ROLE OF OTHER NON H-2 ALLOANTIGENS THAN MLS LOCUS PRODUCTS AS TARGETS OF GVH AND HVG 
RELATED DTH REACTIVITY 
system inoculum recipient challenge response 
BALB/c (BALB/c X DBA/2) 
GvH a 
Fl DBA/2 25.5+0.7c 
BALB/c (BALB/c x DBA/2) Fl B10.D2 0.5+1.2 
system immunizing cells responder challenge response 
b (BALB/c X DBA/2) Fl BALB/c DBA/2 39.2+2.2 HvG 
(BALB/c x DBA/2) Fl BALB/c B10.D2 28.4+3.0 
a. GvH reactions were elicited by i.v. injection of 5 x 107 BALB/c spleen cells in lethally 
irradiated (BALB/c x DBA/2) F) mice. After 5 days the recipient spleen cells were trans-
ferred into BALB/c mice and these mice were challenged with either DBA/2 or B10.D2 spleen 
cells. 
b. HvG reactions were elicited by s.c. injection of 1 x 107 (BALB/c x DBA/2) F 1 spleen cells 
in BALB/c mice. Five days later these mice were challenged with either DBA/2 or B!O.D2 
spleen cells. 
c. DTH responses are expressed as the specific percentual increase in foot thickness. 
Figures represent the arithmetic mean + 1 SEM of 5 mice. 
Fig. 4 
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Development of anti-host DTH reactivity in the spleen of lethally 
irradiated C3H/f mice inoculated with 5 x 107 AKR/FuRdA spleen 
cells (0), in the spleen of lethally irradiated AKR/FuRdA mice 
inoculated with 5 x 10 7 C3H/f spleen cells ( L>) , and in the spleen 
of lethally irradiated (BALB/c x C3H/f) F 1 mice, inoculated with 
5 x 107 AKR/FuRdA spleen cells ( 4D). Each experimental point 
represents the arithmetic mean + 1 SEM of two different experiments 
(n=10). 
In order to study a second Mls locus differing, H-2 compatible 
combination, AKR/FuRdA and C3H/f mice were tested. The transferable 
antihost DTH reactivity was determined at different intervals after 
irradiation and reconstitution of AKR and C3H/f mice with 5 x 107 
C3H/f or AKR spleen cells respectively. As shown in Fig. 4 both 
AKR and C3H/f spleen cells were capable of giving an anti-host 
DTH reactivity, with a maximum response around days 6-8 after 
reconstitution. Thereafter, the reactivity gradually declined. 
The anti-host DTH reactivity of AKR spleen cells in H-2 incompa-
tible, Mls locus incompatible (BALB/c x C3H/f) F 1 mice was also 
studied (Fig. 4). In this combination a strong anti-host DTH 
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response could be seen with a maximum at 4 days after reconstit-
ution, followed by a sharp decline thereafter. Apparently, in an 
H-2 incompatible combination, the Mls locus difference cannot 
maintain the anti-host DTH reactivity on a high level, as is the 
case in H-2 compatible combinations. 
Fig. 5 
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(A) Primary DTH responsiveness of BALB/c (0) and DBA/2 (A) mice 
s.c. immunized with 1 x 107 spleen cells from (BALB/c x DBA/2) F 1 
mice; or BALE/ c ( 8 ) and DBA/2 (A) mice s. c. immunized with 
1 x 107 spleen cells from (BALB/c x DBA/2) F 1 mice which were 
lethally irradiated (850 rad) previously. 
(B) Primary nTH responsiveness of C3H/f (0) mice s.c. immunized 
with 1 x 107 AKR/FuRdA spleen cells, and DTH responsiveness of 
AKR/FuRdA (A) mice s.c. immunized with 1 x 107 C3H/f spleen cells. 
Each experimental point represents the arithmetic mean of + 1 SEM 
of a group of at least 5 mice. 
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TABLE II 
PROLIFERATIVE ACTIVITY DURING THE DEVELOPMENT OF ANTI-GRAFT DTH 
REACTIVITY TO MLS INCOMPATIBLE, H-2 COMPATIBLE SPLEEN CELLS 
immunization a 
(BALB/c X DBA/2) F1 
(BALB/c X DBA/2) F1 
BALB/c 
DBA/2 
recipient 
BALB/c 
DBA/2 
BALB/c 
DBA/2 
b 
response 
3202+212 
999+ 54 
552+ 44 
266+ 20 
stimulation indexc 
5.8+0.4 
3.8+0.4 
a. Immunization was performed s.c. with 1 x 10 7 spleen cells, 
treated before with 25 ~g mitomycin C per ml in order to pre-
vent proliferation of the injected cells. 
b. Figures represent the mean response in cpm + 1 SEM of 5 mice, 
measured 4 days after immunization. Values are corrected for 
background and quenching. Background activity was 35 cpm. 
c. Stimulation index was calculated as proliferative capacity 
(in cpm) of the immune mice divided by the proliferative 
activity {in cpm) of the corresponding control mice. 
Primary DTH responsiveness to Mls locus incompatible spleen cells 
In order to test the contribution of Mls locus incompatibilities 
to HvG reactions, BALB/c and DBA/2 mice were immunized s.c. with 
1 x 107 (BALB/c x DBA/2) F 1 spleen cells and AKR and C3H/f mice 
were immunized s.c. with 1 x 10? C3H/f and AKR spleen cells, res-
pectively. At varying intervals after immunization, these groups 
of mice received a challenge dose of DBA/2, BALB/c, C3H/f and AKR 
spleen cells, respectively. In Fig. 5 the primary DTH reactivity 
of the various combinations is shown. At 2-3 days after immunizat-
ion the DTH reactivity started to increase rapidly. In all combi-
nations the peak reactivity was observed 5 days after immunization. 
Thereafter, the reactivity declined. The DTH reactivity that 
developed during this HvG reaction was mainly directed against non 
H-2 histocompatibility antigens other than Mls locus products. This 
was clear from the relatively high DTH response of BALB/c mice, 
immunized with DBA/2 (Mlsa) spleen cells, challenged with B10.D2 
(Mlsb) spleen cells (Table 1, lower part). 
In order to compare the reactivity in HvG reactions with the res-
ponsiveness in GvH reactions, in which the hosts were lethally 
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irradiated, in a subsequent experiment the immunizing (BALB/c x 
DBA/2) F1 spleen cells were irradiated {850 rad) in vivo before 
harvesting. As can be seen from Fig. SA, in this case also a clear 
primary DTH reactivity developed with an equally high maximum on 
day 5 for both combinations. Only the height of the maximum response 
was lower than that after immunization with non-irradiated spleen 
cells. 
Proliferative activity in the development of anti-graft immune 
reactivity 
The proliferative activity in the development of anti-graft DTH 
reactivity after s.c. immunization of BALB/c and DBA/2 mice with 
1 x 107 (BALB/c x DBA/2) F 1 spleen cells was determined in vivo in 
the inguinal lymph nodes. Both in BALB/c and in DBA/2 mice an in-
creased proliferative activity was observed at 4 days after immunizat-
ion (Table II). In BALB/c mice, however, the proliferative activity 
was higher than in DBA/2 mice, probably due to stimulation by the 
Mlsa locus antigen. 
DISCUSSION 
This study shows that antigens encoded for by the Mls locus can 
elicit a transferable anti-host directed DTH reactivity after trans-
plantation of H-2 compatible, but non H-2 incompatible spleen cells 
in lethally irradiated hosts. The capacity of Mls locus antigens to 
induce distinct anti-host DTH reactivity correlated fully with the 
capacity to induce an one-way MLC response. Thus, in the BALB/c 
versus (BALB/c x DBA/2) F 1 combination, and in the C3H/f versus 
AKR combination, Mlsa locus antigen initiated a positive MLC res-
ponse (Fig. 1) as well as distinct GvH-related DTH reactivity 
(Fig. 3 and 4). The same result was found for MlsC in the AKR versus 
C3H/f combination. On the other hand, in the combination DBA/2 
versus (BALB/c x DBA/2) F1, the Mlsb locus antigen was not able to 
initiate in vitro proliferation (Fig. 1) or splenomegaly (Fig. 2), 
a failure-which coincided with a marginal and short-lasting GvH 
related DTH reactivity (Fig. 3). This finding correlates well with 
our previous study on the role of proliferation in the development 
of specific anti-host immune responsiveness in a fully histo-incom-
patible combination (9). In the earlier study it was found that 
blocking of the proliferative capacity of donor spleen cells with 
mitomycin C (25 ~g per ml) did not prevent the anti-host DTH res-
ponsiveness during the first 2 days after transplantation, but d-id 
so thereafter. Elimination of the proliferative component of react-
ing lymphocytes with the 3H-thymidine suicide technique, showed 
that the maximum proliferative act·ivity preceded the maximal- anti-
host DTH reactivity (9). It is a_lso possible that in Mls locus 
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differing H-2 identical combinations only the early proliferative 
activity is important for the full development of anti-host DTH 
responsiveness. This might explain why the kinetics of the GvH 
related DTH reactivity in the AKR versus C3H/f and C3H/f versus 
AKR combinations is the same, in spite of a prolonged MLC stim-
ulating capacity of the Mlsa positive AKR cells after the third 
day of culture. 
So far, Mls locus antigens have been reported to induce only T 
cell proliferation and not cytotoxic T cells (13,14). However, 
until this moment the results have been obscured by the occur-
rence of numbers of non H-2 incompatibilities still present in 
the first generation of Mls locus typed backcross mice (15). It 
is possible that these minor histo-incompatibilities other than 
Mls locus antigens are also essential in the development of anti-
host immune reactivity. The role of proliferation upon stimulat-
ion with Mls locus differences could be a strengthening of the 
developing anti-host immune reactivity. ROllinghof and Wagner 
(16) showed in their studies an amplification effect of Mls locus 
induced T cell proliferation upon the induction of anti H-2 
cytotoxic T lymphocytes, similar to the proposal of Bach et al. 
in which LD-antigen induced T cell proliferation potentiates anti-
SD cytotoxic responses (17). The question arises whether the trans-
ferable anti-host DTH reactivity in our system is directed against 
Mls locus products themselves or against other non H-2 antigens. 
Our experiments with cross-reacting (12) non H-2 alloantigens 
revealed that the anti-host T effector cells in DTH are directed 
mainly against the Mls locus antigen and not against other non 
H-2 alloantigens (Table 1). In studies with congenic mice (manus-
cript in preparation), differing at the H-2 complex or part of 
the H-2 complex, we found a remarkable parallel. There we could 
demonstrate that the anti-host DTH reactivity is directed almost 
exclusively against I-region antigens, and not against K- and 
D-region antigens. Just like Mls products, I-region antigens 
stimulate T cell proliferation in MLC (18). The inability of K 
and D products to efficiently stimulate T cell proliferation in 
vitro (18) again coincided with the inability to evoke DTH T 
effector cells during a GvH reaction. Klein et al. (19) were 
able to demonstrate cytotoxic effector cells against I-region 
antigens; thus, the possibility has to be considered that the Mls 
system is a complex system with linked genes which could provide 
targets for effector cells (14). 
The role of Mls locus products in the development of host anti-
graft directed T effector cells was completely different from 
that in the GvH situation. In the HvG reaction the role of Mls 
locus differences is of minor importance (Fig. 5 and Table I). 
Other non H-2 differences are probably responsible for most of 
the DTH reactivity after immunization with H-2 compatible spleen 
1M 
cells (Table 1). Although T effector cells specific for Mls locus 
products could not be detected, a distinct proliferation in the 
inguineal lymph nodes 4 days after s.c. immunization with H-2 
identical, non H-2 differing spleen cells was found (Table II). 
Thus, other non H-2 alloantigens than Mls locus products can also 
induce a primary proliferative response in HvG reactions. 
In conclusion, this paper shows that stimulation by Mls locus pro-
ducts is essential for the development of anti-host DTH T effector 
cells after transplantation of allogeneic, H-2 compatible, non H-2 
incompatible spleen cells into lethally irradiated recipients. In 
such GvH reactions other non H-2 alloantigens do not give rise to 
DTH T effector cells. In contrast, in HvG reactions non H-2 allo-
antigens other than Mls locus products are fully capable of inducing 
the generation of DTH T effector cells. 
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H-2 RESTRICTED RECOGNITION OF MINOR HISTOCOMPATIBILITY ANTIGENS 
IN DELAYED TYPE HYPERSENSITIVITY 
Th.H. van der Kwast 
Erasmus University, Department of Cell Biology and Genetics, 
P.O. Box 1738, Rotterdam, The Netherlands. 
SUMMARY 
Subcutaneous (s.c.) immunization of mice with viable allogeneic 
H-2 compatible spleen cells can induce a persistent state of 
delayed type hypersensitivity (DTH) to minor histocompatibility 
(H)antigens which can be evaluated with a footpad swelling 
assay. The importance of H-2 compatibility of the injected spleen 
cells with the recipient for (1) the elicitation of the DTH-
reaction, (2) the induction of DTH-related effector and memory 
T cells, and (3) the activation of T memory cells was examined 
with congenic mouse strains. Spleen cells sharing either the K-
or D-region of the H-2 complex with the recipient could elicit 
strong DTH-reactions to minor H-antigens, though somewhat less 
than did fully H-2 compatible allogeneic spleen cells. H-2 incom-
patible cells, or cells sharing I-region coded antigens only 
elicited relatively weak, though significant, DTH-reactivity to 
the minor H-antigens. Similar H-2 requirements for recipient mice 
were demonstrated in the immune lymphocyte transfer assay. Optimal 
induction of primary DTH and DTH-related T memory cells for minor 
H-antigens also required H-2 identity of the immunizing cells and 
the recipient. To some extent, H-2 incompatible cells were able 
to induce primary DTH-reactivity and memory for minor H-antigens. 
The secondary DTH-reactivity was not or slightly dependent on the 
H-2 haplotype of the cells used for booster injection. 
It is concluded that the DTH-related effector cells are restrict-
ed in their recognition of minor H-antigens by K- or D-region 
coded antigens. Presumably, macrophage processing of the allo-
geneic spleen cells after primary and secondary immunization 
accounts for the capacity of the minor H-antigens to activate 
unprimed T cells and memory T cells when these antigens are pre-
sented on H-2 incompatible cells. 
INTRODUCTION 
Allogeneic skin grafting of mice can induce a state of delayed 
type hypersensitivity (DTH) to minor histocompatibility (H-)anti-
gens (Kon & Klein, 1976). In a previous paper we have shown that 
subcutaneous (s.c.) injection of allogeneic H-2 compatible spleen 
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cells also leads to a strong and stable state of DTH to non H-2 
alloantigens {Vander Kwast et al., in press). Mls locus products 
did not influence the intensity of the primary DTH to minor H-
antigens (Vander Kwast et al., in pressi Wolters et al., submit-
ted for publication). Grafting of allogeneic skin may also result 
in the appearance of sensitized cells in the draining lymph nodes 
whose antigraft reactivity can be assayed by intracutaneous trans-
fer into recipients identical to the donor strain of the graft 
(Brent et al., 1962; Streilein & Billingham, 1970). This immune 
lymphocyte~ransfer (ILT) causes a local Graft-versus-Host (GvH) 
reaction, characterized by oedema and infiltration, which is maxi-
mal at about 24 hr. ILT-reactions to multiple minor H-antigens or 
to a single minor H-antigen can be demonstrated in mice (Streilein 
& Billingham, 1970). S.c. priming of mice with allogeneic H-2 
compatible spleen cells not only induces primary DTH-reactivity, 
but also DTH-related T memory cells (Vander Kwast et al., in press). 
These T memory cells account for the occurrence of secondary DTH 
after booster injection with the specific antigen. Secondary DTH 
to minor H-antigens is characterized by the rapid increase of DTH-
reactivity till above the level of pre-existing DTH. The peak 
reactivity can be observed about 2 days earlier than in primary 
DTH. Transfer experiments revealed that DTH-reactivity to proteins 
could only be transferred into recipients with an identical I-A-
region of the MHC, while contact sensitivity to dinitrofluoro-
benzene was transferable to recipients which have either the same 
K-, I-, or D-region as the sensitized donor strain (Vadas et al., 
1977; Miller, et al., 1977). Transfer of DTH to viral antigens 
required K- or D-region compatibility between donor and recipient 
(Zinkernagel, 1976). H-2 restricted cell-mediated immunity to 
multiple minor H-antigens has been demonstrated in vitro by means 
of the cell-mediated lympholysis (CML) assay. Since in-vivo 
priming of mice with a skin graft or by injection of cells is 
required for the in-vitro induction of CML, only secondary res-
ponses to minor H-antigens could be assayed in CML (Gordon et 
al., 1975; Bevan, 1975). It was then found that efficient lysis 
only occurred when responder cells and target cells have identi-
cal K- or D-regions of the H-2 complex. In this paper the in-vivo 
relevance of the phenomenon of H-2 restriction was investigated 
for the effector phase of primary DTH to minor H-antigens. Further-
more, the optimal conditions for primary and secondary immunizat-
ion for DTH reactivity to minor H-antigens were studied. 
MATERIALS AND METHODS 
Mice 
Female BALB/c (H-2d) and DBA/2 (H-2d) mice were purchased from the 
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Radiobiological Institute TNO, Rijswijk, The Netherlands. Female 
C3Hf (H-2k), B10.A (H-2a), A.SW (H-2 8 ), and B10.AQR (H-2Y 1) mice 
were obtained from the Laboratory Animals centre of the Erasmus 
University, Rotterdam, The Netherlands. Female B10.Br (H-2k) and 
B10.D2 (H-2d) mice were kindly provided by the University of 
Nijmegen, The Netherlands and the Central Bloodtransfusion Service 
in Amsterdam, The Netherlands. Female BALB.B (H-2b) , CBA/J (H-2k) 
and CBA.M523 (H-2ka) mice were kindly provided by the Basel Insti-
tute for Immunology, Basel, Switzerland. Female A (H-2a), A.TL 
(H-2tl), B!O.T (6R) (H-2Y2) and A.TH (H-2t2) mice were commercial-
ly obtained from OLAC Ltd., Bicester, U.K. Female Swiss (H-2s) 
and BlO.scsn (H-2b} mice were commercially obtained from TNO, Zeist, 
the Netherlands. Female AKR/FuRdA (H-2k) mice were bred in our 
department. The age of the responder mice ranged between 12 and 
20 weeks. 
Preparation of cell suspensions 
Spleens or lymph nodes were removed, placed in a balanced salt 
solution (BSS) and squeezed through a nylon gauze filter to pro-
vide a single cell suspension. Nucleated cells were counted with a 
coulter Counter Model B. Viable nucleated cells were counted in 
a haemocytometer using 0.2% trypan blue in BSS as a diluent. 
Antigen and immunization 
Primary and secondary immunization was performed with the appro-
priate allogeneic spleen cells, suspended in a volume of 0.1 ml. 
The priming and booster dose was always 1 x 107 spleen cells. 
A total volume of 50 Vl of this spleen cell suspension was in-
jected s.c. by means of a 28-gauge needle in each of both inguineal 
areas. 
Assay for delayed type hypersensitivity 
DTH-reactions were determined by measuring the difference in 6 
thickness of the hind feet 24 hr after s.c. injection of 8 x 10 
spleen cells into the instep of the right hind leg. The challenge 
dose was administered s.c. in a volume of 20 Vl by means of a 
28-gauge needle. The thickness of the left and right hind feet 
was measured with a footpad meter as described by Bonta and De 
Vos (1965), with some minor modifications. During measurement the 
mice were anaesthetized with ether. 
A control group, consisting of non-immune mice challenged with the 
same spleen cells as the mice to be tested, was always included. 
The specific increase in foot thickness was calculated as the 
relative increase in foot thickness of the immune mice minus the 
relative increase in foot thickness of the control mice. The 
swelling in control mice ranged between 15 and 25%. 
1~ 
Assay for immune lymphocyte transfer reactivity 
The ILT-reactivity in lymph node cells from immunized donors, 
directed against H-antigens of a particular host was determined 
by s.c. injection of 5 x 106 of these lymph node cells into the 
right hind foot of the host to be tested. The hosts received a 
s.c. injection into the left hind foot of 5 x 106 lymph node cells 
from nOn-immune mice, syngeneic with the immunized donor mice. 
This latter injection may result in a normal lymphocyte transfer 
(NLT) reaction. For ILT and NLT the cells were injected in a 
volume of 40 ~l with a 28 gauge needle. Preliminary results in-
dicated that injection of 5 x 106 lymph node cells resulted in a 
maximal ILT-reactivity to minor H-antigens at 24 hr after transfer. 
A control group consisting of recipient mice syngeneic to the 
immunizing donor mice, was always included. These mice were simi-
larly injected with immune and nonimmune lymph node cells, into 
the right and left hind feet, respectively. 
The thickness of both injected feet was measured as in the DTH 
assay. The specific ILT-reactivity was calculated as: _2 (ILT-NLT) - (ILT-NLT) , and was expressed in 10 em. 
test control 
RESULTS 
H-2 restricted recognition of minor H-antigens during the expres-
sion of primary DTH-reactivity 
To investigate the genetic requirements for expression of DTH to 
minor H-antigens, groups of mice were immunized s.c. with 1 x 107 
allogeneic H-2 compatible spleen cells and challenged five days 
later. This challenge was performed with spleen cells derived from 
H-2 congenic mouse strains, which have a genetic background either 
fully (Table 1, Exp. I-III) or partly (Table 1, Exp. IV and V) 
identical to that of the immunizing spleen cells. Subsequently, 
the 24 hr DTH-reactions were measured. It appeared that rather 
strong DTH-reactions could be evoked by spleen cells exhibiting 
either the same K-region (Table 1, Exp. 1b) or the same D-region 
(Table 1, Exp. IIb) coded antigens, though fully H-2 compatible 
spleen cells elicited still higher responses (Table 1, Exp. I 
and IIa). On the other hand, comparatively weak, though significant, 
DTH-reactions were evoked by fully H-2 incompatible spleen cells 
(Table 1, Exp. I-IVc). I-region compatibility with the recipient 
alone was not sufficient for elicitation of stronger DTH-reactions 
than were evoked by fully H-2 incompatible spleen cells (Table 
1, Exp. III-Vb,Vd). The existence of I-region restriction was not 
excluded by these experiments, because of the comparatively low 
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TABLE 1 
H-2 RESTRICTION OF PRIMARY DTH REACTIVITY TO NON H-2 ALLOANTIGENS 
Exp. 
a 
I b 
c 
a 
II b 
c 
a 
III b 
c 
c 
a 
Recipient 
Swiss 
Swiss 
Swiss 
DBA/2 
DBA/2 
DBA/2 
C3Hf 
C3Hf 
C3Hf 
C3Hf 
C3Hf 
C3Hf 
A 
A 
c BlO.A 
d BlO.A 
1 Donor 
A.SW 
A.SW 
A. SW 
B10.D2 
B10.D2 
B10.D2 
BlO.Br 
BlO.Br 
BlO.Br 
AKR 
AKR 
AKR 
BlO.A 
BlO.A 
A 
A 
Challenge 
A.SW 
A.TL 
A 
B10.D2 
2 
Response 
51 + 4 
42 + 3 
21 + 2 
63 + 3 
B10.T(6R) 32 + 1 
BlO.ScSn 
BlO.A 
B10.AQR 
BlO.ScSn 
A 
A.TL 
A.TH 
CBA/J 
CBA.M523 
CBA/J 
CBA.M523 
10 + 1 
22 + 2 
10 + 2 
9 + 2 
23 + 1 
11 + 2 
7 + 3 
18 + 2 
4 + 2 
40 + 3 
26 + 3 
Shared region 
of the 
H-2 complex 
K, I I s I D 
K 
K I, S, D 
D 
K, IA-E 
I, S 
K, IA-E 
I A-E 
K, IA-E 
I A-E 
1. Recipient mice were immunized S.c. with 1 x 10 7 viable spleen 
cells derived from H-2 compatible donor mice. 
2. Five days after s.c. immunization the mice were challenged. 
At 24 hr after challenge the specific increase of foot thick-
ness was determined. Figures represent the mean response ~ 
1 SEM (n=S}. 
3. In these experiments the challenge was performed with spleen 
cells from congenic mice with a genetic background different 
from that of the immunizing spleen cells. 
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DTH reactions in the essential mouse strain combinations. It is 
concluded that the expression of the DTH-reactivity to multiple 
minor H-antigens is strongly restricted by the K- and D-region of 
the H-2 complex. For the K-region, this view is strengthened by 
experiments performed with the mouse strain CBA.M523, which bears 
a mutation in the H-2K locus (Blandova et al., 1975). Spleen cells 
derived from this mutant strain, elicited lower DTH responses 
than spleen cells obtained from the non-mutant CBA/J strain (Table 
1, Exp. Vb and Vd). 
The influence of H-2 restriction on the effector function of DTH-
reactive cells directed against minor H-antigens was also investigate( 
with the ILT-assay. swiss, C3Hf and BALB/c mice were immunized s.c. 
with 1 x 107 allogeneic H-2 compatible spleen cells derived from 
A.SW, B10.Br and nBA/2 mice, respectively. Five days later, 5 x 106 
cells, obtained from the draining inguinal lymph nodes of the 
immunized mice, were assayed for ILT-reactivity to minor H-antigens 
of recipient mice, which were either identical with, or congenic to 
the immunizing mouse strain (Table 2, Exp. I and II). In a similar 
set-up, H-2 congenic mouse strains of a different background than 
the original immunizing strain were used as recipients (Table 2, 
Exp. III). The responses at 24 hr after transfer clearly indicated 
that ILT-reactivity to minor H-antigens was mainly dependent on the 
compatibility of the K-region (Table 2, Exp. Ic) and D-region 
(Table 2, Exp. IIIb) coded antigens of the donor of reactive T lym-
phocytes and the recipient's H-2 antigens. In these experiments, 
no significant ILT-reactivity was found, when the immunized donor 
strain and the recipient strain were either fully H-2 incompatible 
(Table 2, Exp. Id, IIc and IIIb), or only showed similarity in parts 
of the I-region (Table 2, Exp. IIb). 
Immunization for primary and secondary DTH-responsiveness to minor 
H-antigens by s.c. injections of H-2 incompatible spleen cells. 
To compare the priming capacity of H-2 compatible and H-2 incom-
patible spleen cells, groups of C3Hf mice were immunized s.c. 
with either 1 x 107 H-2 compatible B10.Br derived spleen cells, 
or with 1 x 107 H-2 incompatible B10.ScSn derived spleen cells. 
The latter two mouse strains share most minor H-antigens. on 
day 5 after immunization the primary nTH-reactivity to minor 
H-antigens was tested by a challenge injection of B10.A derived 
spleen cells. Since a part of the H-2 complex (a.o. the K-region) 
in this latter strain is identical to that in the responding C3Hf 
mouse strain, a nTH-response to the minor H-antigens was evoked 
(Table 1, Exp. III). Both B10.Br and B10.ScSn derived spleen cells 
were able to induce primary nTH-reactivity, but the H-2 incom-
patible B10.ScSn derived cells did so to a lesser extent (Table 
3, Exp. I). Similarly, s.c. immunization of BALB/c mice with 
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TABLE 2 
H-2 RESTRICTED ILT-REACTIVITY TO NON H-2 ALLOANTIGENS 
Exp. Immunizing 
1 Immunized Recipient 2 Shared region of Response 
strain donor strain strain (ILT-NLT) the H-2 complex 
a A.SW Swiss A.SW 32.5 + 13.8 K, I, S, D 
b A.SW Swiss A.TH 14.5 + 7.6 K, I, S 
A.SW Swiss A.TL 17.5 + 8.5 K I c 
d A.SW Swiss A -1.3 + 6.5 
-
-
B10.Br C3Hf B10.A 26.2 + 8.9 K, I A-E 
B10.Br C3Hf B10.AQR 0.7 + 6.3 I 
B10.Br C3Hf B10. T (6R) -0.6 + 6.3 A-E 
a 
II b 
c 
--
DBA/2 BALB/c B10.T(6R) 30 + 5.8 D 
DBA/2 BALB/c B10.ScSn 3 + 7. 1 
III 3 a 
b 
7 1. The indicated mice were s.c. immunized with 1 x 10 H-2 compatible allogeneic spleen cells. 
Five days later the draining lymph nodes from these mice were taken out, and cell suspens-
ions were made. These cells _were s. c. transferred into the indicated recipient mice. 
2. At 24 hr after s.c. transfer of 5 x 106 lymph node cells from the immunized donor strain 
into the right hind foot of the recipient mice the foot thickness was determined. The res-
ponse was measured as indicated in the Materials and Methods section. The figures represent 
the mean response at 24 hr after transfer: (ILT-NLT) ~ 1 SD (n=4), in 1o-2cm. 
3. In this experiment the congenic recipient strains and the immunizing strain did not have 
an identical genetic background, but they share a large number of minor H-antigens. 
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TABLE 3 
INDUCTION OF PRIMARY DTH-REACTIVITY TO NON H-2 ALLOANTIGENS WITH H-2 COMPATIBLE AND H-2 INCOM-
PATIBLE ALLOGENEIC SPLEEN CELLS 
. . t1 
Donor of the 
Rec1p1en immunizing Exp. 
spleen cells 
--
C3Hf B10.Br 
I C3Hf B10.scsn 
BALB/c B10.D2 
II BALB/c B10.scsn 
BALB/c BALB.B+B10.D2 
Shared region 
of the 
H-2 complex 
K, I I s, D 
K, It S, D 
K,I,S,D 
Challenge 
B10.A 
B10.A 
B10.A 
B10.A 
B10.A 
2 Response 
26 + 4 
-
14 + 1 
-
32 + 3 
-
11 + 3 
-
27 + 2 
1. Recipients were s.c. immunized with the indicated allogeneic H-2 compatible or H-2 incompa-
tible spleen cells. The DTH reactions were elicited with B10.A (H-2a) derived spleen cells. 
The B10.A strain shares the K, IA' IB, IJ and IE region of the H-2 complex with C3Hf (H-2k) 
mice, and the Ic and D region of the H-2 complex with BALB/c (H-2d) mice. 
2. Five days after s.c. immunization the mice were challenged. At 24 hr after challenge the 
specific increase of foot thickness was determined. Figures represent the mean responses 
+ 1 SEM (n~S). 
1 x 107 H-2 incompatible B10.ScSn derived spleen cells led to a 
less intense primary DTH-reactivity to BlO.A spleen cells than 
was observed after s.c. immunization with H-2 compatible B10.D2 
derived spleen cells (Table 3, Exp. II). Suppression of the DTH-
reactivity to minor H-antigens by the accompanying immune response 
to H-2 coded antigens was excluded by simultaneous s.c. injection 
of BALB/c mice with both 1 x 107 H-2 compatible B10.D2 derived 
spleen cells and 1 x 10 7 H-2 incompatible BALB.B spleen cells at 
separate sites in both inguinal areas. The injection of BALB.B 
and B10.D2 spleen cells was carried out at separate sites to 
prevent the occurrence of a mixed lymphocyte reaction between the 
injected B10.D2 and BALB.B spleen cells. The accompanying anti-
BALB.B reaction caused only a slight 1 non-significant reduction 
in primary DTH-reactivity to the minor H-antigens (Table 3, Exp. II). 
The capacity for induction of secondary DTH-responsiveness to minor 
H-antigens by s.c. injection of H-2 incompatible cells was inves-
tigated in C3Hf. mice. These mice were primed with B10 minor H-
antigens by injection of either 1 x 107 H-2 compatible B10.Br 
spleen cells or 1 x 107 H-2 incompatible B10.ScSn spleen cells. 
Six weeks later all mice were boosted s.c. with 1 x 107 B10.Br 
spleen cells. On day 3 after booster the mice were challenged with 
B10.A spleen cells. This latter interval was chosen, since in a 
previous paper it was demonstrated that the DTH-reaction elicited 
on the third day after booster is a good parameter for the level 
of secondary DTH-responsiveness to multiple minor H-antigens (Van 
der Kwast et al., in press). As a negative control for secondary 
DTH-responsiveness, one group of C3Hf mice was included which was 
challenged with B10.A spleen cells on day 3 after a single injec-
tion of 1 x 107 B10.Br spleen cells. The results show that the 
H-2 incompatible B10.ScSn spleen cells can indeed induce secondary 
DTH-responsiveness to minor H-antigens, but to a lesser extent 
than the H-2 compatible B10.Br spleen cells (Table 4), in spite of 
the common B10 background. 
Booster of minor H-antigen primed m~ce by s.c. injection of 
H-2 incompatible spleen cells 
The role of the H-2 haplotype of the cells used for booster in-
jection in secondary DTH to minor H-antigens was studied at first 
in BALB.B mice, which had been primed 4 months previously with 
1 x 107 H-2 compatible viable B10.ScSn spleen cells. The primed 
BALB.B mice were boosted either with 1 x 107 H-2 compatible 
B10.ScSn spleen cells or with 1 x 107 H-2 incompatible B10.Br 
spleen cells. Significant secondary DTH-reactivity was observed 
both after booster injection with H-2 compatible B10.scsn spleen 
cells (Table 5, Exp. Ia) and with H-2 incompatible B10.Br spleen 
cells (Table 5, Exp. Ib). However, the B10.ScSn derived spleen 
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TABLE 4 
PRIMING FOR SECONDARY DTH RESPONSIVENESS BY ALLOGENEIC H-2 COMPATIBLE AND H-2 INCOMPATIBLE 
SPLEEN CELLS 
Donor of the 1 Shared region 2 
Recipient priming of the Booster Challenge Response 
cells H-2 complex 
C3Hf B10.Br K, I, S, D B10.Br B10.A 38 + 2 
-
C3Hf B10.ScSn - B10.Br B10.A 20 + 3 
-
C3Hf - - B10.Br B10.A 4 + 1 
1. C3Hf (H-2k) mice were s.c. immunized for DTH-related memory cells with B10.Br (H-2k) or 
B10.Scsn (H-2b) derived spleen cells, and boosted 3 months later. 
2. Three days after s.c. immunization or booster the mice were challenged. At 24 hr after chal-
lenge the specific increase of. foot thickness was determined. Figures represent the mean 
responses+ 1 SEM (n~S). 
g) 
TABLE 5 
--
BOOSTING OF MINOR H-ANTIGEN-P~IMED MICE WITH H-2 COMPATIBLE SPLEEN CELLS 
1 Donor of Donor of Shared region Challenge 2 Exp. Responder the priming the boosting of the (day of Response 
spleen cells spleen cells H-2 complex challenge) 
a BALB.B B10.ScSn B10.ScSn K, I' S, D B10.ScSn( 3) 26 + 2 
b BALB.B B10.scsn B10.Br - B10.ScSn( 3) 19 + 1 
~ 
I BALB.B B10.ScSn B10.ScSn( 3) -1 + 2 c -
d BALB.B B10.ScSn - B10.ScSn(90) 12 + 2 
a C3Hf AKR B10.Br K, I, S, D B10.A ( 3) 30 + 2 
b C3Hf AKR B10.ScSn - B10.A ( 3) 38 + 2 
II C3Hf B10.Br B10.A ( 3) -2 + 1 c -
d C3Hf AKR - B10.A(120) 13 + 4 
18 Mice were primed by 10 7 allogeneic H-2 compatible spleen cells, boosted 3 months later with 
1 x 107 allogeneic H-2 compatible or H-2 incompatible spleen cells and challenged 3 days 
after the booster injection. 
2. Figures represent the mean response as measured 24 hr after challenge. + 1 SEM (n=S). 
cells induced a somewhat stronger secondary DTH-reactivity than 
did the BlO.Br derived spleen cells. 
In a similar set up, C3Hf mice which had been primed 4 months 
previously with 1 x 107 viable H-2 compatible AKR spleen cells, 
were boosted with either H-2 compatible B10.Br spleen cells or 
H-2 incompatible B10.ScSn spleen cells. Again, significant secon-
dary DTH-reactivity was induced by both the H-2 compatible and 
H-2 incompatible spleen cells (Table 5, Exp. IIa and b). 
DISCUSSION 
The experimental data reported in this paper demonstrate that the 
expression of primary DTH-reactivity to minor H-antigens is res-
tricted by H-2 coded products on the cells used for challenge. 
For primary DTH-reactivity this H-2 restricted recognition seemed 
only partial (Table 1), but in the less sensitive ILT-assay the 
H-2 restricted effector function was rather absolute (Table 2). 
The capacity of allogeneic H-2 incompatible spleen cells to 
elicit a DTH-reaction in mice, immunized with non H-2 alloantigens, 
might be explained by the assumption that host-derived macrophages 
phagocytized some of the H-2 incompatible cells. Thereby, these 
macrophages can present the minor H-antigens of the donor cells, 
together with the MHC-coded antigens of the host, to the activated 
T cells. This latter view might be supported by the complete H-2 
restriction found in the ILT-assay i.e. the inoculum of immune 
lymph node cells contains relatively few macrophages, and phago-
cytosis of the surrounding tissue cells would thus not occur. 
On the other hand, it is possible that the observed incomplete 
H-2 restriction in primary DTH to minor H-antigens is inherent 
in primary cell-mediated immunity to minor H-antigens. Experi-
ments on CML to minor H-antigens suggest this possibility. Thus, 
spleen cells from normal mice are not capable of inducing primary 
in-vitro CML to minor H-antigens 1 but spleen cells derived from 
unprimed, autoimmune disease susceptible, New Zealand Black (NZB) 
mice are able to kill H-2 compatible cells 1 bearing non H-2 allo-
antigens1 after primary in-vitro sensitization (Botzenhardt et 
al. 1 1978). It was found that these NZB-derived cytotoxic T 
cells, generated in vitro after stimulation with allogeneic H-2 
compatible spleen cells cross-react to a considerable extent with 
H-2 incompatible target cells. In CML to minor H-antigens, induced 
by in-vivo priming of normal mice and in-vitro restimulation with 
the same antigens 1 it was shown that about 1% of the induced 
effector T cells could kill H-2 incompatible target cells (Bevan, 
1977). The possibility thus exists that in primary DTH to minor 
1ffi 
H-antigens, a number of the generated effector T cells is able 
to react to H-2 incompatible cells. 
The H-2 restriction of T helper function in the humoral response 
to proteins is encoded in the I-region of the H-2 complex (Katz 
& Benacerraf, 1975), as well as DTH to thymus-dependent antigens 
(Vadas et al., 1977; Miller et al., 1977). In-vitro cytotoxicity 
both to cells bearing multiple minor H-antigens and to virus-
infected target cells is restricted by K- and D-region coded 
antigens of the MHC (Bevan, 1975; Doherty et al., 1976). Simi-
larly, the K- and D-region of the H-2 complex imposes restriction 
on DTH to virally infected target cells (Zinkernagel, 1976) and 
to cells bearing minor H-antigens {Table 1 and 2) . On the basis of 
these findings it may be postulated that DTH may be mediated by 
T cells, belonging either to the cytotoxic T cell line (Lyt-1-2+3+) 
or to the T helper cell line (Lyt-1+2-3-), depending on the anti-
gen to which the DTH-reactivity was induced. 
Allogeneic H-2 incompatible cells, bearing non H-2 alloantigens, 
could induce both primary DTH-reactivity and DTH-related memory 
for these non H-2 allo-antigens. These findings are in harmony 
with the earlier in-vivo experiments on second set graft rejection 
by Snell (1957), and Gasser & Silvers (1972), who showed that 
allogeneic H-2 incompatible skin grafts could accelerate rejection 
of H-2 compatible grafts, presenting identical minor H-antigens 
to those of the first (set) graft. More recently, it was also 
demonstrated that H-2 incompatible male derived cells can presen-
sitize female mice in vivo for CML to the male specific B-Y-antigen 
(Gordon et al., 1976). The capacity of H-2 incompatible spleen cells 
to prime for primary DTH and DTH-related memory and to boost for 
secondary DTH-reactivity may be due to processing of the allogeneic 
H-2 incompatible cells by host-derived macrophages. The present 
results show that priming with H-2 incompatible spleen cells is 
less effective for induction of primary DTH reactivity and DTH-
related memory to minor H-antigens, than priming with allogeneic 
H-2 compatible spleen cells (Table 3). This difference in immuno-
genicity of H-2 compatible and H-2 incompatible spleen cells is 
probably not due to an immune response to the H-2 alloantigens. 
This can be deduced from the finding that simultaneous immunizat-
ion with allogeneic H-2 compatible spleen cells and allogeneic 
H-2 incompatible, non H-2 compatible spleen cells hardly affected 
the response to the non H-2 alloantigens (Table 3). 
It can be concluded that the expression of DTH reactivity to mul-
tiple minor H-antigens is certainly restricted by K- and D-region 
coded antigens, but a role of I-region coded antigens in the 
restriction of DTH could not be excluded. The immunogenicity 
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of minor H-antigens presented to unprimed animals was decreased 
when the immunizing cells were H-2 incompatible with the respon-
der strain. This finding may point to a preferential recognition 
of minor H-antigens on H-2 compatible cells by the unprimed T 
cells. The residual capacity of H-2 incompatible spleen cells to 
induce primary DTH-reactivity and DTH-related memory and the 
booster capacity of H-2 incompatible spleen cells cannot be 
interpreted further in terms of H-2 restriction on the basis of 
the experiments reported in this paper. 
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